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Abstract 
 
Background 
Routine induction of anaesthesia and maintenance haemodialysis are two examples 
of clinical procedures that exert a direct effect on the cardiovascular system. The 
exact incidence of haemodynamic instability during such procedures is not well 
described, as it would have required invasive intra-arterial monitoring, which is not 
justified for routine use. 
As part of two service evaluations, i.e. routine induction of anaesthesia and 
maintenance haemodialysis, we utilised a noninvasive continuous beat-by-beat 
haemodynamic monitor, which works using a finger cuff (Finometer), to assess the 
incidence of haemodynamic instability encountered during these procedures in 
comparison to the conventionally used intermittent noninvasive blood pressure 
(NIBP) measurement protocols.   
Methods 
Using the Finometer, we recorded haemodynamic variables during induction of 
anaesthesia in 100 patients undergoing elective surgery, and during maintenance 
haemodialysis in 25 patients with established renal failure.  
Firstly, we assessed the feasibility of using the Finometer during induction of 
anaesthesia and haemodialysis by evaluating its success rate in providing 
measurements of haemodynamic variables, and by assessing its accuracy in 
comparison to the readings obtained by the conventional NIBP devices during our 
service evaluations.  
Secondly, we assessed the incidence of haemodynamic instability during both 
procedures as detected by the Finometer in comparison to the existing conventional 
intermittent NIBP measurement protocols. 
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Results and discussion 
The Finometer was successful in providing adequate haemodynamic monitoring in 
96% and 86% of the attempts to use it in our service evaluations during induction of 
anaesthesia and haemodialysis respectively. 
The Finometer showed comparable accuracy in terms of BP monitoring to the 
conventional NIBP monitors during induction of anaesthesia and haemodialysis.  
A high incidence of significant hypotension as well as significant hypertension was 
shown during both, routine induction of anaesthesia and maintenance 
haemodialysis, which were underestimated or even missed by the conventionally 
used intermittent NIBP monitoring protocols. During induction of anaesthesia, 19% 
of the patients sustained an episode of hypotension defined as SBP less than 80 
mmHg for more than 1 min, and 53% showed a transient increase of the SBP of 
more than 20% from baseline values. During Haemodialysis, 28% of the patients 
sustained an episode of hypotension defined as SBP less than 90 mmHg for more 
than 10 min, and 16% sustained an episode of severe hypertension defined as SBP 
more than 180 mmHg for more than 10 min.    
 
Conclusion 
Haemodynamic instability is commonly encountered during routine induction of 
anaesthesia and maintenance haemodialysis. Continuous noninvasive finger arterial 
haemodynamic monitoring is more reliable than the conventionally used protocols of 
intermittent NIBP monitoring in detecting such haemodynamic instability, thus, 
providing higher levels of patient safety. Extra and early information about 
haemodynamic variables, as provided by the Finometer, may provide a better insight 
on the exact cause of haemodynamic instability, which may aid the physicians in 
prompt and targeted management.
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1  Overview 
 
Episodes of transient hypotension are common during clinical procedures such as 
induction of anaesthesia or in patients undergoing haemodialysis.1-3 Recent evidence 
suggests that hypotension even for one minute is associated with an increased 1 
year mortality risk after non-cardiac surgery.4, 5 Also an increased 2 year risk of 
mortality has been shown when hypotension is encountered during haemodialysis.6 
The exact incidence and severity of episodes of transient hypotension during 
anaesthesia or during haemodialysis are not well known, as this would require 
continuous blood pressure monitoring, which in the current medical practice involves 
invasive intra-arterial monitoring, a procedure reserved for the more critical 
patients.7 During induction of anaesthesia and haemodialysis, it is common practice 
to monitor BP on intermittent basis via the conventional intermittent non-invasive 
blood pressure monitors (NIBP), which apply the oscillometric method. NIBP 
monitors are usually set at 2-3 min and up to 30 minutes intervals during induction 
of anaesthesia and haemodialysis respectively.   
We aimed to evaluate the anaesthetic service at the time of induction of 
anaesthesia, and the service of haemodialysis in routine clinical settings, by 
assessing the extent and severity of maximum haemodynamic changes that occur, 
the existing level of monitoring of these changes, and their possible impact on 
patient safety.  
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We used the Finometer for continuous monitoring of the haemodynamics during the 
two service evaluations. The Finometer is a non-invasive beat-by-beat continuous 
haemodynamic monitor that uses a finger cuff. It has been shown to be accurate in 
terms of blood pressure monitoring8 and reliable in following the trends of change in 
cardiac output.9 It is widely used in cardiovascular research 10, but its role in clinical 
practice, in particular during anaesthesia or during haemodialysis, is not yet 
established.  We assessed the potential of continuous haemodynamic monitoring, as 
provided by the Finometer, in improving patient safety during these procedures. 
From the data collected during these evaluations we have addressed the following:  
o Feasibility of using the Finometer during induction of anaesthesia and 
haemodialysis by assessing its success rate in providing adequate blood 
pressure recordings, and by comparing the blood pressure measurements 
obtained by the Finometer against those obtained by the conventional non-
invasive blood pressure (NIBP) monitors used in operating theatres and 
haemodialysis units. 
o Evaluation of the haemodynamic changes that occur during induction of 
anaesthesia and haemodialysis in terms of magnitude and time. 
o Comparison of the Finometer and the conventional NIBP monitors in detecting 
episodes of maximum changes in blood pressure, and assessment of the 
potential of continuous haemodynamic monitoring in improving patient safety 
during induction of anaesthesia and haemodialysis. 
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2 Background 
 
2.1  Haemodynamic effects of induction of anaesthesia 
2.1.1 Introduction 
General anaesthesia is a state of unconsciousness, amnesia and analgesia initially 
achieved by the process of induction of anaesthesia, which involves procedures that 
directly affect the cardiovascular system. These procedures include administration of 
anaesthetic drugs and management of the airways. Individual effects of these 
procedures on the cardiovascular system are well known, 11-15 but there is paucity of 
data describing the overall combined effect in a setting of routine induction of 
anaesthesia. 
2.1.2 Cardiovascular effect of drugs commonly used 
during anaesthesia   
Most anaesthetic drugs are known to cause myocardial depression and / or 
vasodilatation, thus, resulting in decrease in BP. During routine anaesthesia settings, 
h\SRWHQVLRQLVXVXDOO\WUHDWHGDFFRUGLQJWRWKHDQDHVWKHWLVW¶VFOLQLFDOMXGJPHQWRI
the situation, by administering intravenous fluids and/or vasopressor drugs such as 
ephedrine and metaraminol.  
2.1.2.1 Inhalational anaesthetics  
Inhalational anaesthetics are gaseous and volatile agents used mainly for 
maintenance of anaesthesia, but can also be used for induction of anaesthesia. 
Nitrous oxide (N2O) is a myocardial depressant, but normally this effect is overcome 
by the stimulation of the sympathoadrenal response16 In left ventricular failure, 
which is associated with high sympathoadrenal activity, hypotension, decreased 
cardiac output and dose dependent decreased coronary flow may occur in response 
to N2O. Therefore its use in patients with cardiac disease is not recommended.
17 
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Halothane causes vasodilatation, myocardial depression, a decreased cardiac output 
and dose dependent hypotension.13, 18  
Isoflurane causes hypotension, which is mainly due to vasodilatation in muscles and 
skin.19 
Sevoflurane affects the cardiovascular system in a similar way to Isoflurane.20 
In a study by Hanouz and colleagues (1998) the effect of halothane, isoflurane and 
sevoflurane in equal doses on isolated rat myocardial contractility was evaluated. 
The three agents produced a dose dependent decrease in myocardial contractility 
expressed as a percentage decrease of control values of the maximum isometric 
active force normalised per cross sectional area (AF), the maximum effect on 
contractility was observed at 2.5 mean alveolar concentration (MAC). Further 
comparison of the three agents in terms of the maximum decrease in AF which is 
expressed as a percentage of the control values at 2.5 MAC, showed 15%, 64% and 
67% of the control value for halothane, isoflurane and sevoflurane respectively. In 
summary, Halothane exerted a significantly more potent negative inotropic effect 
than isoflurane or sevoflurane which exerted similar effects on the inotropicity.21 
2.1.2.2 Intravenous anaesthetics  
Intravenous anaesthetics are mainly used for induction of anaesthesia. They can also 
be used for maintenance of anaesthesia and sedation. 
Sodium Thiopental causes dose dependent hypotension by decreasing the systemic 
vascular resistance22 and the cardiac output.  
Propofol decreases blood pressure in a similar way to thiopental but the effect is 
more profound as compared in equipotent doses.23  
In a study by Rouby and colleagues, comparing the peripheral vascular effects of 
propofol and thiopental, 5 minutes after injection, showed that the mean arterial 
pressure decreased by 39% and 21% respectively (p<0.01). The systemic vascular 
resistance index decreased by 44% and 21% respectively (p<0.05) showing better 
haemodynamic stability with Thiopental.24 
Midazolam causes a dose dependent decrease in blood pressure and vasodilatation.25 
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2.1.2.3 Opioids 
Morphine causes arteriolar and venodilatation through depression of the vasomotor 
centre and also through histamine release. Blood pressure decreases especially when 
the patient is hypovolaemic or receiving other vasodilator medications. A decrease in 
heart rate may also occur due to vagal stimulation.11 
Fentanyl may cause mild hypotension and bradycardia due to vagal stimulation.26 
Alfentanil is a potent short acting opioid with minimal cardiovascular effects, it is 
safely used in cardiac surgery.27  
Remifentanil is similar to Alfentanil in regards to the cardiovascular effects, but with 
faster resolution of effects on discontinuing the drug.28  
In a single blinded randomised controlled study, Twersky and colleagues compared 
the haemodynamic effects of Remifentanil and Fentanyl on 2438 patients. Subjects 
were randomised to receive either intravenous Remifentanil at a dose of 0.5 µg / kg 
/ min for induction of anaesthesia and a dose of 0.25 µg / kg / min for maintenance 
of anaesthesia, titrations of the dose during the operation were carried out according 
WRWKHDQDHVWKHWLVW¶Vjudgment, or to receive intravenous fentanyl at a dose and 
titration that were adjusted also according tRWKHDQDHVWKHWLVW¶Vjudgement.  
Their results showed that systolic and diastolic pressures were 10-15 mmHg lower in 
the remifentanil group, heart rate was also 10-15 beats/m lower in the remifentanil 
group.29 
2.1.2.4 Muscle relaxants  
Muscle relaxants are not known to cause major haemodynamic effects. However, 
Stevens and colleagues in 1997, reported that rocuronium in contrast to 
vancuronium blocks the hypotensive effect of balanced induction of anaesthesia.12 
 
2.1.3 Cardiovascular effects of airway management 
during induction of anaesthesia 
Laryngoscopy and endotracheal intubation cause a transient reflex sympathetic 
stimulation, with an associated increase in the plasma catecholamine levels, 
subsequently increasing the blood pressure and heart rate; this might exert adverse 
effects especially on patients with coronary artery disease and cerebrovascular 
insufficiency.30 Certain drugs used during induction of anaesthesia such as lidocaine, 
fentanyl, and alfentanil, are known to block this sympathetic response.31 
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2.2  Haemodynamic response to haemodialysis 
2.2.1 Introduction 
Haemodialysis is the most commonly employed method of renal replacement 
therapy in patients with end stage kidney disease (ESKD). It became a standard 
treatment for ESKD in the 1960s 32, and since then major advancements in the 
technique have been accomplished, which helped improve the quality of the service 
and patient outcomes. 33 Nevertheless, haemodialysis continues to be associated 
with complications. Efforts are continuously being undertaken by health care 
providers to further improve the quality of the service of haemodialysis. 
Haemodialysis involveVZLWKGUDZDORIEORRGIURPWKHSDWLHQW¶VFLUFXODWLRQDQGits 
passage across an extracorporeal circuit, where it gets in contact with a 
semipermeable membrane. A dialysis solution (dialysate) composed of a sterilised 
mixture of water and electrolytes, with sodium chloride concentrations similar to 
those of normal plasma, is present on the other side of the semipermeable 
membrane. The dialysate flows in the opposite direction to the blood causing 
diffusion of waste products from the blood into the dialysate across the 
concentration gradient created in the semipermeable membrane. Removal of extra 
IOXLGVIURPWKHSDWLHQW¶VFLUFXODWLRQXOWUDILOWUDWLRQLVFDUULHGRXWE\GHFUHDVLQJWKH
pressure on the dialysate side of the machine, causing a pressure gradient across 
the semipermeable membrane allowing water to pass from the blood to the 
dialysate. )LQDOO\WKHFOHDQVHGEORRGLVUHWXUQHGEDFNWRWKHSDWLHQW¶VFLUFXODWLRQ34 
Maintenance haemodialysis is usually prescribed as 3-4 hours sessions, 3 times per 
week.  
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Vascular access to haemodialysis is gained by an intravenous catheter, an arterio-
venous fistula (AVF) or a synthetic graft.35 Bicarbonate and acetate are the two 
types of dialysate solutions available for haemodialysis. Better haemodynamic 
stability is provided by the bicarbonate dialysate in comparison to the acetate 
dialysate, as the latter causes a more extensive vasodilatory effect. 36 
During haemodialysis, a large volume of ultrafiltrate is removed from the circulation 
in a relatively short period of time (3 ± 4 hours), which may cause hypotension if the 
normal compensatory cardiovascular responses to hypovolaemia are not intact.37  
  
 
2.2.2 Normal Cardiovascular responses to 
hypovolaemia 
Physiological compensatory mechanisms in response to hypovolaemia include; 
increased venous tone; increased heart rate with subsequent increase in cardiac 
output to overcome the decreased stroke volume; increased total peripheral 
resistance; redistribution of the blood to the more vital organs.38 Many dialysis 
patients have other associated co-morbid conditions that limit their compensatory 
response to haemodialysis induced hypovolaemia, thus increasing the incidence of 
developing hypotension during haemodialysis.39  Significant hypotension is the most 
common complication of haemodialysis, occurring in 25% to 50% of maintenance 
haemodialysis sessions.2, 3 
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2.2.3 Determinants of haemodynamic responses to 
haemodialysis 
 
Blood volume: During haemodialysis, large volumes of fluid are removed from the 
circulation in a relatively short period of time. Normal cardiovascular compensatory 
mechanisms are responsible for keeping the patient haemodynamically stable during 
haemodialysis.37 The net changes in blood volume are dependent upon the 
ultrafiltration rate (UFR) and the plasma refilling rate (PRR), which are two opposing 
forces.40 The PRR occurs at capillary level and is regulated by the UFR and the 
dialysate sodium concentration through their effects on the oncotic and hydrostatic 
pressures.41 Moreover, the plasma protein concentration, the haematocrit42 and the 
interstitial volume cause an increase in the PRR.37   
Venous tone: Dialysis patients commonly suffer from associated co-morbid 
conditions that may affect the integrity of their baroreflexes, thus reducing their 
venous capacity in response to hypovolaemia. 38 Also the use of a dialysate with low 
sodium content may cause a reduction in the venous tone.43  
 
Peripheral vascular resistance: Vascular resistance is an important factor in 
maintaining blood pressure stability during dialysis induced hypovolaemia.44 
Factors that affect the integrity of peripheral vascular resistance are: 
x Antihypertensive vasodilator drugs e.g. angiotensin converting enzyme 
inhibitors (ACEi) and calcium channel blockers (CCB) obliterate the 
vasoconstrictor response to haemodialysis.  
x Low haematocrit levels, which cause a decrease in blood viscosity and a 
consequent decrease in the total peripheral resistance.45 
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Factors that affect the integrity of both, the venous tone and the peripheral vascular 
resistance are: 
x Ingestion of food during dialysis, by redirecting the blood flow to the 
splanchnic circulation, consequently causing a decrease in the preload and 
afterload.46   
x The use of an acetate dialysate causes venodilatation and arterio-dilatation.47 
x High temperatures cause cutaneous vasodilatation with a reduction in the 
total peripheral resistance and the venous tone.38, 48 
 
Cardiac response: Normal cardiac functions are mandatory for maintaining 
haemodynamic stability during haemodialysis. The cardiac response to hypovolaemia 
is brought by the activation of the sympathetic nervous system, initially causing an 
increase followed by a decrease in the heart rate, also the contractility increases. 
Those responses tend to be inadequate for optimising the cardiac output in response 
to the haemodialysis induced decreased stroke volume.49, 50 The most important 
factor in maintaining the cardiac output is optimal cardiac filling.51 Cardiac diseases 
associated with impaired left ventricular filling such as pulmonary hypertension, 
tricuspid regurgitation and left ventricular hypertrophy will eventually lead to 
hypotension in response to haemodialysis.40   
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2.3  Effect of haemodynamic changes on patient outcome   
During anaesthesia, as during haemodialysis, extreme values of blood pressure are 
known to increase the risk of morbidity and mortality. Moreover, Intraoperative 
hypotension (IOH) has been an area of major interest to researchers recently, for its 
impact on patient outcome.5, 52-55 
No definite figure has yet been adopted as a definition of IOH. However the most 
commonly used is a systolic blood pressure value of less than 80 mmHg, a mean 
blood pressure less than 55-60 mmHg or a more than 20-25% decrease from 
baseline values of systolic or mean blood pressure values.55 In a study by Bijker and 
colleagues in 2009, a comparison of 16 different definitions of IOH for prediction of 1 
year mortality after non-cardiac surgery was performed, results showed  a trend of 
an increased risk of 1 year mortality when there was a more than 1 minute duration 
of systolic blood pressure values lower than 80 mmHg, mean blood pressure lower 
than 60 mmHg or a more than 40-45% decrease from baseline values of both 
systolic and mean blood pressure in the elderly patients.4   
Monk and colleagues in 2005, studied the effect of IOH on 1 year mortality in non-
cardiac patients, results showed an increase in the relative 1 year mortality risk of 
3.6% for every minute where the systolic blood pressure was lower than 80 mmHg.5 
0RUHRYHU2¶5HLOO\DQGFROOHDJXHVVKRZHGWKDW6%3HTXDORUORZHUWKDQPP+JLV
an independent predictor of mortality. They also showed a linear relationship 
between mortality and SBP lower than 90 mmHg.56 
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During induction of anaesthesia, the depressive effects of the anaesthetic drugs, and 
the cardiovascular responses to airway management, which tends to increase 
sympathetic stimulation resulting in elevations in blood pressure and heart rate, are 
usually well tolerated. However, elderly patients, and/or those who are at higher 
risks of coronary artery disease and cerebrovascular disease are more prone to 
exaggerated cardiovascular responses with a resultant increase in the incidence of 
cerebrovascular strokes, myocardial infarctions and sudden deaths.57, 58 
Patients on maintenance haemodialysis are at more than 30 times higher risks of 
morbidity and mortality than healthy age matched individuals. That is mainly due to 
uraemic complications, hypertension59 and more importantly heart failure which 
affects 25-50% of patients undergoing maintenance haemodialysis. 60 
Atherosclerosis independent myocardial hypoperfusion is possibly the cause of 
myocardial stunning, which is a well known complication of maintenance 
haemodialysis.61 Recurrent episodes of myocardial stunning eventually lead to 
chronic heart failure.62 Myocardial stunning is known to be aggravated by 
intradialytic hypotension and it can be reverted by better haemodynamic stability 
during haemodialysis.63, 64 Shoji and colleagues confirmed that intradialytic 
hypotension is associated with an increased risk of 2 year mortality.6 
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2.4  Blood pressure monitoring 
2.4.1 Introduction 
Blood pressure is one of the most important routine measurements in health care, 
and because of its fluctuating nature, blood pressure monitoring is always needed 
for the purpose of diagnosis and treatment of hypertension.65 
Blood pressure variability is a well known character of the cardiovascular system. 
This can be observed on measuring blood pressure from different arterial sites and 
the reason for this is the different individual arterial properties.66 Furthermore blood 
pressure is constantly changing throughout the day67 and throughout each 
respiratory cycle.68 
This normal variability of blood pressure creates a grey zone that makes it hard for 
physicians to diagnose hypertension. Researchers are constantly introducing 
accurate methods for monitoring blood pressure, which are easily applicable, for 
diagnosis and management of hypertension.69 Furthermore, cardiovascular disease 
can be predicted by the extent of blood pressure variability.70 
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2.4.2 Methods of measuring blood pressure 
  Blood pressure can be either measured indirectly or directly by using the non-
invasive or the invasive techniques respectively:  
2.4.2.1 Indirect noninvasive method 
Ways to measure blood pressure non-invasively: 
x Riva-Rocci/Korotkoff, RRK (Auscultatory method) 
x Marey (Oscillometric method) 
x Peñáz/Wesseling (Finometer)  
 The auscultatory and oscillometric methods measure blood pressure intermittently 
at the exact instant of measuring; on the other hand the non-invasive cardiac output 
monitor (Finometer) provides continuous monitoring of the blood pressure and 
cardiac output, through implementing the Modelflow® Technology. The Modelflow® 
estimates the blood pressure and cardiac output through analysing the blood 
pressure waveform by the use of a nonlinear three-element model of aortic input 
impedance. The three elements are; the characteristic aortic impedance, the arterial 
compliance and the systemic vascular resistance.71, 72 
2.4.2.1.1 Riva-Rocci/Korotkoff (RRK) (Auscultatory method) 
This method was discovered by Riva-Rocci in 1896, the Korotkoff criteria                                      
followed in 1905. 
Applying pressure using an inflatable upper arm cuff that slightly exceeds the 
systolic blood pressure, will block the brachial artery, the cuff pressure is reflected 
on a manometer. A stethoscope is applied distal to the arm cuff and over the arterial 
site. The cuff then is gradually deflated, systolic blood pressure corresponds to the 
beginning of sounds (Phase I Korotkoff sounds) and diastolic pressure corresponds 
to either the muffling of sounds (Phase IV Korotkoff sounds) or to the sound 
disappearance (Phase V Korotkoff sounds). This issue remains unsettled.73, 74 
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2.4.2.1.2 Marey (Oscillometric method) 
In 1876 Marey discovered that by applying an inflatable arm cuff, arterial oscillations 
are detected. The point of maximal oscillations is a reflection of the mean blood 
pressure, and the points where oscillations begin and end are not exactly 
corresponding to systolic and diastolic blood pressure values, those values are 
obtained by approximation. Recent technical modifications to the oscillometric blood 
pressure measuring devices have increased their accuracy.75 This method is applied 
by the noninvasive blood pressure devices (NIBP) that are widely used in routine 
clinical settings. 
 
Figure 1. NIBP device 
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2.4.2.1.3 Peñáz / Wesseling (Finometer) 
The Finometer utilises the Peñáz volume-clamp method and the physiocal 
(physiological calibrating) criteria of Wesseling to obtain a continuous pulse 
waveform recording. 
 
Figure 2. Finometer screen showing a continuous pulse waveform 
 
The Volume-clamp method of Peñáz: The volume clamp method is based on the 
G\QDPLFXQORDGLQJRIWKHILQJHU¶VDUWHULDOZDOO,WVLGHDLVWRNHHSWKHGLDPHWHURIWKH
artery continuously constant. A finger inflatable cuff is used, to which an infrared 
photo-plethysmograph is attached that detects any changes in the arterial diameter. 
In response to any change in diameter, an electro pneumatic system will act by 
changing the cuff pressure in response to that change. Accordingly, when the arterial 
diameter increases following a rise in blood pressure the cuff will inflate and when 
the diameter decreases following a drop in blood pressure the cuff will deflate, thus 
keeping the arterial diameter always constant. The cuff pressure is a reflection of the 
intra-arterial pressure waveform and it¶VPHDVXUHGE\DQHOHFWURQLFJDXJH76  
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The Physiocal (physiological calibration) criteria of Wesseling: The physiocal criteria 
of Wesseling states that the intra-arterial pressure will be equal to the recorded 
finger cuff pressure only in the unloaded diameter of the finger artery, where the 
transmural pressure is zero. Therefore in order to obtain the accurate arterial blood 
pressure, the unloaded diameter of the finger artery must be obtained and used as 
the volume-clamp set point. Physiocal calibrations are made at regular intervals by 
temporary interruptions to the measuring procedure. The volume-clamp servo loop 
is opened and the pressure in the cuff is kept midway between the systolic and 
diastolic blood pressure readings of the previous pulsation. Pressure volume 
relations are recorded by the plethysmograph and analysed by a computer algorithm 
that brings the volume-clamp finger artery diameter set point. 77 Ultimately, a pulse 
waveform is obtained, which is further analysed by the Modelflow algorithm to 
generate a continuous estimate of the cardiac output. The Modelflow algorithm is 
discussed in more details in section 2.6.4. 
 
 As mentioned before, measuring blood pressure by the auscultatory and 
oscillometric methods, only provide intermittent blood pressure recordings 
corresponding to the exact time where the measurements have been taken. On the 
other hand invasive intra-arterial blood pressure monitoring offers continuous blood 
pressure measurements, but its invasive nature limits its use to the more critical 
patients. Blood pressure monitoring using continuous non-invasive technologies such 
as the Finometer may provide easily applicable alternatives which also has the merit 
of continuous cardiac output monitoring.72 
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2.4.2.2 Direct invasive method 
This invasive method is accomplished by inserting an intra-arterial catheter which is 
then connected to an external pressure transducer at heart level.78 Invasive blood 
pressure monitoring will continuously show the actual intra-arterial pressure and its 
variability. 
 
 
Figure 3. Philips IntelliVue MP30 monitor screen displaying an intra-arterial BP trace in red 
colour (reproduced from Philips)  
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2.5  Cardiac Output Monitoring 
2.5.1 Introduction 
The first trial to discover the circulatory system was in 1733 when Hales inserted a 
EUDVVSLSHLQWRDPDUH¶VDUWHU\DQGFRQQHFWHGLWWRDJODVVWXEH+HNHSWREVHUYLQJ
the arterial pulsations through the transparent glass tube, he then repeatedly 
disconnected the brass pipe from the artery, left the mare to bleed about a pint of 
blood each time, reconnected and observed for the effect of bleeding on the arterial 
pulsations.79  
In 1970 measurement of the cardiac output was accomplished by the insertion of a 
balloon tipped pulmonary artery catheter (Swan Ganz Catheter)80 , and since then 
its use was widespread in the diagnosis and management of the critically ill.81 82 
Proper insertion of the flow directed pulmonary artery catheter can provide 
intermittent accurate estimates of the central venous pressure (CVP), right sided 
intra-cardiac pressures, pulmonary artery pressure (PAP), pulmonary artery 
occlusive pressure (PAOP), cardiac output (CO) and systemic vascular resistance 
(SVR).83 The pulmonary artery catheter measures the cardiac output by the 
intermittent thermodilution technique, which is an application of Fick's principle 
where temperature is used as an indicator, discussed in details in section 2.5.2.1.  
Pulmonary artery catheters carry the risk of complications related to central venous 
cannulation such as, bleeding, hematoma, arterial puncture, catheter related sepsis, 
haemothorax and pneumothorax.84 Other complications related to the use of the 
pulmonary artery catheter are: Arrhythmias 85, Thromboembolism86, knotting87, 
pulmonary valvular endocarditis 88, air embolism89, pulmonary haemorrhage, 
pulmonary infarction, distal pulmonary artery rupture which could be encountered 
during insertion or during balloon inflation, and misinterpretation of pulmonary 
artery catheter data.83  
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It was believed that the pulmonary artery catheter's use was associated with a 
prevalent mortality rate and it should have been reserved for the highly indicated 
patients.90, 91 However more recent trials showed that the use of pulmonary artery 
catheters does not affect mortality.82, 92 
The pulmonary artery consensus conference in 1997, disapproved a moratorium for 
the pulmonary artery catheter and recommended for further randomised controlled 
studies focusing on further evaluation of pulmonary artery catheters, it also 
recommended using pulmonary artery catheters in indicated patients after weighing 
the harms against the benefits by expert hands, if benefits outweigh the harms then 
it should be used after informing the patient or relatives.93 The Pulmonary artery 
catheter is a useful tool for monitoring the haemodynamics of professionally selected 
patients, when it is properly applied and the data obtained is interpreted 
competently.94 
2.5.2 Principles of Measuring Cardiac Output  
2.5.2.1 )LFN¶V3ULQFLSOH 
Adolf Fick in 1870 discovered that blood flow across an organ can be measured by 
calculating the arterio-venous concentration gradient of a certain indicator after it 
has been injected into the blood supply of the organ. Accordingly cardiac output can 
be measured by calculating the pulmonary arterio-venous concentration gradients of 
oxygen and carbon dioxide (oxygen consumption and carbon dioxide production). 
Eqn1  ? ?ൌ  ? ? ? ? ? ? ? െ  ? ? ? ? 
 VO2 (O2 uptake); CvO2 (mixed venous O2 content); CaO2 (arterial O2 content). 
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2.5.2.2 Indicator Dilution Technique 
George Stewart used the indicator dilution technique to measure cardiac output; he 
injected a salt solution in the blood supply of different organs and detected the 
arrival of salt in the blood returning from those organs by electrodes.95 Hamilton 
continued what Stewart has started, he used phenolphthalein as an indicator and by 
blood sampling it was possible to draw the arterial concentration against time curve 
(Indicator dilution curve). On applying the Stewart/Hamilton equation, cardiac 
output will be inversely proportional to the area under the curve. 
 
 
 
Figure 4. Indicator dilution curve (reproduced from Jonas et al, 1999)96 
 
 
Eqn2   Applying Stewart/Hamilton equation for thermal dilution  ? ?ൌ  ? ? ? ?െ  ? ? ?? ? ? ? ? ? ? ? ? ? ?  
V (Volume injected.), TB (Blood temperature.), TI (Injectable temperature.), K1&K2 
(Computational constants.), TB (t) dt (change in blood temperature as a function of 
time.) 
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Measuring the cardiac output by the use of a thermal indicator was first 
accomplished by Fegler in 1954 on dogs.97 Later in 1968 Branthwaite and Bradley 
measured the cardiac output in man by injecting a thermal indicator in the right 
atrium through a central line and measured the temperature in the pulmonary artery 
by using a thermistor tipped pulmonary artery catheter.81 The thermal dilution 
technique is considered the gold standard for measuring cardiac output in the clinical 
setting. However less invasive methods of measuring cardiac output are now 
showing comparable results.82 
 
Figure 5. Thermal dilution curve recorded from the pulmonary artery after the injection of 
indicator into the right atrium (reproduced from Conway and Lund-Johansen, 1990)98 
W1 (actual thermal dilution curve), W2 + W3 (area of the curve produced by 
conduction of heat through the catheter wall as a result of injection of thermal 
indicator), a + b (areas of the curve produced by recirculation of thermal indicator 
from the superior and inferior vena cava respectively). 
 
  
42 
 
2.5.2.3 Arterial waveform analysis 
 
In 1899 Frank explained that the total peripheral resistance can be calculated by 
measuring the aortic pulse wave velocity and the cardiac output can be derived from 
the total peripheral resistance and the mean blood pressure. 
 
Eqn3 Relation between cardiac output, mean arterial pressure and total                                       
peripheral     resistance.  ? ? ൌ  ? ? ? ? ? ? 
 
Kouchoukos and colleagues in 1970 measured the stroke volume as the area under 
the systolic part of the aortic pressure waveform which corresponds to the pressure 
change from the end of diastole to the end of systole. 99 
  
43 
 
 
 
Figure 6. Aortic pressure waveform (reproduced from Cerutti et al, 2001)100 
 
Furthermore Wesseling and colleagues studied the pulse wave and were able to 
extract the cardiac output from it by using the Modelflow technique, which provides 
computational analysis of the blood pressure wave by using the non linear three-
element model of aortic input impedance (described in details later).71, 101, 102 
 
2.5.2.4 Doppler Ultrasonography 
Doppler Ultrasound can be used to calculate the cardiac index (CI) through 
measuring the aortic blood velocity and the aortic diameter. It is an accurate 
measure when compared to the conventional thermodilution technique.103 
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2.6  Review of cardiac output monitoring devices 
2.6.1 LiDCO Plus 
2.6.1.1 Introduction 
The LiDCO Plus is a minimally invasive cardiac output monitor utilising two systems:  
x The lithium indicator dilution cardiac output (LiDCO) and  
x The Pulse cardiac output real-time (Pulse CO). 
The lithium indicator dilution cardiac output LiDCO method is widely validated for its 
accuracy in terms of cardiac output monitoring.104, 105 The LiDCO Plus system uses 
lithium indicator dilution for calibrating the cardiac output estimates generated by 
the Pulse CO method, once every 8 hours. After calibration, the Pulse CO will provide 
reliable continuous beat-by-beat measurements of the BP, heart rate (HR), stroke 
volume (SV), CO, and the preload responsiveness parameters (stroke volume 
variation (SVV) and pulse pressure variation (PPV)) through analysing the arterial 
pressure waveform by the computated Pulse CO algorithm.106 
2.6.1.2  Operation and technology of LiDCO Plus 
Lithium indicator dilution LiDCO component measures the cardiac output 
intermittently by using the indicator dilution technique, where lithium acts as the 
indicator. The amount of lithium used is small and pharmacologically insignificant; 
0.002-0.004 mmol/kg. Lithium can be either injected into a central or peripheral 
vein.107 The arterial lithium concentration is then measured by an ion selective 
HOHFWURGHZKLFKLVFRQQHFWHGWRWKHSDWLHQW¶VDUWHULDOOLQHWKHDUWHULDOEORRGIORZLQJ
through this electrode is kept constant at 4 ml/ hour by means of a peristaltic pump. 
A lithium concentration gradient against time curve is drawn and the cardiac output 
is estimated from the area under the curve by using the equation: 
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Eqn4  ? ?ൌ  ?  ?  ? ? ?  ?  ? ? െ  ? 
Li, lithium dose is expressed in mmol; A, area under the lithium concentration time 
curve; PCV, packed cell volume which is calculated as follows: 
Eqn5  ? ? ? ൌ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?? ?  ?Ȁ ? ? ?    
Lithium is distributed in plasma, therefore, correction for the packed cell volume is 
required.108 The injection procedure is repeated three times and the obtained cardiac 
output readings are averaged.109  
The Pulse CO component measures cardiac output continuously on beat-by-beat 
basis through analysing the whole arterial waveform by using a pulse power 
algorithm.106 Unlike Wesseling's pulse contour method which calculates the cardiac 
output by analysing the systolic part of the arterial waveform.71 Pulse CO uses a 
three step pulse power algorithm, which first transforms the arterial pressure 
waveform into a volume time waveform, second it calculates the nominal stroke 
volume and the heart beat duration and third it converts the nominal stroke volume 
and accordingly the cardiac output into accurate values by using a calibrating 
factor.108 
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2.6.1.3 Validation of LiDCO Plus    
Two studies published in 1997 both compared the lithium indicator dilution cardiac 
output (LiDCO component of LiDCO Plus) with the pulmonary artery catheter 
thermodilution technique and they both showed comparable results.104, 105 
Furthermore, the Pulse CO component was successfully validated against the 
thermodilution technique106 and against the lithium indicator dilution technique after 
being calibrated.110  
2.6.1.4 Limitations 
LiDCO Plus should not be used in patients weighing less than 40 kg, pregnant and 
those on oral lithium medications.111 Also, cardiac output measurements of the 
LiDCO Plus are unreliable in patients receiving muscle relaxant infusions, as muscle 
relaxants can cause malfunctioning of the lithium measuring electrode.108 
Furthermore, the need for training staff on performing lithium dilution calibrations, 
and the time taken to calibrate, add to the limitations. 
 
2.6.2 LiDCO Rapid 
A new monitor that has been developed which is technically the Pulse CO component 
of the LiDCO Plus monitor, steering away from the limitations of the LiDCO Plus, in 
the sense that it is compact, easily applied in less than a minute, and does not 
require lithium calibration. This device tracks the trend of change in flow and 
resistance, providing continuous monitoring of the BP, HR, SV, CO, and also preload 
responsiveness parameters (SVV and PPV).112  
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2.6.3 Edwards FloTrac sensor and Vigileo monitor 
2.6.3.1 Introduction 
The Edwards FloTrac sensor/ Vigileo monitor is a minimally invasive reliable 
continuous cardiac output monitoring device. It provides accurate measurements of 
cardiac output without the necessity of calibrating against other cardiac output 
monitoring techniques.113, 114 7KH)OR7UDFVHQVRULVFRQQHFWHGWRWKHSDWLHQW¶V
peripheral arterial line at one end and to two simultaneous monitors on the other 
end; a standard monitor used for arterial pressure monitoring and the Vigileo 
monitor. The Vigileo monitor uses a technology that processes arterial signals 
REWDLQHGIURPWKH)OR7UDFVHQVRUWRJHWKHUZLWKWKHSDWLHQW¶VFKDUDFWHULVWLFGDWDOLNH
the age, sex and body surface area. Calculates the cardiac output (CO), cardiac 
index (CI), stroke volume (SV), stroke volume index (SVI) and stroke volume 
variation (SVV) and displays those estimates at 20 second intervals. Furthermore, 
connecting the monitor to a central venous catheter can provide estimates of the 
systemic vascular resistance (SVR) and the Systemic vascular resistance index 
(SVRI).115  
2.6.3.2 Technology used for cardiac output monitoring 
The FloTrac sensor / Vigileo monitor system measures the cardiac output on 
continuous basis by applying the following formula of arterial pulsatility:116  
Eqn6  ൌ   ?  ? ? ?  
SD (AP), the standard deviation of the arterial pressure throughout a 20 second 
interval; PR, pulse rate; K, constant value that is a reflection of the arterial 
FRPSOLDQFHDQGWKHYDVFXODUUHVLVWDQFH.LVGHULYHGIURPWKHSDWLHQW¶VFKDUDFWHULVWLF
data of age, sex, body surface area and the arterial waveform characteristics.117 
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2.6.3.3 Validation  
A validation study conducted by McGee and Janvier comparing the Edwards FloTrac / 
Vigileo system with the intermittent thermodilution technique in a total of 36 cardiac 
surgery and critically ill patients, showed comparable cardiac output 
measurements.118 Another study compared the cardiac output measurements 
obtained by the Edwards FloTrac / Vigileo system with those obtained by the 
continuous and intermittent thermodilution techniques in fifty post-operative cardiac 
surgery patients. Results showed that the Edwards FloTrac / Vigileo system is 
accurate and reliable.119 
2.6.3.4 Limitations 
The Edwards FloTrac / Vigileo system may provide unreliable measurements in the 
presence of arterial wave artifacts for example kinking or presence of air inside the 
tubing system, aortic regurge, severe peripheral vasoconstriction, irregular pulse 
and the presence of an intra-aortic balloon pump. Its use in paediatric patients is still 
not studied.9, 116 
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2.6.4  Finometer (Finapres Medical Systems BV, 
Arnhem, the Netherlands) 
Accurate measurements of cardiovascular parameters including the blood pressure 
and cardiac output provide important tools in clinical practice.120 Reliable blood 
pressure measurement is important for the proper diagnosis and management of 
conditions associated with abnormal blood pressure such as hypertension, in order 
to minimise the risks of developing complications like coronary artery disease, 
cerebro-vascular stroke, peripheral vascular disease, congestive heart failure and 
renal failure.121 Furthermore, monitoring of the cardiac output is essential for the 
management of the critically ill and surgery patients.71  
Until recently the intermittent thermodilution technique was the most commonly 
used in monitoring cardiac output.82 However newer less invasive techniques that 
are showing comparable results are being adopted.122 
 We are of opinion that the Finometer being easily applicable, non-invasive, 
hazardless, showing comparable results to other established methods as observed in 
many cardiovascular studies123, 124 and not missing acute hemodynamic events,125 
may show a good potential for haemodynamic monitoring of patients in intensive 
care units122 and routine clinical settings.  
The Finometer is a non-invasive beat-by-beat haemodynamic monitor that generates 
a continuous pulse waveform by means of a finger cuff. As described earlier, it uses 
the Peñáz volume-clamp method 76 and the physiocal (physiological calibrating) 
criteria of Wesseling 77 to obtain a continuous pulse waveform recording. The pulse 
waveform is then analysed by the Modelflow technique, which is a computer analysis 
of the blood pressure wave by using the non-linear three-element model, providing 
continuous blood pressure and cardiac output monitoring.101, 102 Modelflow technique 
is further discussed in the following section.
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Figure 7. Non-invasive continuous haemodynamic monitor (Finometer) 
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2.6.4.1 Technology used by the Finometer 
The Finometer is composed of:126  
x Three different sized finger cuffs  
x Return-to-flow calibration system using an upper arm Riva-Rocci/Korotkoff 
(RRK) brachial cuff  
x Automatic height correction unit (HCU) 
x Main unit and monitor  
x Analog input/output box and  
x Internal storage for all recorded data with the ability to download on a 
connected computer or of online downloading to a remote computer  
The Finometer offers non-invasive beat-to-beat arterial pressure monitoring via 
applying the following techniques: 
x As described earlier in section 2.4.2.1.3, the Finometer uses the Peñáz volume-
clamp method and the physiocal (physiological calibrating) criteria of Wesseling 
to obtain a continuous pulse waveform recording. The pulse waveform is further 
analysed by the Modelflow technique, which determines the other derived 
variables on beat-by-beat basis, namely the CO, SV, TPR, left ventricular 
ejection time (LVET) which is the time between beginning of upstroke and 
dicrotic notch, inter beat interval (IBI) which is the time between two beats, 
ascending aortic impedance (Zao) and total arterial compliance (Cwk).  
x The Modelflow technique is a computer based algorithm that analyses the blood 
pressure waveform by using the non-linear three element model, which 
represents the three characteristics of aortic input impedance; the aortic 
compliance, characteristic impedance and systemic vascular resistance. The 
compliance is a reflection of aortic elasticity, impedance reflects the opposing 
force created by the aorta towards the blood flowing from the heart and the 
systemic vascular resistance reflects the resistance to blood flowing from aorta 
to periphery.71  
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x Reconstructed brachial arterial pressure waveform is then obtained to correct for 
the arterial blood pressure differences that naturally occur between central and 
peripheral arteries. The systolic blood pressure tends to be higher peripherally, 
which is mainly due to propagating pulse wave amplifications which depend on 
frequency and accordingly on heart rate, while diastolic and mean blood 
pressures are lower peripherally.127 In order to overcome this site related blood 
pressure difference, the Finometer provides a reconstructed brachial arterial 
pressure waveform, by means of waveform filtering (transfer function) which 
corrects for the waveform changes resulting from pulse propagation, and by 
calibrating with the brachial arterial pressure by means of a (Riva-
Rocci/Korotkoff) cuff.128, 129 
x The feature of hydrostatic height correction is available in the Finometer to 
correct for hand movements to correspond with the heart level.130  
x Proper size of finger cuff must be used as loosely fitting cuffs will   provide 
inaccurate results.131 
 
2.6.4.2 Advantages and uses 
The Finometer has an established role in routine cardiovascular research  studies 
involving, blood pressure variability,132 baroreflex sensitivity,133 arrhythmias, 
pacemakers and cardiac resynchronization,134 exercise, postural effects,10 tilt tests 
and neuro-cardiogenic syncope studies.135 However its use in a cohort of patients in 
routine clinical practice has not been demonstrated yet.  
We suggest that the Finometer might potentially be a useful tool for monitoring 
cardiovascular parameters in haemodialysis and patients undergoing surgery due to 
its easy handling and its non-invasive nature when compared to the other invasive 
methods. In this project we will evaluate the feasibility of using the Finometer in 
haemodialysis units and operating theatres. 
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2.6.4.3 Disadvantages and limitations 
 
x Finger arterial vasoconstriction  
The presence of finger arterial vasoconstriction127 and cold fingers might affect the 
integrity of photo plethysmographic readings. Nevertheless, it is usually possible to 
obtain readings in cases where fingers are cold and cases of vasoconstriction, only 
when it is severe does it impede the plethysmographic measurements.77, 136 Studying 
the effect of hand warming to 44°C temperature on finger blood pressure 
measurements, showed a decrease in the naturally occurring over estimation of 
systolic blood pressure,137 which is observed when comparing central and peripheral 
arterial pressure readings. It is mainly due to propagating pressure wave 
amplifications.127 On the other hand, cooling of the hand produced an over 
estimation of systolic and diastolic blood pressures, which was reversible with re-
warming.138  
x Young age less than 6 years  
Use of the Finometer in young age 0-6 is still under development. Tanaka and 
colleagues compared the finger arterial blood pressure with the brachial blood 
pressure that is obtained by auscultatory methods. They found that Finapres follows 
blood pressure trends of change accurately in children139 Andriessen and colleagues 
found that the Finometer is feasible for monitoring blood pressure in young age, as 
SXOVHZDYHVLQ\RXQJDJHUHVHPEOHDGXOW¶VSXOVHZDYHV+RZHYHUWKHDGXOWSK\VLRFDO
algorithm that is used by the current Finometer needs adaptation to meet with the 
very young age vascular physiology.140 
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2.6.4.4 Validation of the Finometer 
2.6.4.4.1 Introduction 
Continuous blood pressure monitoring is invaluable in many critical clinical 
circumstances.141 The availability of a non-invasive hazardless device that can 
provide continuous beat-by-beat accurate measurements or even measurements 
that follow the trends of the actual blood pressure and cardiac output remains an 
interesting issue for researchers.142-144 
2.6.4.4.2 Validation of Finapres (old version of the Finometer) for blood pressure 
monitoring 
Finapres is the older version of the Finometer, deprived of the options of 
reconstructed return to flow brachial pressure, wave form filtering and hydrostatic 
level correction.144 Two studies, one conducted by Van Egmond and colleagues and 
published in 1985 on a total of 32 patients, 20 of whom were major surgery 
patients, 5 open heart surgery and 7 intensive care patients. The other study was 
conducted by Parati and colleagues and published in 1989, 16 uncomplicated 
hypertensive patients and 8 normotensive were enrolled in the study. Comparing the 
Finapres blood pressure recordings with the intra-arterial blood pressure in both 
studies showed that the Finapres provided an accurate estimate of the blood 
pressure.145, 146  
A study performed by Aitken and colleagues that was published in 1991 on 10 
patients undergoing local resection of choroidal melanomas, a procedure requiring 
induction of hypotension. Blood pressure obtained by Finapres was compared with 
the intra-arterial blood pressure, systolic blood pressure and heart rate values were 
comparable, whilst the diastolic and the mean blood pressures were 
overestimated.147 
 In another study performed by Farquhar, published in 1991 involving 10 ICU 
patients and comparing the Finapres with the intra-arterial blood pressure. Finapres 
showed inaccurate blood pressure estimates, however the trend estimation of the 
changes was clinically acceptable.148  
Regarding the study by Aitken and colleagues, they compared the quantitative 
values and they didn't correlate trend similarities, whereas Farquhar noticed that 
there was stability in the differences between results. 
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Considering the inaccurate results obtained by Finapres in both studies, an important 
issue that needs to be highlighted is that both studies were performed using the 
older version of the Finometer (Finapres) deprived of the reconstructed return to 
flow brachial artery pressure which was proven to reduce the pressure differences 
between the Finometer and intra-arterial blood pressure.144 
2.6.4.4.3 Validation of the Finometer (new version) for blood pressure monitoring  
Hehenkamp and colleagues performed a study to validate Portapres which is the 
portable version of the Finometer against the standard Riva-Rocci/Korotkoff (RRK) 
method, 30 normotensive pregnant ladies and 20 pre-eclamptic patients were 
enrolled in the study and Portapres showed comparable results.143  
A study focusing on the evaluation of the reconstructed brachial pressure waveform 
which is an option present in the new version (the Finometer) was performed by 
Guelen and colleagues and published in 2003 on 37 post coronary angiography 
patients. Basically, the comparison was made between the brachial arterial pressure 
that is brought by the Finometer through applying the RRK method and each of the 
following: 1) Original finger arterial pressure, 2) Waveform filtered and level 
corrected arterial pressure and 3) The return-to-flow calibrated, waveform filtered & 
level corrected arterial pressure. Observations were; a reduction in the pressure 
difference between finger and brachial intra-arterial pressures when waveform 
filtering and level corrections were used. Furthermore when the return-to-flow 
calibration was added, the reduction in the pressure difference was not as big but 
still met with the Association for the Advancement of Medical Instrumentation AAMI 
criteria149 for evaluation of automated blood pressure devices.144  
Schutte and colleagues performed a validation study on the Finometer in measuring 
blood pressure against the Riva-Rocci/Korotkoff sphygmomanometric method. 102 
females; 24 were hypertensive, 25 obese normotensive and 35 lean normotensive 
were enrolled in this study. Results of the Finometer met with the validation criteria 
of the Association for Advancement of Medical Instrumentation (AAMI)149 and the 
British Hypertension Society (BHS).8, 150 The AAMI and the BHS criteria for validation 
of BP devices are described in details in sections 4.2.7 and 4.2.6 respectively. 
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2.6.4.4.4 Validation of the Finometer for cardiac output monitoring   
2.6.4.4.4.1  Validation of the Modelflow algorithm     
The Modelflow is a computer algorithm present in the Finometer, which estimates 
the cardiac output on continuous basis from the arterial pressure wave by simulating 
a non-linear three element model of the aortic input impedance. The three elements 
of the Modelflow are aortic characteristic impedance, arterial compliance and 
systemic vascular resistance.71 Arterial pressure waves are obtained either invasively 
by the intra-arterial method or non-invasively by finger arterial pressure devices. 
 A Modelflow validation study was performed by Jellema and colleagues on 32 
critically ill patients. The invasive intra-arterial pressure waveform was used to 
estimate the cardiac output by using the Modelflow technique and values were 
compared with those of the thermodilution technique. The comparison showed good 
correlation of results when calibrations were done with the thermodilution technique 
once every two days.151  
In another study conducted by Jansen and colleagues, published in 2001 which also 
compared the cardiac output estimated by Modelflow simulation of invasive intra-
arterial pulse waveform and the thermodilution technique, in 54 patients undergoing 
open heart surgeries. Comparable results were obtained after one calibration only 
per patient.152  
2.6.4.4.4.2 Validation of the Finometer  
Validation studies of the Finometer in terms of CO monitoring produced mixed 
results, both accuracy and inaccuracy have been demonstrated. However, there was 
general agreement on the usefulness of the Finometer in the detection of CO trends. 
Inaccuracy of the finger arterial pressure (FINAP) has been reported in a study by 
Remmen and colleagues; they compared CO measurements obtained from the 
pulmonary artery catheter and the FINAP in 28 healthy subjects. Their results 
showed no significant correlation between the FINAP and the pulmonary artery 
catheter CO measurements , the bias was -1.7 L / min, and the 95% limits of 
agreement ranged between -4.6 L / min and +1.1 L / min (r = 0.28 and p = 0.13). 
On the other hand, several studies have shown reliability of the FINAP in monitoring 
the CO.153 Harms and colleagues compared 155 SV measurements obtained by the 
pulmonary artery catheter and the FINAP in 9 healthy individuals who were 
subjected to orthostatic stress conditions during the study. Their results showed 
accuracy of the FINAP in comparison with the pulmonary artery catheter (r = 0.97 
and p < 0.001).154 Tam and colleagues compared 45 CO readings obtained by FINAP 
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and a respiratory method using open-circuit acetylene uptake (C2H2) in 9 healthy 
subjects. They further performed another comparison after calibration of the FINAP 
with the C2H2. Their results before calibration showed significant correlation between 
the FINAP and the C2H2 (r = 0.784 and p < 0.01). The bias was 1.83 L / min, and 
the 95% limit of agreement ranged between -6.23 L / min and +9.89 L / min, the 
regression line between FINAP and C2H2 CO readings showed a slope of more than 1, 
indicating that the FINAP arterial pressure overestimated the CO in comparison with 
the C2H2. The results after calibration showed that FINAP is accurate in bringing 
absolute values, the bias was 0.24 L / min, and the 95% limits of agreement ranged 
from -6.58 L / min to +7.05 L / min (r = 0.931 and p < 0.01). 155 
Azabji Kenfack and colleagues compared 10048 CO readings measured by the 
Modelflow noninvasively from the finger (FINAP) and invasively from the radial 
artery in 7 healthy subjects. The regression line was displaced upwards with a slope 
significantly higher than 1, indicating that the FINAP overestimated the value of CO 
in comparison with the radial artery. The bias was 1.44 L / min, and the 95% limits 
of agreement ranged between -4.12 L / min and +7.01 L / min (r = 0.603). 156 
Hirschl and colleagues compared 323 pairs of FINAP and pulmonary artery catheter 
cardiac index (CI) readings in 46 critically ill patients. The Bias was 0.14 L / min / 
m2, and the 95% limits of agreement ranged between -0.6 L / min / m2and +0.88 L 
/ min / m2 (p < 0.001). They also showed that there was a large variation between 
the FINAP and the pulmonary artery CI readings in 23% of the measurements. 142  
2.6.4.4.5 Summary 
The Finometer is fairly accurate in terms of blood pressure monitoring.8 However, as 
the current evidence stands, it can be said that it has not been shown to be accurate 
in generating absolute cardiac output measurements, but it has been shown that it 
accurately follows the trends of changes in cardiac output.9 
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2.6.5  Nexfin 
The Nexfin is the most recent development in finger arterial pressure technology, 
which has been applied also by the Finometer. It measures the same haemodynamic 
variables as the Finometer with equal accuracy.157 The Nexfin in contrast with the 
Finometer has the merit of being compact and easy to use. Furthermore, it obtains 
the true brachial arterial pressure by merely correcting for individual characteristics 
rather than physically taking brachial arterial pressure measurements, thus, allowing 
a rapid start of the device. It also can provide pulse oximetry and continuous 
haemoglobin concentration monitoring. 
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2.7  Endothelial function monitoring 
2.7.1 Introduction 
The vascular endothelium forms a semi-permeable membrane that acts as a barrier 
which prevents the larger blood constituents from moving out of the blood vessels 
and on the other hand allows the movement of water and solutes.158 
The endothelium also plays an important role in regulating the immune response 
against pathogens, by producing adhesion molecules that bind to leukocytes 
enabling them to migrate to inflamed areas.159   
It is also involved in the process of angiogenesis160 and very importantly in the 
regulation of vascular tone through the production of both vasodilator and 
vasoconstrictor mediators. Vasodilator mediators are: nitric oxide (NO), prostacyclin, 
bradykinin 161 and endothelium derived hyperpolarising factor. These four vasodilator 
mediators also inhibit platelet aggregation.162 Vasoconstrictor mediators are:  
angiotensin II, endothelin, thromboxane A2 and prostaglandin H2.
163 
As discussed above, the endothelium is involved in many vital roles; hence 
endothelial dysfunction is likely to be a major cause of morbidity and mortality,164 
which urges the need for endothelial function testing. It was found that an easily 
applicable way of determining the endothelial function is by measuring the tone 
regulatory function of the endothelium.165 In endothelial dysfunction, nitric oxide 
production decreases hence causing an increased vascular tone and stiffness,164 also 
an increased incidence of atheroma development.166 
Arterial stiffness is a reflection of the degree of age related changes and 
atherosclerosis. Accordingly it is considered an independent risk factor for coronary 
artery disease. 167 Therefore, the importance of early identification of  arterial 
stiffness in order to adopt preventive measures of atherosclerosis promptly to arrest 
the disease progression.168 Carotid ± Femoral Pulse wave velocity is considered the 
gold standard for measuring arterial stiffness.169  
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Pulse wave velocity is the time taken by the blood pressure wave to cover a certain 
distance between two set points of the arterial system. It is affected by the arterial 
elasticity, arterial thickness and the blood density. Hence an increase in the arterial 
stiffness will eventually increase the pulse wave velocity.170  
Arterial endothelial dysfunction is the first event that occurs in the process of 
atherosclerosis, its early detection is invaluable for the prevention of atherosclerosis 
progression. Endothelial function integrity can be estimated by measuring the 
vasomotor function of arteries after giving intra-arterial injections of drugs that 
cause the release of endothelial nitric oxide.171, 172 The use of this procedure is 
limited by its invasive nature. Recently non-invasive techniques that measure the 
arterial stiffness and the endothelial function via pulse wave analysis have been 
developed.171  
2.7.2 Pulse wave analysis 
Photo plethysmography is a simple, noninvasive and accurate way of obtaining a 
digital volume pulse, from which the stiffness and the reflection indices that 
correspond to the large artery stiffness and the small artery vasomotor function 
respectively are generated.173 Photo plethysmography operates through emission of 
an infrared light through the capillary bed of the finger tip. Changes in blood volume 
occurring in the capillary bed during pulsations will eventually change the amount of 
light absorbed. Those changes in light absorption that reflect changes in blood 
volume are interpreted and a digital volume pulse waveform is obtained.174 The 
digital volume pulse waveform is composed of a systolic component which is a 
resultant of transmission of the blood pressure wave from the aortic root to the 
finger (peak A) and a diastolic component (peak B) which is caused by the 
backwards reflection of the pressure wave from the aorta to the finger after it has 
been transmitted from the left ventricle to the periphery via aorta (figure 8).175  
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Figure 8. A Pulse waveform (reproduced from Millasseau et al, 2002)176 
 
 
2.7.3  Interpreting the DVP (Digital volume pulse): 
The amplitude of the diastolic component of the DVP depends on the intensity of 
blood pressure wave backwards reflection and is directly related to the endothelial 
vasomotor function of the small arteries. The time difference between the diastolic 
and the systolic peaks corresponds to the PWV (Pulse wave velocity) and it depends 
on the arterial stiffness. 
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RI (Reflection index) is the ratio between the amplitudes of the diastolic peak 
(peak B) and the systolic peak (peak A) and is expressed as a percentage. Reflection 
index is considered a measure of the intensity of pulse wave reflection and the 
endothelial function (figure 8).175  
Eqn7  ൌ Ȁ  ?  ? ? ?      
SI (Stiffness index) corresponds to the pulse wave velocity which is used mainly 
to measure arterial stiffness in large arteries. SI is calculated by dividing the 
VXEMHFW¶VKHLJKWLQPHWUHVE\WKHWLPHLQVHFRQGVEHWZHHQWKHV\VWROLFDQGGLDVWROLF
peaks (PPT) (figure 8).175, 176  
Eqn8  ൌ Ȁ ? ?  
 
2.7.4  Validation of pulse wave analysis for reliability 
in evaluating the arterial stiffness and endothelial 
function  
Studies comparing the PWV (carotid ± femoral) which is considered the gold 
standard method for measuring the arterial stiffness 169 with the stiffness index (SI) 
obtained by the DVP showed a good correlation in results. 175, 176 Reflection index 
(RI) obtained by the DVP was shown to correlate well with the vascular tone in 
several studies.175, 177, 178 
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3  Aim of thesis 
 
In the context of evaluating BP aberrations during routine anaesthesia service at 
the time of induction and also during routine haemodialysis, the Finometer was 
used to determine: 
x The gross haemodynamic changes that occur during these procedures 
x Whether the Finometer provides extra information, and hence potential for 
better patient safety, than the non-invasive blood pressure monitors that are 
currently used in practice 
3.1  Service evaluation  
This thesis is designed to evaluate WKHµVWDQGDUGSUDFWLFH¶NIBP monitoring that is 
conventionally used during two routine clinical situations where BP aberrations 
are anticipated to happen, namely, induction of anaesthesia and haemodialysis. 
In view of emerging evidence that both, hypotension and hypertension 
encountered during induction of anaesthesia and haemodialysis are associated 
with poor patient outcome 5, 6, 179, 180, we wished to evaluate our current practice 
of monitoring BP intermittently to see if it provided adequate information about 
the extent and severity of BP aberrations. The underpinning principal is that 
correct and timely information regarding BP changes will aid the physician for 
early diagnosis and management of those haemodynamic mishaps, and 
eventually improve the level of patient safety.  
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To evaluate this, the following questions were framed: 
x Are blood pressure measurements obtained by the Finometer comparable to 
those obtained by the conventional non-invasive blood pressure monitors in 
terms of accuracy? 
x Do significant haemodynamic changes occur during routine induction of 
anaesthesia and maintenance haemodialysis, and do blood pressure values 
reach the threshold for intervention during these procedures? 
x Is the Finometer a better detector of episodes of maximum blood pressure 
changes as they occur than the conventional non-invasive blood pressure 
devices? 
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4 Generic methods 
4.1 Devices 
This section describes the procedures of operating the devices that were used in 
both our service evaluations of routine induction of anaesthesia and maintenance 
haemodialysis. 
4.1.1  Finometer 
The Finometer has been discussed in details in sections 2.4.2.1.3 and 2.6.4 
4.1.1.1 Procedure of operating the Finometer 
We attached the brachial cuff to one of the SDWLHQW¶V arms, and attached the 
appropriate sized finger cuff to either the index or the middle finger of the same 
arm; we always made sure that the finger cuff cables were along the palm side of 
the finger. The finger cuff size is considered appropriate when both of its 
longitudinal edges are in line, this means that that they neither overlap nor be 
apart. Finometer was then switched on and patient data including age, sex, 
weight and height were entered.  
The height correction unit (HCU) is formed of a transparent thin tube containing 
water with two ends; a finger end and a heart level end. It is connected to the 
Finometer by a thin cable. Both the finger and the heart level ends of the HCU 
were initially brought together to employ height correction system during 
monitoring. 
When started, Finometer delivers an un-calibrated finger arterial pressure 
waveform. Calibration with the brachial BP, can take approximately 2 minutes. A 
reliable continuous beat-by beat haemodynamic monitoring is provided 
thereafter.  
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Indicating WKH)LQRPHWHU¶VUHDGLQJVDWVSHFLILFWLPHVZKHQUHOHYDQWHYHQWV
happened, such as the start and end of the procedure, was accomplished by 
pressing the [mark] button. This has allowed us to review the )LQRPHWHU¶V
readings corresponding to those events after having retrieved the data from the 
Finometer.  
After data has been collected from the patient, the Finometer was switched off 
and the brachial and finger cuffs were then disconnected from the patient (Figure 
7). 
4.1.1.2 Procedure of data retrieval from the Finometer 
Retrieval of the data from the Finometer was done on the same day of data 
collection, to ensure that work does not accumulate especially since vast 
amounts of data were available per patient. It also needs to be mentioned that 
the Finometer can store up to 24 hours worth of haemodynamic data, and it 
tends to overwrite when its memory is full. Retrieval of data was done using the 
BeatScope version 1.1a software (product of Finapres Medical Systems BV, 
Arnhem), which was installed on a laptop. The Finometer and the laptop were 
switched on, and connected to one another via an RS232 cable. 
[Finometer research] mode was selected from the options on the Finometer 
screen. The BeatScope program that was installed on the laptop was opened, and 
data from Finometer downloaded (figure 9).  
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Figure 9. First step in downloading data from the Finometer via BeatScope 
 
A 4 hour haemodialysis file approximately took 30 minutes to download (figure 
10).  
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Figure 10. Second step in downloading data from the Finometer via BeatScope 
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Figure 11. Third step in downloading data from the Finometer via BeatScope 
 
After downloading was completed, we used the window to open the required file 
as a continuous waveform. We then chose the portion of the file that we needed 
to download by highlighting the needed portion of the file. We then exported data 
from file to the chosen file directory (figure 12).  
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Figure 12. Fourth step in downloading data from the Finometer via BeatScope 
 
 
The exported file was then transferred into Microsoft excel format, which was 
saved ready for analysis.  
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4.1.2  Pulse contour analysis 
The finger pulse contour analysis was discussed in details in section 2.7.2, 2.7.3 
and 2.7.4  
We used the Pulse Trace device (Micro Medical, Gillingham, Kent, UK) for pulse 
contour analysis. 
4.1.2.1 Procedure of operating the Pulse Trace device  
The Pulse Trace device has a chargeable battery, but it can also work by direct 
connection to the electricity source. To collect data using Pulse Trace device, the 
finger probe was attached WRWKHSDWLHQW¶VLQGH[RUPLGGOHILQJHUof either arm, 
provided that the chosen finger was not the one used by the Finometer. The 
finger probe had to be clamped to the finger with its cable along the dorsal side 
of the finger.  7KHSDWLHQW¶VVH[DJHDQGZHLJKWZHUHentered and a continuous 
pulse waveform was displayed on the screen. For measurements the device 
recorded pulse waveforms over a period of 20 seconds, and further analysed 
them to generate values for  PPT, RI, SI and vascular age (VA). The Pulse Trace 
device has the option of storing data, but due to the limited amount of data 
required in our service evaluation, we manually noted the readings on a patient 
data sheet. The device was then switched off and the finger probe removed from 
the patient (Figure 13). 
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Figure 13. The Pulse Trace device (Micro Medical, Gillingham, Kent, UK) 
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4.1.3 Non-invasive blood pressure monitoring 
(NIBP) 
Intermittent NIBP monitors are routinely used in operating theatres and 
haemodialysis units for the purpose of blood pressure monitoring. The NIBP 
monitors apply the oscillometric method, by which they provide SBP, DBP and 
MBP readings on intermittent basis, according to either a preset interval 
adjustment (automatic mode) or upon request (manual mode). 
In both our service evaluations, the attending staff were the ones who set the 
frequency at which the NIBP measurements were to be taken according to their 
standard practice, and they personally operated the NIBP devices, we did not 
interfere in the routine care by any means. 
It needs to be mentioned that the NIBP devices that were used in the operating 
theatres were built into the main anaesthesia monitors, and the frequency of 
measurements was set between 2 and 4 minutes. 
During haemodialysis, NIBP monitoring was achieved by using portable NIBP 
devices, and only two readings were taken; a predialysis and a post dialysis 
reading. 
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4.2  Analysis 
The haemodynamic data that was collected in both our service evaluations of 
routine induction of anaesthesia and maintenance haemodialysis was tested for 
normality, and was shown to be normally distributed. Moreover, continuous data 
are usually considered parametric.181 Graphpad Prism software (Graphpad 
software, California, USA) was used for statistical analysis. Our results are 
expressed as mean (SD) unless otherwise mentioned. 
This section describes the techniques that were used to analyse our data. 
4.2.1 6WXGHQW¶VWWHVW 
6WXGHQW¶VWWHVWRIGLIIHUHQFHRIPHDQVLVXVHGWRDVVHVVLIWKHPHDQVRI
samples showed a significant difference. Two types of t tests can be performed 
depending on the source of data; an unpaired t test is used when the data is 
collected from 2 independent groups, whereas a paired t test is used when the 
data is collected from the same group with the measurements taken at 2 
different time points. The null hypothesis would denote that there are no 
differences between the 2 groups that are to be compared. Results of the t test 
may show a significant difference between the means of the two groups when the 
p value is less than 0.05 (evidence to reject the null hypothesis), or may not 
show a significant difference between the means of the two groups when the p 
value is more than 0.05 (evidence to accept the null hypothesis).  
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4.2.2 Analysis of variance DQG7XNH\¶VSRVWKRFWHVW 
The use of a t test is limited to comparing the means of 2 groups. In order to 
compare the means of 3 or more measurements within same groups, testing with 
analysis of variance (ANOVA) for repeated measurements would be the 
appropriate choice. The null hypothesis in this case would be that there is no 
significant difference between the means that are to be compared.  
Further analysis of the data by 7XNH\¶VSRVWKRFWHVWDOORZs the testing of all 
possible 2-way comparisons for significant differences of means.182 
 
4.2.3 Chi-squared test 
Chi-squared test is used to test for the presence of a significant difference 
between the expected and the observed data in 1 or more categories of 
quantitative data with a sample size more than 10. The null hypothesis in this 
situation would be that there is no significant difference between the expected 
and the observed data. If the resultant p value is less than 0.05, the null 
hypothesis is rejected implying that a significant difference lies between the 
groups, whereas, if the p value was more than 0.05, the null hypothesis would be 
accepted meaning that there is no significant difference between the groups. 
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4.2.4 Bland and Altman technique 
The Bland and Altman technique is considered the gold standard for the 
assessment of agreement between the same measurements obtained from a 
novel device and a validated device, thus, supplying grounds for the possibility of 
the former to replace the latter.183 Two sets of simultaneous measurements from 
the novel device and the old device are taken. The data from both devices are 
plotted on a graph and the line of equality drawn (the line where all points of 
data would have lied upon if both devices delivered the same readings). The 
correlation coefficient (r) of the two devices is then calculated. It should be noted 
that the r assesses the strength of association, but not the agreement, and it is a 
value between -1 and +1, with -1 being the highest negative correlation and +1 
being the highest positive correlation (Figure 14).   
 
 
Figure 14. An example of plotted measurements obtained from two devices with the line of 
equality drawn (reproduced from Bland and Altman, 1986)184 
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It is well known that any two different devices cannot deliver identical 
measurements every time a measurement is taken simultaneously. This explains 
the need for assessing the degree of agreement between both devices, to ensure 
that the measurements obtained by the novel device lie within a clinically 
acceptable range of difference from the old device. A graph plot of the differences 
between each two simultaneous readings that are obtained from both devices 
against their average values is plotted. The 95% limit of agreement is then 
calculated from the mean difference (Bias) and the standard deviation (SD) of 
the differences (95% of the differences would occur between -1.96 SD and +1.96 
SD, provided that the differences are normally distributed). The narrower the 
95% limit of agreement, the better is the agreement between the two devices. 
The acceptable range of limits of agreement is decided according to the clinical 
impact of such range. Accordingly, reference ranges for BP measurements do not 
exist.  
As an indicator of precision, the variability of the bias and the 95% limits of 
agreement are also calculated (95% confidence intervals). 184  Figure 15 displays 
an example of a Bland and Altman plot.  
 
Figure 15. An example of a Bland and Altman plot of differences against averages 
(reproduced from Bland and Altman, 1986)184 
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4.2.5 Linear regression 
Linear regression is used to model the relation between 2 variables, an outcome 
variable and a predictor variable. The data of the 2 variables are plotted on a 
graph. An assessment of the correlation coefficient should be done first, since 
there would be no point to fit a linear regression line if the correlation was not 
significant. If the 2 variables showed a significant correlation, the best straight 
line is drawn across the data (linear regression line). From the linear regression 
line, new values of one variable can be brought from the other. The square of the 
correlation coefficient (r2) LVFDOFXODWHGDQGLWLVXVHGWRDVVHVVWKHµJRRGQHVVRI
ILW¶$KLJKHUYDOXHLQGLFDWHVDJRRGILW 185 (Figure 16). 
 
Figure 16. An example of a linear regression line (reproduced from Petrie et al, 2002)185 
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4.2.6 The British Hypertension Society (BHS) 
protocol for validation of BP devices 
The BHS protocol for validation of BP measuring devices was published in 1990 
and revised in 1993. According to the BHS protocol, the validation of a novel 
device is performed against the standard mercury sphygmomanometer 
technique. The minimum sample size required for the validation study is 85 
subjects. Three observers, 2 mercury devices and the device to be tested are 
required for the study. The 2 mercury devices and the test device are all 
connected sequentially to the subject as shown in figure 17.  
 
Figure 17. Procedure for sequential validation in the same arm (reproduced from Obrien 
1993, et al)150 
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It is preferable to use the same arm rather than both arms to limit the inter-arm 
factor of error. Observers 1 and 2 are each assigned to one of the 
sphygmomanometer devices, while observer 3 is assigned to the test device. In 
each subject, 7 BP measurements are taken according to the sequence shown in 
figure 18. 
 
Figure 18. Sequential BP measurements according to the BHS protocol (reproduced from 
Braam 2003, et al)186 
 
The time lag in between the 7 consecutive readings should be kept between 30 
and 60 seconds. After the data has been collected, the differences in values 
between the mercury device and the test device are calculated. The BHS criteria 
are met when a BP machine achieves grade A or B for both SBP and DBP when 
compared to the sphygmomanometer method according to table 1. The grades 
correspond to the cumulative percentage of SBP and DBP measurements 
occurring within 5, 10 and 15 mmHg differences from the sphygmomanometer 
measurements. Only a device that has achieved a grade A or B for both SBP and 
DBP can be valid for use in healthcare.150 
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Table 1. BHS criteria for validation of a novel BP device 
Absolute difference between standard and test device 
 PP+J PP+J PP+J 
Cumulative 
percentages 
SBP % DBP% SBP % DBP% SBP % DBP% 
Grade A 60 60 85 85 95 95 
Grade B 50 50 75 75 90 90 
Grade C 40 40 65 65 85 85 
Grade D Lower than grade C 
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4.2.7 The Association for the Advancement of 
Medical Instrumentation (AAMI) protocol for 
validation of BP devices 
The AAMI protocol for validation of BP measuring devices was published in 1987 
and revised in 1992. According to the AAMI protocol, the validation of a novel 
device is carried out against the mercury sphygmomanometer device in at least 
85 subjects. For every subject, 3 sets of BP readings are taken by 2 trained 
observers (one assigned to the mercury device and the other to the study 
device). Simultaneous measurements are preferable to sequential 
measurements. The mean difference between the mercury device and the study 
device along with the standard deviation of the mean difference (SDD) are 
calculated for both the SBP and DBP. A device is considered valid for use in 
PHGLFDOSUDFWLFHRQO\LIWKHDEVROXWHPHDQGLIIHUHQFHZDVPP+JDQGWKH
6''ZDVPP+JIRUERWKWKH6%3DQG'%3149 
It needs to be mentioned that in both our service evaluations of induction of 
anaesthesia and maintenance haemodialysis, we have not abided completely to 
either of the protocols of the BHS and the AAMI, as we validated the Finometer 
against the conventionally used NIBP device rather than the standard mercury 
device, which are no more available in clinical settings.   
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5 A service evaluation of routine induction of 
anaesthesia involving an assessment of the 
adequacy of currently used intermittent 
noninvasive blood pressure (NIBP) devices in 
detecting episodes of transient hypotension  
5.1  Introduction 
Significant Intraoperative hypotension is associated with hazardous patient 
outcomes post surgery.4, 5 Hence, tight regulation of the BP during anaesthesia 
has been an issue of major concern to anaesthetists for its impact on patient 
safety.  
Perfusion of the vital organs is maintained by the process of autoregulation which 
strictly keeps the MBP between 60 and 120 mmHg.187 A decrease in MBP to a 
value of less than 60 mmHg is known to cause a state of hypoperfusion.188  
Hypotension is commonly encountered during anaesthesia1, it is usually mild and 
well tolerated. However, if significant episodes of hypotension are to be 
sustained, the  perfusion and subsequently the integrity of the vital organs such 
as the brain, kidney, and liver will be affected.189 In patients with low cardiac 
reserves the situation is even worse, as even the mild forms of hypotension can 
be intolerable. Recent evidence suggests that Intraoperative hypotension 
involving levels of MBP lower than 60 mmHg even for 1 min is associated with an 
increased risk of 1 year mortality after non-cardiac surgery.4, 5 Adverse patient 
outcomes in response to Intraoperative hypotension explain the necessity for its 
effective identification and management. 
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The haemodynamic effects of individual drugs and techniques used in 
anaesthesia are well illustrated. However, relatively little is known about the 
gross haemodynamic effect of induction of anaesthesia in routine clinical practice, 
which involves the administration of different drugs and the employment of 
techniques simultaneously in a short period of time. The reason for this is that in 
the current clinical practice, continuous haemodynamic monitoring requires intra-
arterial catheterisation; an invasive procedure that is not routinely employed. 
As discussed earlier, the Finometer is a continuous beat-by-beat noninvasive 
haemodynamic monitor that generates a continuous blood pressure waveform by 
applying a finger cuff. Important haemodynamic parameters such as the heart 
rate, systolic, diastolic and mean blood pressure, stroke volume, cardiac output 
and total peripheral resistance are derived on continuous basis from the 
generated blood pressure waveform. The Finometer is accurate in terms of blood 
pressure monitoring8 and it accurately tracks the trend of change in cardiac 
output.9 For this reason it is being widely used in the field of cardiovascular 
research; 10, 132-135 however its role as a haemodynamic monitor in routine clinical 
practice is not well recognised.  
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5.2  Aim  
Considering the emerging evidence suggesting that Intraoperative hypotension is 
associated with an increased morbidity and mortality risk after non-cardiac 
surgery, we conducted a service evaluation and used continuous noninvasive 
haemodynamic monitoring brought by the Finometer, to assess the severity of 
hypotension encountered during routine induction of anaesthesia. We have 
specifically chosen the period of induction of anaesthesia, because it involves a 
variety of drugs and procedures that exert a direct effect on the cardiovascular 
system delivered to the patient in a short period of time. Routine induction of 
anaesthesia is conventionally monitored by the NIBP devices set at 2 ± 4 
minutes. We compared BP monitoring during induction of anaesthesia using 
Finometer with the NIBP devices that are being used conventionally. Then we 
assessed the adequacy of BP surveillance provided by the intermittent NIBP 
monitors in relation to the Finometer during the course of induction of 
anaesthesia. 
Our core objective in this service evaluation was to assess the adequacy of the 
currently used NIBP monitoring in detecting BP changes and thus the level of 
patient safety they provide during routine induction of anaesthesia.   
To evaluate this, we followed a 3 step analysis protocol: 
o Step 1: We compared the blood pressure measurements simultaneously 
obtained by the Finometer and the NIBP during routine induction of 
anaesthesia 
o Step 2: We characterised the haemodynamic changes occurring during 
routine induction of anaesthesia as assessed by the Finometer  
o Step 3: We evaluated the ability of the conventional intermittent NIBP 
monitors to instantly detect maximum changes in BP as they occur in 
comparison with the Finometer 
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5.3  Patients and methods 
5.3.1 Patients 
This service evaluation was conducted in the operative WKHDWUHVRIWKH4XHHQ¶V
Medical Centre Campus, Nottingham University Hospital NHS Trust, over a period 
of 6 months from April to October 2009. One hundred patients undergoing 
induction of anaesthesia in routine clinical practice were involved in our service 
evaluation.  
5.3.2 Methods 
5.3.2.1 Patient recruitment  
Operating theatres in 4XHHQ¶V0HGLFDO&HQWUHdelivering general anaesthesia were 
approached one hundred and ten times. Patients were recruited for evaluation if 
the attending anaesthetist agreed, and the evaluation could be carried out on the 
basis of availability of equipment and the timing of induction of anaesthesia.  
Once the above criteria were met, the service evaluation was fully explained to 
the patients and the attending staff, in terms of the purpose behind conducting it, 
a brief description of the Finometer and the pulse plethysmograph. We also gave 
emphasis to the fact that the service evaluation would not interfere with the 
treatment received in any way and that they can opt out of the evaluation at any 
time without that affecting their standard care in any means. We also explained 
that their personal details would be kept confidential and that this service 
evaluation is a one off event that takes place only during the period of induction 
of anaesthesia.  
There were no selection criteria in selecting patients, any patient undergoing 
induction of anaesthesia regardless of age, gender or type of surgery was 
recruited. A verbal approval from the patient for taking part in the service 
evaluation was ensured.  
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5.3.2.2 Data collection 
'DWDZDVJDWKHUHGIURPWKHSDWLHQWWKHSDWLHQW¶VKRVSLWDOILOH1,%3PRQLWRU
Finometer and from the attending anaesthetist. It included the following: 
x Demographic data (age, gender, height and weight) 
x Co-morbidities  
x Prescribed medications 
x American Society of Anesthesiologists physical status classification (ASA) 
x Type of surgery 
x Anaesthetic drugs used during induction of anaesthesia 
x Airway management procedures attempted during induction of 
anaesthesia 
x Full record of the NIBP measurements before and during induction of 
anaesthesia 
x Finometer data 
x Pulse plethysmograph data (SI and RI)  
All the data collected apart from WKH )LQRPHWHU¶V GDWD, was manually noted on 
pre-designed patient data sheets. 
5.3.2.3 Methodology protocol 
In anaesthesia practice, the NIBP arm cuff is usually not used on the arm where 
the intravenous (IV) line is inserted, in order for it to not interfere with the 
administration of medications and IV fluids every time an NIBP measurement is 
to be taken. We compared readings from contralateral arms rather than the same 
arm, due to the fact that simultaneous Finometer and NIBP measurements are 
not always successful from the same arm, as the NIBP measurements will 
completely block the arterial supply of the arm, and the Finometer might stop 
working. Therefore, we chose to apply the Finometer on the IV line arm (NIBP 
contralateral arm), as the Finometer only takes one brachial calibration 
measurement before the start of induction of anaesthesia, thus, it would not 
interfere with the drug and fluid administration.  
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On the arm that was chosen for the purpose of Finometer monitoring, an 
appropriately sized Finometer finger cuff was wrapped around the index or 
middle finger along with the Finometer¶V brachial cuff. The Finometer was 
switched on, and a brachial arterial measurement was taken for calibration. Once 
calibrated, the Finometer was kept operating throughout the whole period of 
induction of anaesthesia. The procedure of operating the Finometer is discussed 
in details in section 4.1.1.1.  
For the purpose of VWDQGDUGLVDWLRQZHXVHGWKH)LQRPHWHU¶VFORFNWRQRWHWKH
timings of all actions taken during the procedure of induction of anaesthesia on 
WKHSDWLHQW¶VGDWDVKHHWV7KRse actions included the start and end of the 
procedure, and the NIBP measurements. 
Every time an NIBP measurement was taken by the attending staff, we 
simultaneously pressed the )LQRPHWHU¶V>PDUN@EXWWRQ, specifically at the 
moment when the NIBP measurement was displayed on the anaesthesia monitor. 
This enabled the labelling of the )LQRPHWHU¶Vreading that corresponded to this 
NIBP measurement upon retrieval of the haemodynamic data RQWKH)LQRPHWHU¶V
raw data excel spreadsheets. We also noted the values of all the NIBP 
measurements that were taken during induction of anaesthesia along with their 
timing, on the patient data sheet. The procedure of data retrieval from the 
Finometer is discussed in details in section 4.1.1.2.   
Using the Pulse Trace device, a pre induction of anaesthesia pulse wave analysis 
measurement of the SI and RI was taken and noted on the patient data sheet. 
The procedure of operating the Pulse Trace device is discussed in details in 
section 4.1.2.1. Induction of anaesthesia was then started.   
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This service evaluation did not interfere with the procedure of induction of 
anaesthesia including the frequency of NIBP measurements. 
After completion of the process of induction of anaesthesia and when the 
anaesthetist was ready to move the patient from the anaesthetic room to the 
operating theatre, a post induction of anaesthesia pulse wave analysis SI and RI 
measurement was obtained and noted on the patient data sheet. 
The Finometer and the Pulse Trace device were switched off, disconnected from 
the patient, and the patient was moved from the anaesthetic room to the 
operating theatre. 
5.3.2.4 Data management 
Using BeatScope version 1.1a software (product of Finapres Medical Systems BV, 
Arnhem), beat-by-beat non-averaged raw data from the Finometer was retrieved 
on a computer in Microsoft excel format. The procedure of data retrieval from the 
Finometer is discussed in details in section 4.1.1.2.  
To be able to aQDO\VHWKH)LQRPHWHU¶V data, we needed to identify the 
haemodynamic readings that corresponded to different time points in induction of 
anaesthesia on the FinometeU¶VUDZGDWDH[FHOVSUHDGVKHHWVQDPHO\WKHVWDUW
and end of induction of anaesthesia, recordings at 0.5 minute intervals from the 
start to the end of induction of anaesthesia, measurements that correspond to 
the NIBP measurements that were taken during induction of anaesthesia, the 
highest and the lowest BP )LQRPHWHU¶Vreadings, and a few conditional criteria 
involving times spent when BP values were at predetermined levels. An example 
RIDSDWLHQW¶V )LQRPHWHU¶VUDZGDWDH[FHOVSUHDGVKHHWLVVKRZQLQILJXUH19; 
however, data in between highlighted time points was compressed for the 
purpose of illustration.    
 
Firstly, we were able to identify WKH)LQRPHWHU¶VUHDGLQJVWKDWFRUUHVSRQGHGWR
the NIBP measurements, E\PHDQVRIWKH³>)LQ@(YHQW0DUN´ODEHOs that were 
displayed on the )LQRPHWHU¶VUDZGDWDH[FHOspreadsheet. For the purpose of 
certainty, we double checked the exact timings from the manually noted timings 
RQWKHSDWLHQW¶VGDWDVKHHWV. We then highlighted the rows that displayed those 
readings RQWKH)LQRPHWHU¶VUDZGDWDH[FHOVSUHDGVKHHWand labeled them 
according to their sequence i.e. NIBP1, NIBP2, NIBP3 and NIBP4. The NIBP1 
reading was strictly at the time of pre induction of anaesthesia, whereas, NIBP2, 
NIBP3 and NIBP4 occurred either during induction of anaesthesia or post 
induction of anaesthesia. That depended upon the duration of the procedure of 
induction of anaesthesia, which ranged between 2 and 4 minutes.  
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Secondly, we used a different colour to highlight the rows in the )LQRPHWHU¶VUDZ
data excel sheet that corresponded to both, the timing of the start and the timing 
RIHQGRIWKHSURFHGXUHDQGODEHOHGWKHP³VWDUW´DQG³HQG´UHVSHFWLYHO\  
Using the same colour, we then highlighted the rows in the )LQRPHWHU¶VUDZGDWD
excel spreadsheet that displayed the haemodynamic variables at 0.5 minute 
intervals from the start of induction of anaesthesia all the way to the end, and 
labeled them as 0.5 min, 1 min, 1.5 min, 2 min, 2.5 min, 3 min, 3.5 min and 4 
min accordingly.  
Thirdly, the highest and lowest BP readings along with their corresponding values 
of CO, SV, HR and TPR were identified by using conditional formatting. 
Conditional formatting is a tool in Microsoft excel that enables the identification of 
the maximum values per variable from the whole data set. Using this tool, we 
were able to identify the highest and lowest SBP, DBP and MBP values. We then 
chose the row in the spreadsheet that represented the highest and lowest BP 
readings on the basis of, if 2 out of the 3 variables (SBP, DBP and MBP) were 
shown to coincide in being the highest and lowest readings respectively. We then 
used a different colour to highlight both the highest and the lowest BP rows that 
were chosen, and labeled WKHPDVWKH³KLJKHVW´DQGthe ³ORZHVW´UHDGLQJ. It 
needs to be mentioned that on rare occasions, no 2 readings happened to 
coincide in being the highest or lowest readings. In this case we used the SBP as 
the indicator of the highest and lowest BP readings. 
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Fourthly, we identified the absolute values of each of the 20% increase, 20% 
decrease, 30% increase, 30% decrease, 40% increase and 40% decrease of the 
SBP, DBP and MBP from baseline values (NIBP1) per patient. These values along 
with their corresponding rules were entered on separate occasions to the 
FRQGLWLRQDOIRUPDWWLQJWRROSHUSDWLHQW¶VUDZGDWD)LQRPHWHUVKHHW7KH
conditional formatting tool automatically highlighted all the rows that contained 
rules involving each of these criteria. For example, if we wanted to highlight all 
the MBP readings that showed a more than 30% increase from baseline, and the 
baseline MBP was 100 mmHg. In this case, the absolute value of the 30% 
increase from baseline would be 130 mmHg. We entered the number 130 in the 
conditional formatting tool of excel, followed by entering a rule that asks it to 
highlight all the MBP cells that contain a number higher than 130.  This has 
allowed us to calculate the time spent during each of the specified criteria. We 
also used conditional formatting to highlight the rows that contained 
measurements of the SBP that were less than 90 mmHg and rows that contained 
measurements of the MBP that were lower than 55 mmHg per patient and we 
calculated the total time spent in each.    
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Figure 19$QH[DPSOHRIWKH)LQRPHWHU¶VUDZGata sheets.  Haemodynamic data in 
between the highlighted events were deleted to be able to compress the file for the 
purpose of demonstration. 
   
)LQDOO\DOOWKHKLJKOLJKWHGGDWDIURPWKH)LQRPHWHU¶VUDZGDWDH[FHOVKHHWVZHUH
accordingly transferred into 4 master excel spreadsheets, each designed to tackle 
a different question: 
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5.3.2.4.1 Master spreadsheet 1 - Comparing blood pressure recordings obtained 
by the Finometer and the NIBP device 
This master spreadsheet was divided into 4 groups of columns according to the 
sequence of the NIBP measurements that were taken (NIBP1, NIBP2, NIBP3 and 
NIBP4). Each group of columns was further divided into 8 sub-columns, which 
ZHUH ODEHOHGDV1,%3¶V+56%3'%3DQG0%3DQG)LQRPHWHU¶V+56%3'%3
and MBP.  
Four sets of paired simultaneous Finometer and NIBP readings (NIBP1, NIBP2, 
NIBP3 and NIBP4), which were taken from the 100 patients at the times of pre, 
during and post induction of anaesthesia, were transferred from both the 
)LQRPHWHU¶V UDZ GDWD spreadsheet and the patient data sheets to master 
spreadsheet 1. This was accomplished by transferring the data sets that were 
labeled NIBP1, NIBP2, NIBP3 and NIBP4 from both the )LQRPHWHU¶V UDZ GDWD
spreadsheet and the patient data sheets to their specific columns on master 
spreadsheet 1 that were also labeled as, NIBP1, NIBP2, NIBP3 and NIBP4. The 
sums of paired measurements per set were 100, 95, 91 and 25 for NIBP1, NIBP2, 
NIBP3 and NIBP4 respectively. A total of 311 paired BP readings were available. 
This master spreadsheet was also designed to include other types of data, each 
in a designated column. The data included was the age, gender, diagnosis, 
surgical procedure, height, weight, smoking, ASA classification, diabetes (DM), 
hypertension (HTN), coronary artery disease (CAD), chronic obstructive 
pulmonary disease (COPD), and prescribed medications (steroids, statins and 
anti-hypertensive, anti-ischaemic heart disease and glycaemic control drugs). 
Also, anaesthetic drugs (thiopental, propofol, sevoflurane, isoflurane, nitrous 
oxide (N2O), Opioids (morphine, fentanyl, alfentanil and remifentanil), muscle 
relaxants (Succinyl choline, atracrurium and rocuronium), benzodiazepines, and 
vasopressor drugs. The type of airway procedure was also included (oral and 
nasal endotracheal tube (ETT), laryngeal mask airway (LMA) and tracheostomy 
tube). It needs to be mentioned that all the categorical data included in this 
master spreadsheet wHUHVFRUHGE\HLWKHU³´RU³´DFFRUGLQJWRWKHDEVHQFHRU
the presence of the parameter respectively, for example,  
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if a patient was hypertensive, ³1´ was to be typed into the designated cell in the 
master spreadsheet, whereas, if not hypertensive, ³0´ was to be typed in the 
designated cell.      
5.3.2.4.2 Master spreadsheet 2 ± Gross haemodynamic changes that occurred 
during routine induction of anaesthesia as detected by the Finometer 
Master spreadsheet 2 was divided into 2 main sections, the first section was 
GHVLJQHGWRGHDOZLWKWKH)LQRPHWHU¶VGDWDDQGthe second section was designed 
to deal with the data obtained from the Pulse Trace device.  
The first section was divided into 9 groups of columns according to their 
corresponding time intervals during the course of induction of anaesthesia (pre-
induction (baseline) reading, 0.5 min, 1 min, 1.5 min, 2 min, 2.5 min, 3 min. 3.5 
min and 4 min). Each group of columns was formed of 7 sub-columns that were 
labeled as SBP, DBP, MBP, HR, SV, CO and TPR. 
From the )LQRPHWHU¶VUDZGDWDVSUHDGVKHHWs, the highlighted rows of data that 
were labeled as baseline, 0.5 min, 1 min, 1.5 min, 2 min, 2.5 min, 3 min. 3.5 
min and 4 min were transferred each to its designated position on master 
spreadsheet 2. 
The Pulse wave analysis data was manually transferred from the patient data 
sheets to their corresponding positions in master spreadsheet 2. The differences 
between the pre and post induction of anaesthesia SI and RI readings along with 
the percentage change of the pre and post induction readings, were calculated 
using the formula tool in Microsoft excel. 
5.3.2.4.3 Master spreadsheet 3 - Time and magnitude of haemodynamic changes 
as detected by the Finometer  
Master spreadsheet 3 was divided into 2 main identically designed sections, the 
highest )LQRPHWHU¶VBP reading (peaks) and the lowest )LQRPHWHU¶V BP reading 
(troughs) sections. Each of these sections was composed of 3 groups of columns 
(baseline reading, peak / trough absolute value, and percentage change of peak / 
trough from baseline reading columns). Each of the columns was further divided 
into 7 columns, which displayed the values of SBP, DBP, MBP, HR, CO, SV and 
TPR. A separate column that showed the time lag between the peak / trough and 
the next available NIBP measurement was also included.  
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Data including the baseline readings, and the peak and trough values were 
WUDQVIHUUHGIURPWKH)LQRPHWHU¶VUDZGDWDVKHHWVWRPDVWHUVSUHDGVKHHW7KH
percentage changes of peaks and troughs were calculated on master spreadsheet 
3 using Microsoft H[FHO¶V³IRUPXOD´WRRO The time lags between the peaks / 
troughs and the next available NIBP measurements were calculated from the 
)LQRPHWHU¶VUDZGDWDVKHHWV 
5.3.2.4.4 Master spreadsheet 4 - Time and magnitude of haemodynamic changes 
as detected by the NIBP  
Master spreadsheet 4 was divided into 2 main identically designed sections, the 
highest NIBP reading (peaks) and the lowest NIBP reading (troughs) sections. 
Each of the sections was composed of 3 groups of columns (baseline reading, 
peak / trough absolute value, and percentage change of peak / trough from 
baseline reading columns). Each of the columns was further divided into 4 
columns, which displayed the values of SBP, DBP, MBP, and HR. A separate 
column that showed the time lag between the peak / trough and the next 
available NIBP measurement was also included. Data including the baseline 
readings, and the peak and trough values were transferred from the 100 SDWLHQWV¶
data sheets to master spreadsheet 4. The percentage changes of peaks and 
troughs were calculated on master spreadsheet 4 XVLQJ0LFURVRIWH[FHO¶V
³IRUPXOD´WRRO7KHWLPHODJVEHWZHHQWKHSHDNVWURXJKVDQGWKHQH[WDYDLODEOH
NIBP measurements were calculated from the SDWLHQWV¶ data sheets.  
 
Having completed the 4 master spreadsheets, the data were ready for further 
analysis. Analysis of the data will be discussed in details later, each in its relevant 
section. 
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5.4  Results: Cohort analysis 
In our service evaluation, the Finometer measurements were attempted in 104 
patients in total, out of whom; measurements were not successful in 4 patients 
due to inability of the Finometer to detect a pulse waveform. Successful 
measurements were generated in 100 patients, equating to a 96% success rate. 
On the other hand NIBP devices failed to detect blood pressure measurements 5 
times out of 316 attempts and that was due to substantial decreases in the blood 
pressure, which were detected by the Finometer at that time. 
With regards to the Pulse trace device, only 52 complete sets of pre and post 
induction SI and RI recordings were successful out of 100 attempts. 
 The characteristics of our cohort of patients are displayed in table 2. The type of 
surgery, and the drugs and techniques used during induction of anaesthesia are 
displayed in tables 3 and 4 respectively.  
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Table 2. Cohort characteristics (n = 100) 
 Mean (SD), n of patients or percentage 
Age 53 (19) years 
Gender  
o Male 50% 
o Female 50% 
Height (cm) 171 (8)  
Weight (kg) 77 (16)  
ASA  
o ASA 1 22 patients  
o ASA 2 50 patients 
o ASA 3 24 patients 
o ASA 4 4 patients 
Smokers 18% 
DM 6% 
HTN 33% 
CAD 9% 
COPD 6% 
Prescribed medications  
o Statins 9% 
o Steroids 5% 
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Table 3. Type of surgery (n = 100) 
Procedure Percentage 
Emergency 20% 
Hepato-pancreatico-biliary (HPB) 16% 
Gastro-intestinal (GI) 17% 
Orthopaedics 7% 
Neuro-surgery 10% 
Ear- nose - throat surgery (ENT) 22% 
Dental 6% 
Neuro-X-ray 2% 
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Table 4. Anaesthetic drugs and techniques used during induction of anaesthesia (n = 100) 
 Percentage 
Anaesthetic drug  
o Propofol 96% 
o Thiopental 4% 
o Midazolam 7% 
o Sevoflurane 58% 
o Isoflurane 37% 
o N2O 5% 
Opioid  
o Morphine 2% 
o Fentanyl 63% 
o Alfentanil 23% 
o Remifentanil 8% 
Muscle relaxant  
o Succinyl Choline 10% 
o Rocuronium 47% 
o Atracrurium 26% 
Vasoactive drugs 3% 
Airway management technique  
o ETT (oral) 85% 
o ETT (nasal) 5% 
o LMA 6% 
o Tracheostomy tube 1% 
 
Of the 100 patients, a vasoconstrictor agent was administered to 3 patients 
during the course of induction of anaesthesia due to major decreases in blood 
pressure according to measurements obtained by NIBP device. Endotracheal 
intubation was unsuccessful in 1 patient, and the surgery was postponed. Two 
patients underwent minor surgical procedures including manipulation under 
anaesthesia of total knee replacement and evacuation of retained products of 
conception to which neither endotracheal intubation nor laryngeal mask airway 
were attempted.   
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5.5  Results: Comparison of blood pressure 
measurements using NIBP and the Finometer 
during routine induction of anaesthesia  
This section presents an evaluation of the accuracy of the Finometer during 
routine induction of anaesthesia, by comparing its BP readings to those 
simultaneously obtained by the NIBP device during routine induction of 
anaesthesia. 
5.5.1 Data handling and statistics 
The data that we needed for comparing the measurements of the Finometer with 
the NIBP¶V was obtained from master spreadsheet 1.  Master spreadsheet 1 is 
discussed in details in section 5.3.2.4.1. 
All the 311 pairs of simultaneous NIBP and Finometer SBP, DBP and MBP 
measurements were transferred collectively from master spreadsheet 1 to the 
Prism software for further statistical analysis. Using the Prism software, we 
performed an assessment of the correlation and linear regression to each set of 
311 pairs of the SBP, DBP and MBP variables obtained from both the NIBP and 
the Finometer. The correlation and linear regression techniques are discussed in 
details in section 4.2.5. 
We also assessed for the agreement between both the NIBP and the Finometer 
devices using the Bland and Altman analysis in the Prism software. This was 
carried out for each set of the 311 pairs of SBP, DBP, and MBP data. It needs to 
be mentioned that we have performed a naïve analysis and not corrected for 
repeated measurements as our sample size was big (100 patients) in relation to 
the small number of repeated measurements (3.1 measurements).190 The Bland 
and Altman technique is discussed in details in section 4.2.4.  
For further assessment of the accuracy of the Finometer in comparison to the 
NIBP, we applied the BHS and the AAMI criteria for accuracy of novel BP devices. 
We collectively gathered the 311 pairs of both, the SBP and DBP sets of data 
from master spreadsheet 1 and transferred the data to a new clear excel sheet 
for the purpose of working out the BHS criteria on the gathered SBP and DBP 
data. The BHS workout excel sheet consisted of 2 sets of columns, one for the 
SBP and the other for the DBP.  
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Each set of columns was further divided into 3 sub-columns, including an NIBP 
SBP/DBP column, a Finometer SBP/DBP column and a column for the difference 
between the values of both devices. We used the ³countif´ tool in excel, which 
counts the cells in a certain variable column that contain a pre set rule to 
calculate the number of readings present in the (difference between devices) 
column of each of the SBP and DBP, which contained values that are less than 
5.1 mmHg, 10.1 mmHg and 15.1 mmHg. From these values we calculated the 
percentages of each of the numbers of readings that were PP+J
mm+JDQGPP+JIURP the total 311 readings, and applied the BHS criteria 
for accuracy of BP devices as illustrated in table 1. 7KH³FRXQWLI´WRROLVGLVFXVVHG
in more details in section 6.3.2.4. 
The AAMI criteria for accuracy of BP devices were also applied to the same sets 
of SBP and DBP data. The BHS and the AAMI criteria are discussed in details in 
sections 4.2.6 and 4.2.7 respectively.  
 We also compared the NIBP and the Finometer in terms of the ability to track 
the changes in BP during induction of anaesthesia. Baseline NIBP (SBP, DBP and 
MBP) readings and Finometer (SBP, DBP and MBP) readings along with the 
second NIBP (SBP, DBP and MBP) readings and Finometer (SBP, DBP and MBP) 
readings were transferred from master spreadsheet 1 to a clear excel sheet.  
On this excel sheet, the percentage changes of both, the second NIBP (SBP, DBP 
and MBP) readings and the second Finometer (SBP, DBP and MBP) readings from 
their corresponding baseline values were calculated. 95 simultaneous NIBP and 
Finometer (SBP, DBP and MBP) percentage change readings were available, 
which were then transferred to the Prism software for further analysis. The 
analysis included correlation and linear regression along with Bland and Altman 
techniques, which were described in details earlier. 
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5.5.2 Results  
5.5.2.1 Correlation, and Bland and Altman analysis of the BP 
measurements of NIBP vs. Finometer   
The averaged values of the 311 simultaneous pairs of NIBP and Finometer 
measurements obtained from our 100 patients, were 130 (27) vs. 131 (30) 
mmHg for SBP, 72 (17) vs. 76 (17) mmHg for DBP and 94 (20) vs. 97 (21) 
mmHg for MBP.  
On applying correlation and linear regression analysis to each of the 311 
simultaneous pairs of SBP, DBP and MBP measurements, a significant correlation 
was shown between the measurements of the NIBP and the Finometer. The r2 
and p values for the SBP, DBP and MBP were r2 = 0.75 and P<0.0001, r2 = 0.51 
and P<0.0001, and r2 = 0.74 and P<0.0001 respectively. 
As mentioned earlier in section 4.2.4, the Bland and Altman technique assesses 
the limits of agreement of two devices, by plotting the differences against the 
averages of the readings simultaneously obtained from both devices on a graph. 
From this graph, the bias and the 95% limits of agreement are calculated. We 
applied the Bland and Altman technique and assessed the limits of agreements 
between the NIBP and the Finometer. The 311 pairs of simultaneous SBP, DBP 
and MBP measurements were plotted on 3 graphs. Our results showed that the 
bias and the 95% limits of agreement between the NIBP and the Finometer were 
within an acceptable range.  The bias for SBP, DBP and MBP was -0.82, -3.83 and 
-3.12 mmHg respectively and the 95% limits of agreement (mean difference ± 
1.96 SD) for the SBP, DBP and MBP were -31 to +29, -29 to +21 and -25 to +18 
mmHg respectively. The line of goodness of fit showed that the Finometer under-
read the SBP values in relation to the NIBP. It over-read the DBP at values lower 
than 70 mmHg and under-read it at values above 70mmHg. It showed that both 
devices were equal in terms of the MBP. See figures 20, 21 and 22. 
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Figure 20. Pooled data for the SBP measurements of NIBP vs. Finometer.  Upper panel: 
Correlation and linear regression of pooled data for NIBP against Finometer. Lower panel: 
Bland-Altman plot of the differences between NIBP & Finometer against their averages.  
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Figure 21. Pooled data for the DBP measurements of NIBP vs. Finometer.  Upper panel: 
Correlation and linear regression of pooled data for NIBP against Finometer. Lower panel: 
Bland-Altman plot of the differences between NIBP & Finometer against their averages. 
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Figure 22. Pooled data for the MBP measurements of NIBP vs. Finometer.  Upper panel: 
Correlation and linear regression of pooled data for NIBP against Finometer. Lower panel: 
Bland-Altman plot of the differences between NIBP & Finometer against their averages.  
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5.5.2.2 The BHS validation 
As mentioned earlier in section 4.2.6, the British Hypertension Society criteria for 
accuracy of BP machines are met when a BP machine achieves grade A/B when 
compared to the sphygmomanometer method according to the calculations 
displayed on table 1. On applying the BHS criteria to our 311 simultaneous pairs 
of SBP and DBP measurements, we found similar accuracy of the Finometer, but 
in comparison with the NIBP device (table 5). 
 
Table 5. Assessment of the accuracy of the Finometer by applying the BHS criteria (n of 
readings = 311) 
Absolute difference between NIBP and Finometer 
 PP+J PP+J PP+J 
Cumulative 
percentages 
SBP % DBP% SBP % DBP% SBP % DBP% 
71 85 81 92 90 95 
Grade  A A B A B A 
 
5.5.2.3 The AAMI validation 
As mentioned earlier in section 4.2.7, The AAMI criteria for accuracy of BP 
machines are met when the mean difference between the novel device and the 
mercury device is less than 5 mmHg, with a standard deviation of less than 8 
mmHg for both the SBP and the DBP. We applied the AAMI criteria and used the 
NIBP as the standard device to validate against instead of the mercury device, to 
all our 311 pairs of NIBP and Finometer SBP and DBP sets of data. Our results 
showed that the Finometer failed to meet the AAMI criteria for accuracy of BP 
devices. The mean difference (standard deviation) between the Finometer and 
the NIBP was ± 0.8 (15.2) mmHg for SBP, and ± 3.8 (12.7) mmHg for DBP. 
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5.5.2.4 Comparison of NIBP and Finometer in terms of the ability to track 
relative changes in BP 
As mentioned earlier in section 5.5.1, we compared 95 pairs of simultaneous 
NIBP and Finometer (SBP, DBP and MBP) percentage change from baseline 
readings, using correlation, linear regression, and Bland-Altman analysis.  
A significant correlation was shown between the NIBP and the Finometer in terms 
of tracking BP changes from baseline. The r2 and p values for the dSBP, dDBP 
and dMBP were r2 = 0.76 and P<0.0001, r2 = 0.69 and P<0.0001, and r2 = 0.82 
and P<0.0001 respectively. 
 Bland and Altman analysis showed that the bias for dSBP, dDBP and dMBP was -
4.1, 2.29 and -1.03 % respectively, and the 95% limits of agreement (mean 
difference ± 1.96 SD) for the dSBP, dDBP and dMBP were -27 to +18, -24 to +27 
and -20 to +18 % respectively. See figures 23, 24 and 25. 
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Figure 23. Pooled data for the dSBP measurements of NIBP vs. Finometer.  Upper panel: 
Correlation and linear regression of pooled data for NIBP against Finometer. Lower panel: 
Bland-Altman plot of the differences between NIBP & Finometer against their averages. 
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Figure 24. Pooled data for the dDBP measurements of NIBP vs. Finometer.  Upper panel: 
Correlation and linear regression of pooled data for NIBP against Finometer. Lower panel: 
Bland-Altman plot of the differences between NIBP & Finometer against their averages. 
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Figure 25. Pooled data for the dMBP measurements of NIBP vs. Finometer.  Upper panel: 
Correlation and linear regression of pooled data for NIBP against Finometer. Lower panel: 
Bland-Altman plot of the differences between NIBP & Finometer against their averages. 
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5.5.3 Discussion 
Our aim in this section was to assess the accuracy of the Finometer in terms of 
BP monitoring, in comparison with the conventional NIBP device. Using 
correlation and linear regression techniques, a significant correlation was shown 
between the NIBP and the Finometer, the r2 and p values for the SBP, DBP and 
MBP were r2 = 0.75 and P<0.0001, r2 = 0.51 and P<0.0001, and r2 = 0.74 and 
P<0.0001 respectively. Bland and Altman analysis for assessment of the limit of 
agreement between the NIBP and the Finometer in our data, showed that the 
bias for SBP, DBP and MBP was -0.82, -3.83 and -3.12 mmHg respectively, and 
the 95% limits of agreement (mean difference ± 1.96 SD) for the SBP, DBP and 
MBP were -31 to +29, -29 to +21 and -25 to +18 mmHg respectively. The 
Finometer under-read the SBP values in relation to the NIBP. It over-read the 
DBP at values lower than 70 mmHg and under-read it at values above 70mmHg. 
Both devices were equal in terms of the MBP. As mentioned earlier, the AAMI 
criteria for validation of BP measuring devices considers a ELDVRIPP+JDQG
a VWDQGDUGGHYLDWLRQRIGLIIHUHQFH6''RIPP+Jas acceptable. According 
to these criteria, an acceptable range of 95% limits of agreement (1.96 SD) 
between two devices equates to 16 mmHg. Moreover, in a study by McCann and 
colleagues 5607 pairs of simultaneous noninvasive BP (Vasotrac) and intra-
arterial BP readings were compared. Their results in terms of Bland-Altman 
analysis of the SBP showed that the bias was 1.7 mmHg and that the 95% limit 
of agreement was -15.7 to 19.1 mmHg, and these results were considered 
acceptable for accuracy.191 Furthermore, Bruya and Demand stated that an 
acceptable range of difference between direct and indirect BP monitoring is 5 to 
20 mmHg in critically ill patients, and that a range of up to 30 mmHg is 
considered acceptable in certain conditions such as post cardiac and vascular 
surgeries.192 Accordingly, our results in terms of the limits of agreement can be 
considered clinically acceptable.   
Furthermore, we applied both the BHS criteria and the AAMI criteria for validation 
of novel BP devices to our data. The Finometer met the BHS criteria. However, it 
failed to meet the AAMI criteria.  
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We also showed that the Finometer is comparable to the NIBP in terms of 
tracking the relative changes in BP during induction of anaesthesia. The r2 and p 
values for the dSBP, dDBP and dMBP were r2 = 0.76 and P<0.0001, r2 = 0.69 and 
P<0.0001, and r2 = 0.82 and P<0.0001 respectively. Bland and Altman analysis 
showed that the bias for dSBP, dDBP and dMBP was -4.1, 2.29 and -1.03 % 
respectively, and the 95% limits of agreement (mean difference ± 1.96 SD) for 
the dSBP, dDBP and dMBP were -27 to +18, -24 to +27 and -20 to +18 % 
respectively. 
Our results indicate that the Finometer is a fairly accurate BP monitoring device 
for clinical use. 
Similar accuracy of the Finometer in terms of BP monitoring was shown in several 
other studies. Hehenkamp and colleagues performed a study to validate 
Portapres, which is the portable version of the Finometer against the standard 
Riva-Rocci/Korotkoff (RRK) method, 30 normotensive pregnant ladies and 20 
pre-eclamptic patients were enrolled in the study. Portapres met the AAMI 
criteria for accuracy of BP measuring devices. In regards to the BHS criteria, only 
DBP measurements met the criteria. A possible explanation for their failure to 
meet the BHS criteria could be the small number of subjects enrolled in their 
study, as it was clearly mentioned in the BHS protocol150 that a minimum of 85 
subjects are needed to validate a BP device.143  
Another study by Guelen and colleagues assessed the accuracy of the Finometer 
against the brachial arterial pressure that is generated by the Finometer through 
applying the RRK method, on 37 post coronary angiography patients. Their 
results showed that the Finometer met the AAMI criteria149 for accuracy of 
automated blood pressure devices.144  
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Schutte and colleagues also performed a validation study and subsequently 
compared the Finometer to the Riva-Rocci/Korotkoff sphygmomanometer 
method. 102 females; 24 were hypertensive, 25 obese normotensive and 35 lean 
normotensive were the subject of the study. Accuracy of the Finometer was 
assessed using the AAMI, and the BHS criteria of validation of BP devices in both, 
the total 102 patients and each of the subgroups. The Finometer met the 
validation criteria of the AAMI, and the BHS in all subgroups groups and in total.8 
It should be noted that a possible limitation to our work, is that we did not totally 
abide to the BHS and the AAMI protocols, in the sense that we compared the 
Finometer to the NIBP device rather than the standard mercury method. Also, 
according to these criteria, simultaneous readings from the same arm are 
preferable to simultaneous readings from contralateral arms. As mentioned 
earlier, we compared readings from contralateral arms rather than the same arm 
in our service evaluation, due to the fact that if both devices were applied to the 
same arm, the Finometer might have stopped working every time the NIBP 
device took a measurement.  The fact that we did not totally abide to the AAMI 
protocol may explain the failure of our results to meet its criteria.  
5.5.4 Conclusion 
The Finometer has met the BHS criteria for accuracy of BP machines, and has 
shown reliability in terms of BP monitoring during induction of anaesthesia. 
Hence, it shows potential for use in operating theatres, in particular, whenever 
continuous BP monitoring is required.  
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5.6  Results: Haemodynamic changes during routine 
induction of anaesthesia  
This section presents an assessment of the haemodynamic changes that occur 
during routine induction of anaesthesia, including the incidence of transient 
hypotension episodes as detected by the Finometer. 
5.6.1 Data handling and statistics 
The data required for the assessment of the gross haemodynamic changes that 
occur during induction of anaesthesia was retrieved from master spreadsheet 2. 
Master spreadsheet 2 is discussed in details in section 5.3.2.4.2. 
In regards to the assessment of the incidence of transient hypotension episodes, 
we obtained the required data for each patient from the SDWLHQW¶VFRUUHVSRQGLQJ
)LQRPHWHU¶VUDZGDWDVKHHW, as discussed in section 5.3.2.4. 
The highest BP (peaks) and lowest BP (troughs) readings that occurred during 
induction of anaesthesia were obtained from master spreadsheet 3. Master 
spreadsheet 3 is discussed in details in section 5.3.2.4.3. 
Firstly, to assess the gross haemodynamic changes that occurred during the 
period of induction of anaesthesia, we transferred the haemodynamic data of 
SBP, DBP, MBP, HR, SV, CO and TPR at baseline, 0.5 min, 1 min, 1.5 min, 2 min, 
2.5 min, 3 min, 3.5 min and 4 min intervals from master spreadsheet 2 to the 
Prism software, and applied ANOVA with repeated measures DQG7XNH\¶VSRVW
hoc test to the intervallic GDWDRIHDFKYDULDEOH$129$DQG7XNH\¶VSRVWKRFWHVW
is discussed in details in section 4.2.2. 
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We then assessed the effect of induction of anaesthesia on arterial stiffness, by 
transferring the pre and post induction values of the SI and RI from master 
spreadsheet 2 to the Prism software. Using prism software, we used a paired 
6WXGHQW¶VWWHVWWRFRPSDUHHDFKRIWKHSUHDQGSRVWLQGXFWLRQUHDGLQJs of SI, 
and the pre and post induction readings of RI.  
Secondly, we used 4 definitions of transient hypotension episodes during 
induction of anaesthesia: SBP < 80 mmHg, MBP < 55 mmHg, and a more than 
40% decrease in SBP and MBP from baseline values, all for more than 1 minute. 
We further defined a clinically significant change in BP as a 20% change from its 
baseline value.193 We pinned out the number of patients who had a clinically 
significant decrease / increase in SBP, DBP and MBP. The data needed for these 
assessments of BP changes was gathered IURPWKH)LQRPHWHU¶VUDZGDWD
spreadsheets, as described in section 5.3.2.4.   
Thirdly, we used master spreadsheet 3 to bring the values of the BP peaks and 
troughs during induction of anaesthesia, along with their corresponding HR, SV, 
CO and TPR values. The percentage changes of all those values from their 
baseline values were also brought from master spreadsheet 3. We then 
transferred all that data to the Prism software, and performed a paired t test to 
compare the peak / trough of each of the SBP, DBP and MBP variables with their 
baselinHYDOXHV:HDOVRFRPSDUHGWKHSHDN¶VWURXJK¶VFRUUHVSRQGLQJ values of 
SV, CO, HR and TPR with their baseline values using a paired t test.  
Finally, we classified our patients into 2 groups; a hypertensive group (33 
patients) and a normotensive group (67 patients), and compared the 
hypertensive responses to induction of anaesthesia in both groups. Absolute and 
relative values of the SBP, DBP and MBP were obtained from master spreadsheet 
3, and transferred to the Prism software. An un-paired t test was performed 
using the Prism software to compare both groups of patients in terms of the 
absolute and relative values of each of the SBP, DBP and MBP peaks and troughs. 
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5.6.2 Results 
 
The most commonly used anaesthetic agents during induction of anaesthesia 
were propofol, an opioid, and isoflurane or sevoflurane. 
 
5.6.2.1 Sample of Finometer traces recorded by BeatScope software from 
patients undergoing induction of anaesthesia  
 
3 samples of Finometer traces showing the BP changes in response to induction of 
anaesthesia are displayed in figures  
 
Figure 26, 27 and 28. A drop in BP is usually encountered shortly after the start 
of induction of anaesthesia. It is sustained till endotracheal intubation is carried 
out, which leads to a sudden rise in the BP.  
 
 
Figure 26. Finometer trace 1 (patient 81) 
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Figure 27. Finometer trace 2 (patient 37) 
 
 
 
 
 
Figure 28. Finometer trace 3 (patient 10) 
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5.6.2.2  Haemodynamic changes during induction of Anaesthesia 
The blood pressure decreased significantly as early as 30 seconds after induction 
of anaesthesia. There were corresponding significant decreases in the SV and CO. 
However, corresponding changes in heart rate (HR) and total peripheral 
resistance (TPR) were not significant (table 6). 
 
 
Table 6. Mean (SD) of haemodynamic variables during induction of anaesthesia as 
assessed by the Finometer 
 
Interval 
(min) 
Baseline 
(n=100) 
0.5 min 
(n=99) 
1.5 min 
(n=98) 
2.5 min 
(n=81) 
3.5 min 
(n=32) 
P value 
HR  
(beats/m) 
77 (15) 80 (17) 76 (18) 77 (17) 80 (22) 0.6767 
SBP 
(mmHg) 
145 (23) 125 (37) 119 (39) 116 (44) 127 (27) <0.0001* 
DBP 
(mmHg) 
78 (14) 73 (20) 73 (22) 71 (25) 77 (27) 0.0272* 
MBP 
(mmHg) 
103 (16) 92 (24) 91 (28) 89 (32) 96 (33) 0.0008* 
SV (ml) 77 (32) 67 (28) 59 (25) 59 (25) 61 (22) <0.0001* 
CO (l/m) 5.9 (2.6) 5.2 (2.3) 4.4 (2) 4.5 (2.2) 4.9 (2.1) <0.0001* 
TPR (MU) 1.35 
(0.96) 
1.47 
(1.35) 
1.74 
(1.96) 
1.49 
(1.04) 
1.53 
(1.36) 
0.6016 
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5.6.2.3 Incidence and magnitude of hypotension encountered during 
induction of anaesthesia 
 
According to the definitions of hypotension used (SBP less than 80 mmHg, MBP 
less than 55 mmHg and a more than 40% decrease from baseline SBP and MBP 
readings for more than 1 minute), 9-30% of the patients had an episode of 
transient hypotension as detected by the Finometer during induction of 
anaesthesia. Of the 100 patients, 19 patients have sustained an episode of 
hypotension where the SBP was less than 80 mmHg for more than 1 minute (see 
tables 7 and 8).  
 
Table 7. Number of patients with episodes of hypotension sustained for more than 1 
minute during induction of anaesthesia as indicated by SBP less than 80 mmHg, MBP less 
than 55 mmHg and a more than 40% decrease from baseline SBP and MBP readings.  
Finometer SBP <80 MBP <55 SBP >40% Ļ  MBP >40% Ļ  
n of patients 
(n = 100) 
19 
 
9 
 
 
30 
 
 
19 
 
 
 
 
Table 8. Number of patients sustaining the episode of SBP < 80 mmHg 
Interval >1 min >2 min >3 min >4min 
n of patients 
(n = 100) 
19 6 6 1 
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5.6.2.4 Clinically significant drops in BP 
 
Clinically significant drops in BP, defined as a more than 20% decrease from the 
baseline values of the SBP, DBP and MBP were encountered in 83%, 64% and 
73% of our patients respectively at some stage during induction of anaesthesia 
and more than 30% of those sustained it for more than 2.5 minutes.  
 
5.6.2.5 Maximum decrease in BP encountered during induction of 
anaesthesia 
 
The percentage changes of the SBP, MBP and DBP values during the lowest blood 
pressure readings (troughs) from their baseline values were 38%, 32% and 28% 
respectively. 
 Using a paired t test to compare the SBP, DBP and MBP values during the BP 
trough with their baseline values, a statistically significant decrease in the SBP, 
MBP and DBP was shown. See table 9.  
The corresponding changes in HR, CO, SV and TPR from their baseline values are 
displayed in table 10; the changes in HR, CO, SV and TPR were 3%, 24%, 23% 
and 8% respectively. 
 Using a paired t test to compare the HR, CO, SV and TPR during the BP trough 
with their baseline values, a statistically significant decrease in the CO and SV 
was shown. The HR and TPR remained stable.  
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Table 9.  Percentage change of lowest BP readings (troughs) from baseline as detected by 
the Finometer (n = 100) 
 
Baseline 
 
Trough 
% change of 
trough from 
baseline 
P value 
SBP (mmHg) 145 (23) 89 (26) 38 % <0.0001* 
MBP (mmHg) 103 (16) 70 (16) 32 % <0.0001* 
DBP (mmHg) 78 (14) 56 (16) 28 % <0.0001* 
 
 
 
 
Table 10. The changes in HR, CO, SV &TPR during the BP trough (n = 100) 
 Baseline 
Reading 
during BP 
trough 
% change 
from baseline 
P value 
HR (beats/min) 77 (15) 75 (18) 3 % 0.1024 
CO (l/min) 5.9 (2.6) 4.2 (2.1) 24 % <0.0001* 
SV (ml) 77.1 (32) 56.0 (25) 23 % <0.0001* 
TPR (MU) 1.4 (1) 1.3 (1) 8 % 0.79 
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5.6.2.6 Clinically significant rises in BP 
Clinically significant elevations in BP, defined as a more than 20% increase from 
the baseline values of the SBP, DBP and MBP were encountered in 53%, 74% and 
67% of our patients respectively at some stage during induction of anaesthesia.  
 
5.6.2.7 Maximum increase in BP encountered during induction of 
anaesthesia 
The percentage changes of the SBP, MBP and DBP values during the highest 
blood pressure readings (peaks) from their baseline values were 24%, 29% and 
33% respectively.  
Using a paired t test to compare the SBP, DBP and MBP values during the BP 
peaks with their baseline values, a statistically significant increase in the SBP, 
MBP and DBP was shown. See table 11.  
The corresponding changes in HR, CO, SV and TPR from their baseline values are 
displayed in table 12; the changes in HR, CO, SV and TPR were 19%, 4%, 18% 
and 64% respectively.  
Using a paired t test to compare the HR, CO, SV and TPR during the BP peaks 
with their baseline values, a statistically significant decrease in the CO and SV 
and a statistically significant increase in the HR and TPR was shown.  
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Table 11.  Percentage change of highest BP readings (peaks) from baseline as detected by 
the Finometer (n = 100) 
 
Baseline 
 
peak 
% change of 
peak from 
baseline 
P value 
SBP (mmHg) 145 (23) 180 (34) 24 % <0.0001* 
MBP (mmHg) 103 (16) 133 (26) 29 % <0.0001* 
DBP (mmHg) 78 (14) 104 (23) 33 % <0.0001* 
 
 
 
 
Table 12. The changes in HR, CO, SV &TPR during the BP peak (n = 100) 
 Baseline 
Reading 
during BP 
peak 
% change 
from baseline 
P value 
HR (beats/min) 77 (15) 89 (20) 19 % <0.0001* 
CO (l/min) 5.9 (2.6) 5.3 (2.9) 4 % 0.0107* 
SV (ml) 77.1 (32) 61 (32) 18 % <0.0001* 
TPR (MU) 1.4 (1) 1.96 (1.3) 64 % <0.0001* 
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5.6.2.8 Comparison of hypertensive vs. normotensive patients in terms 
of magnitude and percentage change of BP peaks from baseline 
during induction of anaesthesia  
 
As mentioned earlier in section 5.6.1, we assigned our patients into 2 groups 
according to the incidence of hypertension amongst them, into a hypertensive 
group and a normotensive group.  
Using an unpaired t test, we then compared the two groups¶ SBP, DBP and MBP 
absolute values during the highest BP readings (peaks). We also compared the 
percentage changes of these SBP, DBP and MBP values from their baseline values 
in both groups. No significant difference between the 2 groups in either of the 
comparisons was shown (table 13).   
 
Table 13. Hypertensive vs. normotensive hypertensive response to induction of 
anaesthesia 
 
Hypertensive 
(33/100) 
Normotensive 
(67/100) 
P value 
Peak SBP 187 (36) 177 (33) 0.1592 
Peak MBP 133 (30) 133 (24) 0.99 
Peak DBP 102 (27) 106 (21) 0.497 
dSBP 24% 26% 0.7448 
dMBP 27% 33% 0.259 
dDBP 32% 38% 0.281 
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5.6.2.9 Effect of induction of anaesthesia on arterial stiffness 
 
Table 14 shows a comparison between the pre induction and post induction of 
anaesthesia readings of the SI and RI. A statistically significant difference is 
shown between pre and post induction of anaesthesia readings of both, SI and 
RI. 
 
Table 14. Effect of induction of anaesthesia on stiffness index (SI) and reflection index RI 
(n of readings = 52)  
 
Pre induction of 
anaesthesia 
Post induction of 
anaesthesia 
% change p value 
SI 
(m/s) 
10.15 (3.38) 8.56 (2.86) 16 % 0.0039* 
RI (%) 70 (14) 61 (17) 13 % 0.0006* 
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5.6.3 Discussion 
We used continuous noninvasive haemodynamic monitoring by the Finometer as 
part of this service evaluation to characterise the haemodynamic changes that 
occur during routine induction of anaesthesia.  
Collective analysis of our LQGLYLGXDOSDWLHQW¶Vhaemodynamic data showed that 
there was a significant decrease in BP as early as 0.5 minutes from the start of 
induction of anaesthesia. There were corresponding significant decreases in the 
SV and CO, HR and TPR remained stable however. 
The incidence of transient hypotension episodes that lasted for more than 1 
minute in our patients ranged between 9 and 30%. That depended upon the 
definition of hypotension that we used. As discussed later in this section, previous 
studies reported that episodes of hypotension of SBP less than 80 mmHg are 
associated with poor patient outcomes. Of the 100 patients, 19 patients had such 
an episode of SBP less than 80 mmHg for more than 1 minute. 
We defined a clinically significant change in BP as a more than 20% change from 
its baseline value. Clinically significant transient decreases in BP were 
encountered in more than 60% of our patients at some stage during induction of 
anaesthesia. On the other hand, clinically significant transient increases in BP 
were encountered in more than 50% of our patients at some stage during 
induction of anaesthesia. 
During induction of anaesthesia, both the lowest BP readings (troughs) and the 
highest BP readings (peaks) that were recorded by the Finometer showed a 
statistically significant change from their baseline values. CO and SV values 
during both the troughs and peaks in BP were significantly lower than their 
baseline readings. Moreover, during the BP trough the HR and TPR remained 
stable, but during the BP peak, the HR and TPR were significantly higher than 
their baseline values.  
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We also showed that in our cohort of patients, there was no significant difference 
between the hypertensive patients and the normotensive patients in terms of 
both, the magnitude of the BP peaks and their relative change from baseline. 
In terms of the assessment of the effects of induction of anaesthesia on arterial 
stiffness, we found a statistically significant difference between the pre and post 
induction of anaesthesia values of both the SI and the RI.  
Confirming our finding of the high prevalence of hypotension during induction of 
anaesthesia, Bijker and colleagues applied the 25 most frequently used 
definitions of Intraoperative hypotension (IOH) in literature, on 15,509 patients 
undergoing non-cardiac surgery. Their results showed an incidence of IOH that 
ranged between 5% and 99% according to the IOH definition implied.55 Possible 
explanations for their wider range of incidence of IOH compared to our findings; 
is that they used 25 definitions of IOH in contrast to only the 4 definitions that 
were used in our service evaluation, also, the fact that our observations were 
only during induction of anaesthesia, compared to the entire operative procedure 
BP surveillance in their study.  
Another study that was published in 2009 by Bijker and colleagues focused on 
the association of IOH with 1 year mortality after non-cardiac surgery.  The most 
frequently used 16 IOH definitions in previous literature were applied on 1705 
patients undergoing non-cardiac surgery. Their results showed that the following 
definitions showed a trend of a higher 1 year mortality rate in elderly patients: 
SBP lower than 80 mmHg, MBP lower than 60 mmHg and a 40-45% decrease in 
both SBP and MBP from baseline values, all definitions for a duration of at least 1 
minute.4 Furthermore, Monk and colleagues showed a 3.6% increase in 1 year 
mortality risk for every 1 min the SBP was lower than 80 mmHg during non-
cardiac surgery.5 These results may serve as an explanation to the reason for 
specifically choosing those 4 definitions of hypotension in our service evaluation. 
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2¶5HLOO\DQGFROOHDJXHVUHWrospectively identified the incidence of hypotension 
episodes in 2383 patients who have been anaesthetised for surgery. They defined 
hypotension episodes as SBP values between 90 and 70 mmHg for more than 5 
minutes in case of continuous BP monitoring, and for 3 consecutive readings in 
case of NIBP monitoring. Their results showed that SBP levels that were equal to 
or lower than 85 mmHg were independent predictors of mortality. They also 
showed a linear relationship between mortality and SBP values lower than 90 
mmHg.56  
Sympathetic stimulation encountered during surgery at times like induction of 
anaesthesia, can elevate the blood pressure by 20 ± 30 mmHg in normotensive 
patients. This response is exaggerated even more in hypertensive patients.194   
Reich and colleagues studied the effect of Intraoperative hypertension on the 
negative surgical outcome (NSO), which was defined as: a more than 10 days 
stay in hospital with a postoperative morbid state, or in-hospital mortality. 797 
patients were the subject of their study, who were further divided into 2 groups; 
388 patients with long operation durations (more than 220 min operation 
duration) and 409 patients with short operation durations (less than 220 min 
operation duration). The BP and HR raw data was available at 15 second intervals 
from computerised anaesthesia information systems (CompuRecord; Philips, 
Andover, MA), from which the median values of the SBP, DBP MBP and HR were 
calculated per 5 minute epoch. Their results showed, no significant association 
between the incidence of epochs of SBP > 160 mmHg and NSO in the short 
operation duration group. However, in the long operation duration group, 48% of 
the patients had an epoch of SBP above 160 mmHg during the course of the 
operation, and that was associated with a NSO.179 $SRVVLEOHOLPLWDWLRQWR5HLFK¶V 
study is that only one definition of hypertension based on an absolute value was 
used rather than the relative change from baseline.  
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It needs to be mentioned that we have not assessed for the incidence of episodes 
of hypertension, as we were just studying the effects of anaesthesia during the 
short period of induction, where hypertension is likely to occur only momentarily 
in response to intubation. Thus, we only assessed for the acute BP elevations in 
response to induction of anaesthesia. 
Owing to the fact that this was a service evaluation where we did not make any 
changes to the standard of care that was delivered to our patients, we were only 
able to assess the crude changes in arterial stiffness rather than the endothelial 
function changes in response to induction of anaesthesia. Measurement of the 
endothelial function is a procedure involving a relative assessment of the effects 
of two drugs on the arterial stiffness; salbutamol, which is a ß2-adrenoreceptor 
agonist that initiates an endothelial dependent vasodilatory response via 
stimulating endothelial nitric oxide synthase, and glyceryl trinitrate, which 
initiates an endothelial independent vasodilatory response mediated by nitric 
oxide (NO)178, 195 Then the effects of induction of anaesthesia on arterial stiffness 
were to be assessed and compared to the measured endothelial function. 
Our results indicate that the Finometer shows potential for routine use in 
operating theatres via providing comprehensive noninvasive continuous 
haemodynamic monitoring especially during the period of induction of 
anaesthesia, where substantial fluctuations in the BP are likely to occur, along 
with the high incidence of transient hypotension episodes that are known to be 
associated with deleterious patient outcomes. 
Further studies are warranted to assess for perioperative morbidity and mortality 
in association with haemodynamic aberrations that occur during anaesthesia. 
Other studies to assess the effect of anaesthetic drugs used during induction of 
anaesthesia on the endothelial function are also encouraged. Finally, studies to 
evaluate whether extra information about haemodynamic changes, as assessed 
by the Finometer, have an impact on clinical management of haemodynamics 
during induction of anaesthesia.  
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5.6.4 Conclusion 
BP instability is commonly encountered during routine induction of anaesthesia. 
Decreases in BP at the start of induction of anaesthesia are associated with a 
stable HR and TPR, and a decreased SV and CO, whereas, increases in the BP at 
airway management are associated with a rise in HR and TPR, and a fall in SV 
and CO.  
Transient significant hypotension episodes are commonly encountered during 
induction of anaesthesia. 
The hypertensive response to intubation was similar in hypertensive and 
normotensive patients. 
A decline in the arterial stiffness in response to induction of anaesthesia occurs.  
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5.7 Results: Conventional intermittent blood pressure 
monitoring or continuous noninvasive 
haemodynamic monitoring in detecting maximum 
changes in BP that occur during routine induction of 
anaesthesia 
 
In this section, we have compared the ability of the conventional NIBP monitoring 
and the continuous noninvasive haemodynamic monitoring (Finometer) in 
detecting BP aberrations that occur during induction of anaesthesia.  
 
5.7.1 Data handling and statistics 
 
We obtained the percentage change from baseline values of the lowest BP 
readings (troughs) and the highest BP readings (peaks), of the Finometer and the 
NIBP from master spreadsheets 3 and 4 respectively. We then transferred these 
readings to the Prism software, and using a paired t-test, we compared the 
1,%3¶VDQGWKH)LQRPHWHU¶s percentage changes from baseline values of the SBP, 
DBP and MBP readings during the BP trough / peak. Master spreadsheets 3 and 4 
are discussed in details in sections 5.3.2.4.3 and 5.3.2.4.4 respectively. 
We also compared the Finometer and the NIBP devices in terms of the number of 
patients detected, who had either a 30% increase or a 30% decrease in BP from 
baseline values, by using a Chi squared test in Prism software. The data that was 
used for this comparison was obtained from the SDWLHQWV¶FiQRPHWHU¶VUDZGDWD
spreadsheets, which are discussed in details in section 5.3.2.4. 
The time lag between both the highest and the lowest blood pressure values 
recorded by the Finometer and their next available NIBP measurement, were 
obtained from master spreadsheet 3.   
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5.7.2 Results  
5.7.2.1 Comparison between the Finometer and the NIBP for the ability 
to detect BP troughs 
On comparing the NIBP and the Finometer devices in terms of the ability to 
detect the maximum decreases in BP (troughs) from their baseline values, we 
found that the intermittent measurements by NIBP underestimated the 
magnitude of the BP troughs in comparison to the Finometer, as shown in table 
15.  
We then compared the ability of both devices to detect the number of patients 
who had a significant decrease in BP during induction of anaesthesia, defined as 
more than 30% decrease in SBP, DBP and MBP from baseline values regardless 
of the duration. The number of patients who had significant hypotension was 
underestimated by the NIBP in comparison to the Finometer (Table 16); this was 
mainly because the intermittent recordings often missed the maximum changes 
seen on continuous monitoring due to the time lag between the drop in BP and 
the next available NIBP reading, as shown in table 17. The mean time lag 
between lowest BP readings detected by the Finometer and the next available 
NIBP readings was 1 m 29 s.  
 
Table 15. Comparison between percentage changes of lowest blood pressure readings 
from baseline (NIBP vs. Finometer) (n = 100)  
 
% change of trough 
from baseline 
(NIBP) 
% change of trough 
from baseline 
(Finometer) 
Difference P value 
SBP 24 % 38 % 14 %  <0.0001* 
DBP 22 % 28 % 6 % <0.0001* 
MBP 22 % 32 % 11 % <0.0001* 
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Table 16.  n of readings >30% decrease from baseline as detected by NIBP vs. Finometer 
 
n of readings>30% 
decrease from base 
(NIBP) n=100 
n of readings>30% 
decrease from base 
(Finometer) n=100 
p value (Chi 
squared test) 
SBP 27 63 <0.0001* 
DBP 25 33 0.2745 
MBP 25 52 0.002* 
 
 
Table 17. Time lag between lowest blood pressure readings detected by the Finometer and 
next available NIBP readings 
Time lag < 1 min 1-2 min > 2 min 
n of patients 
(n = 100) 
37 35 28 
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5.7.2.2 Comparison between Finometer and NIBP for the ability to detect 
BP peaks  
We compared the NIBP and the Finometer devices in terms of the ability to 
detect the maximum increases in BP (peaks) from their baseline values. Our 
results showed that the intermittent measurements by NIBP underestimated the 
magnitude of the BP peaks in comparison to the Finometer as illustrated in table 
18.  
We then compared the ability of both devices to detect the number of patients 
who had a significant hypertension during induction of anaesthesia, defined as 
more than 30% increase in SBP, DBP and MBP from baseline values regardless of 
the duration. The number of patients who had significant hypertension was 
underestimated by the NIBP in comparison to the Finometer (Table 19); as the 
case with hypotension, this was mainly because the intermittent recordings often 
missed the maximum changes seen on continuous monitoring due to the time lag 
between the BP peak and the next available NIBP reading, as shown in table 20. 
The mean time lag between highest BP readings detected by the Finometer and 
the next available NIBP readings was 1 m 54 s.  
 
Table 18. Comparison between percentage changes of highest BP readings from baseline 
(NIBP vs. Finometer) (n = 100)  
 
% change of peak 
from baseline 
(NIBP) 
% change of peak 
from baseline 
(Finometer) 
Difference P value 
SBP 12 % 25 % 13 %  <0.0001* 
DBP 16 % 36 % 20 % <0.0001* 
MBP 22 % 31 % 9 % <0.0001* 
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Table 19.  n of readings >30% increase from baseline as detected by NIBP vs. Finometer 
 
n of readings>30% 
increase from base 
(NIBP) n=100 
n of readings>30% 
increase from base 
(Finometer) n=100 
p value (Chi 
squared test) 
SBP 5 41 <0.0001* 
DBP 14 55 <0.0001* 
MBP 13 48 <0.0001* 
 
 
Table 20. Time lag between highest BP readings detected by the Finometer and next 
available NIBP readings 
Time lag < 1 min 1-2 min > 2 min 
n of patients 
(n = 100) 
20 36 44 
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5.7.3 Discussion 
In this section, we assessed the ability of the NIBP to provide sufficient BP 
surveillance during routine induction of anaesthesia by comparing it with 
continuous noninvsive BP monitoring using the Finometer. It was shown in 
section 5.6 that routine induction of anaesthesia is associated with substantial BP 
changes.  
Firstly, we compared the NIBP¶V and the Finometer¶V ability to detect the 
magnitude of both BP peaks and BP troughs. Our results showed that the NIBP 
underestimated the magnitude of both the BP peaks and the BP troughs in 
comparison to the Finometer. 
Secondly, ZHFRPSDUHGERWKGHYLFHV¶DELOLW\WRLGHQWLI\WKHQXPEHURISDWLHQWV
who had significant hypotension and the number of patients who had significant 
hypertension during induction of anaesthesia. The NIBP underestimated both, the 
number of patients who had significant hypotension and the number of patients 
who had significant hypertension in comparison with the Finometer.  
Thirdly, we indicated the time lag between each of the BP peaks and the BP 
troughs that were detected by the Finometer and their next available NIBP 
measurements. The average time spent between each of WKH)LQRPHWHU¶V%3
troughs and BP peaks, and their next available NIBP measurements was 1 m 29 s 
and 1 m 54 s respectively.  
In support of our findings, Dueck and Jameson compared the ability of NIBP and 
continuous noninvasive BP monitoring brought by the Tensys T-line® device, in 
detecting episodes of hypotension, defined as SBP <85 mmHg for more than 5 
min, in 25 patients during the whole period of anaesthesia. The NIBP missed 
22% of the hypotension episodes and there was a delayed detection in a further 
22% in comparison with continuous noninvasive BP monitoring.196  
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Furthermore, Siebig and colleagues assessed the advantage of using continuous 
noninvasive BP monitoring by means of a CNAP® device (CN Systems, Graz) in 
40 sedated patients undergoing endoscopic procedures. A total of 103117 CNAP 
measurements and 333 NIBP measurements were recorded and analysed. They 
calculated the variance of the CNAP readings during the time between each two 
consecutive NIBP readings (NIBP interval). Mean (SD) of the NIBP intervals was 
7.5 (4.6) minutes. Results of variance in relation to baseline NIBP values showed 
a 30.85% decrease and a 22.43% increase of the CNAP MBP readings for every 
NIBP interval.  Moreover, they noticed that 15.8% of the readings that were 
obtained by the CNAP showed a clinically significant (more than 20%) change 
from baseline NIBP values. They also showed that 3.6% of their CNAP SBP values 
were below 100 mmHg and that none of those were detected by the NIBP. A 
possible limitation to their study is that the ethics committee did not accept 
blinding of the CNAP BP measurements to the attending endoscopists, which 
explains the long NIBP intervals and the possibility of overestimating the 
inaccuracy of the NIBP in detecting BP changes in their results.193 
Our results show that during induction of anaesthesia, continuous noninvasive BP 
monitoring using the Finometer provides better surveillance of the BP in 
comparison to the conventional intermittent NIBP devices, which would allow the 
attending anaesthetist to promptly intervene in response to potentially harmful 
BP aberrations and achieve a tighter BP control. Extra safety to the patient may 
be added in doing that. Further studies are warranted to explore this potential. 
5.7.4 Conclusion 
Significant changes in BP are encountered during routine induction of 
anaesthesia. Their magnitude is underestimated, and detection delayed or missed 
by NIBP monitors. Continuous noninvasive BP monitoring by the Finometer 
provides more comprehensive BP surveillance during induction of anaesthesia, 
which may enhance patient safety. 
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5.8 Results: An example of the haemodynamic changes 
during the whole period of anaesthesia as detected 
by the Finometer 
 
We approached one of the neuro-surgery oSHUDWLQJWKHDWUHVLQ4XHHQ¶V0HGLFDO
Centre NHS Trust, as part of our service evaluation. The same procedure of 
patient and anaesthetist consent that was discussed earlier was followed. 
We recruited a 77 year old male patient, known hypertensive on a beta blocker, 
and his ASA was 2. He was diagnosed with a chronic subdural haematoma and 
scheduled for burr-hole evacuation.  
The Finometer was applied to the patient and was kept running all the way from 
the pre induction period till the patient was moved from the operating theatre to 
UHFRYHU\)LQRPHWHU¶VGDWDZDVUHWULHYHGRQD)LQRPHWHU¶VUDZGDWDH[FHOVKHHW
:HXVHGWKH)LQRPHWHU¶VUDZGDWDH[FHOVKHHWWRSORWWZRJUDSKVERWKVKRZLQJ
the haemodynamic variables at 10 second intervals. One graph displayed the 
SBP, DBP, MBP, HR, SV (figure 29), and the other displayed the CO and TPR 
(figure 30). We used two graphs rather than one, to accommodate the range 
differences between different haemodynamic variables. In both graphs we used 
blue longitudinal lines to mark the time points corresponding to NIBP 
measurements that were taken during the procedure, and red longitudinal 
labeled lines to mark the time points corresponding to actions taken during the 
whole period of anaesthesia.   
The NIBP data was manually noted on a patient data sheet. We transferred the 
1,%3¶66%3'%3DQG0%3GDWDIURPWKHSDWLHQWGDWDVKHHWLQWRDQHZFOHDUH[FHO
VKHHWDQGSORWWHGDWKLUGJUDSKWKDWGLVSOD\HGWKH1,%3¶66%3'%3DQG0%3
values over time (figure 31). Once again, we used red longitudinal labeled lines 
to mark the time points corresponding to actions taken during the whole period 
of anaesthesia. 
  
139 
 
The red longitudinal labeled lines in the 3 graphs (figures 29, 30, and 31) 
represented the following actions: 
Line A: One litre intravenous fast drip administered. 
Line B: Start of induction of anaesthesia. 
Line C: Endo-tracheal intubation. 
Line D, G and H: Metaraminol (alpha adrenergic agonist that causes 
vasoconstriction) administered. 
Line E: Knife to skin. 
Line F: One litre intravenous slow drip administered. 
Line I: Skin stitches. 
Line J: Anaesthetics reduced. 
Line K: Suctioning. 
Line L: Extubation and airway placement. 
 
Anaesthesia was induced by propofol and rocuronium, and maintained by 
sevoflurane. 
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Figure 31.  Graph showing the changes in SBP, DBP and MBP as detected by the NIBP during a whole surgical procedure. Red lines correspond to actions 
taken during the procedure 
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This shows how a number of peaks and troughs in BP can be detected by continuous 
Finometry, and that the associated changes in CO and TPR can guide the 
anaesthetist to undertake appropriate corrective measures.  
On the other hand, haemodynamic information generated by the NIBP during the 
whole period of general anaesthesia was limited to the detection of few points when 
WKH%3GURSSHGWRDQ6%3OHYHOPP+J 
In the pre-induction of anaesthesia period, both the SV and the CO were low; their 
values were 42 ml and 1.99 L / min respectively. The BP was maintained by an 
elevated TPR of 2.771 MU (normal TPR range is 0.6-1.4 MU (mmHg/ml/sec)), 
indicating that the patient was dehydrated. Over the course of anaesthesia and 
surgery, administration of IV fluids seems to have increased the CO and decrease 
735DQGVWDELOLVHSDWLHQW¶VRYHUDOOFRQGLWLRQ6XFKLQIRUPDWLRQLVQRWSRVVLEOHIURP
NIBP alone. 
In summary, conventional NIBP monitoring indicated that our patient was 
haemodynamically stable prior to surgery. However, the extra haemodynamic 
information that was generated by the Finometer revealed that the patient was 
GHK\GUDWHG2QWKHEDVLVRIWKH)LQRPHWHU¶VH[WUDLQIRUPDWLRQ,QWUDYHQRXVIOXLGV
ZHUHDGPLQLVWHUHGDQGWKHSDWLHQW¶VYROXPHVWDWXVZDVVKRZQWRnormalise 
approximately 1 hour after induction. This extra knowledge that was offered by the 
Finometer raises the question of whether the quality of care provided to the patient 
in terms of better haemodynamic stability would have further improved, if we had 
used the Finometer a few hours before the operation to noninvasively detect the 
SDWLHQW¶VYROXPHVWDWXVDWDQHDUOLHUVWDJHKHQFHJLYLQJWKHFKDQFHWRRSWLPLVHWKH
SDWLHQW¶VYROXPHVWDWXVSULRUWRVXUJHU\   
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5.9  Summary 
Our results have clearly demonstrated that continuous noninvasive haemodynamic 
monitoring using the Finometer provides better surveillance of blood pressure 
changes than the conventional NIBP during induction of anaesthesia. In order to 
demonstrate that, we carried out a 3 step analysis protocol of our beat-by-beat 
data:  
First, we assessed the feasibility of using the Finometer during induction of 
anaesthesia, and it has shown both accuracy and reliability in terms of BP monitoring 
in comparison with the conventional NIBP device.  
Second, we characterised the haemodynamic response to routine induction of 
anaesthesia. Significant decreases in the BP were shown that were associated with 
falls in the SV and CO. Also, significant increases in the BP were shown, which were 
associated with rises in the HR and TPR, and falls in the SV and CO. We also 
demonstrated that the BP reached unsafely low levels which were sustained for more 
than 1 min in 9-30% of our patients depending on the definition of hypotension 
used.  
Third, we showed that continuous noninvasive BP monitoring using the Finometer is 
more reliable in instant detection of the commonly occurring BP aberrations than the 
conventional intermittent NIBP monitors, which not only underestimated, but even 
missed more than 50% of those aberrations Also, extensive time lags between the 
BP aberrations that were detected by the Finometer and their next available NIBP 
measurements were encountered.  
Monitoring of induction of anaesthesia by NIBP devices has long been considered 
standard practice. However, based on our findings of the high incidence of significant 
changes in the BP, we believe that noninvasive continuous haemodynamic 
monitoring of routine induction of anaesthesia may provide better patient safety. 
Furthermore, additional data generated by the Finometer such as SV, CO and TPR 
may serve as guidance for prompt and proper management of haemodynamics. 
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A possible limitation to our service evaluation is that when we applied the BHS and 
AAMI criteria for accuracy of BP devices, we compared the Finometer with the NIBP, 
rather than the standard sphygmomanometer method, which is not used currently in 
clinical practice. Also we compared Finometer and NIBP readings taken from 
contralateral arms, which is not preferable by the BHS and AAMI protocols. Lastly, 
the Finometer readings were not blinded to the anaesthetists.  
In our service evaluation, we showed an association between hypotension during 
induction of anaesthesia and a significant decrease in SV, which validates the 
question whether preoperative fluid optimisation can provide better haemodynamic 
stability during anaesthesia. We also believe that the Finometer can be used to 
characterise the haemodynamic responses to different anaesthetic agents and 
procedures during the whole course of anaesthesia.  
We also showed the potential benefits of using the Finometer during the whole 
period of anaesthesia in comparison with the current NIBP measurement protocols. 
In conclusion, continuous noninvasive BP monitoring using the Finometer is 
acceptable in terms of BP monitoring. Potentially, it provides higher levels of patient 
safety during routine induction of anaesthesia than the conventional intermittent 
NIBP monitors, through better detection of BP aberrations. Further studies are 
encouraged to assess the feasibility of using continuous noninvasive BP monitoring 
during the entire surgical procedure. 
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6  A service evaluation of maintenance haemodialysis 
involving an assessment of the adequacy of the 
currently used intermittent noninvasive blood 
pressure (NIBP) devices in detecting BP 
aberrations 
6.1  Introduction 
 
Patient safety has been an area of major concern to health care providers during the 
last 3 decades. Major advancements in quality assessment tools and protocols have 
been accomplished. Many health care areas have been successfully assessed, and 
subsequently, measures to enhance the level of patient safety have been adopted.197 
During maintenance haemodialysis, where a large volume of fluids (2-4 litres) is 
removed from the circulation over a period of 3-4 hours, putting into consideration 
that the blood volume of a patient on haemodialysis is approximately 4.5 litres, of 
which the plasma volume contributes to almost 3 litres. Therefore, it would not be 
surprising if haemodynamic instability occurred during haemodialysis, especially that 
patients on chronic haemodialysis are known to have a variety of co-morbid 
conditions that may affect the integrity of their regulating cardiovascular responses 
to haemodialysis induced hypovolaemia. However, traditional intermittent 
monitoring of blood pressure in dialysis units does not reflect the need for enhanced 
haemodynamic monitoring which these patients would require. 
Ideally, maintenance haemodialysis would be best monitored haemodynamically on 
continuous basis using an intra-arterial catheter, but due to its invasive nature and 
the risk of complications, its routine use in chronic haemodialysis patients is not 
justified. Maintenance haemodialysis is conventionally monitored by the intermittent 
NIBP devices; a predialysis and a post-dialysis reading are usually taken. Extra NIBP 
readings are taken whenever the patient experiences symptoms suggestive of 
hypotension, such as unexplained anxiety, headache, nausea, vomiting and 
muscular cramps.   
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6.2     Aim  
Considering recent evidence suggesting that Intradialytic BP aberrations are 
associated with a poor patient outcome, we conducted this service evaluation and 
used continuous noninvasive haemodynamic monitoring by the Finometer, to assess 
the severity of both, intradialytic hypotension and intradialytic hypertension during 
maintenance haemodialysis. We have specifically chosen the procedure of 
maintenance haemodialysis as we anticipated major haemodynamic changes to 
occur during its course. Explanations for these anticipated haemodynamic changes 
are discussed in the previous section.  
We assessed WKH)LQRPHWHU¶Vfeasibility in terms of BP monitoring during 
maintenance haemodialysis, by comparing its accuracy and success rate with the 
NIBP devices that are being used conventionally.  
Our main objective in this service evaluation was to assess the adequacy of the 
currently employed NIBP monitoring protocols in detecting BP aberrations and thus 
the level of patient safety they provide during maintenance haemodialysis.    
To evaluate this, we followed a 3 step analysis protocol: 
o Step 1: We compared the blood pressure measurements simultaneously 
obtained by the Finometer and the NIBP during maintenance haemodialysis 
o Step 2: We characterised the haemodynamic changes occurring during 
maintenance haemodialysis as assessed by the Finometer 
o Step 3: We evaluated the ability of the intermittent NIBP monitors to instantly 
detect maximum changes in BP as they occur in comparison with the Finometer 
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6.3  Patients and methods 
6.3.1 Patients 
 
This service evaluation was conducted in the Haemodialysis Unit of the Nottingham 
City Hospital NHS Trust, over a period of 4 months from September to December 
2009. Twenty five patients undergoing maintenance haemodialysis were the subject 
of our service evaluation.   
  
6.3.2 Methods 
6.3.2.1 Patient recruitment  
The Renal Unit at Nottingham City Hospital is composed of two haemodialysis units 
for stable patients. The Main Dialysis Unit and the Centenary Unit which can 
accommodate up to 26 and up to 14 patients per dialysis session respectively, with a 
total capacity of 40 patients per session.  
Each of the haemodialysis units delivers 3 haemodialysis sessions per day, six days a 
week. The first session starts at 7:00 am and ends at 11:00 am, the second session 
starts at 12:00 pm and ends at 4:00 pm and the third session starts at 6:00 pm and 
ends at 10:00 pm. Chronic haemodialysis patients typically attend 3 evenly spaced 
haemodialysis sessions per week, for example on Monday, Wednesday and Friday.  
We did not approach unstable patients, who were dialysed in a third unit called the 
Lamley unit. 
A total of 33 stable patients undergoing maintenance haemodialysis were 
approached. Patient information leaflets were handed out to patients 2-3 days prior 
to the haemodialysis session that was to be evaluated. The service evaluation was 
fully explained in terms of the purpose behind conducting it. We briefly described the 
Finometer and how it works. We also gave emphasis to the fact that there was no 
obligation to taking part and that the service evaluation would not interfere with the 
treatment received in any way and that they can opt out of the evaluation at any 
time without that affecting their standard care in any means.  
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We also explained that their personal details will be kept confidential and that this 
service evaluation is a one off event that takes place during one haemodialysis 
session only. There was no bias in selecting patients; any patient undergoing 
maintenance haemodialysis regardless of age or gender was recruited. A verbal 
approval from the patient for taking part in the service evaluation was ensured. The 
patient was monitored with Finometer if he / she agreed.  
  
6.3.2.2 Data collection 
'DWDZDVJDWKHUHGIURPWKHSDWLHQWWKHSDWLHQW¶VKRVSLWDOILOH the renal unit 
computer record system (RS 6000 and NOTIS systems), the NIBP monitor, the 
Finometer and from the attending staff. The data collected included the following: 
x Demographic data (age, gender, height, weight and vintage) 
x Co-morbidities  
x Prescribed medications 
x Dialysis related technical information (Interdialytic weight gain, residual 
urine, fluid to be removed, pump speed and type of vascular access) 
x Renal related medical history (duration on haemodialysis and duration on 
renal replacement therapy) 
x Full record of the NIBP measurements predialysis and post-dialysis 
x Finometer data 
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6.3.2.3 Methodology protocol 
 
Flow chart 
Potential Participant given information 2-3 days before haemodialysis session 
       
Patient approval obtained before commencing haemodialysis 
       
Finometer blood pressure cuff & finger cuff attached 
       
Haemodialysis starts 
       
Haemodialysis ends 
       
Disconnecting Finometer 
       
Data analysis 
 
 
Haemodialysis was delivered either through an arterio-venous (AV) Fistula or a 
central line. In patients with AV fistulae, the Finometer was applied to the non-
access arm, to not interfere with the dialysis procedure and also due to the fact that 
the normal haemodynamic properties of the fistula arm would have been altered. In 
patients with central lines, the use of either arm was considered acceptable, thus, 
we applied the Finometer to the arm opposite to that which was chosen by the 
attending staff for NIBP measurements.  
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It needs to be mentioned that simultaneous Finometer and NIBP measurements 
from the same arm are not always successful, as the NIBP measurements will 
completely block the arterial supply of the arm, so the Finometer may stop working. 
 An appropriately sized finger cuff was applied to the index or middle finger and the 
Finometer was started. Cross over between the 2 fingers during haemodialysis was 
done whenever the patient felt uncomfortable because of the finger cuff. The 
procedure of operating the Finometer is discussed in details in section 4.1.1.1. 
Concerning patients with AV fistulae, NIBP measurements were strictly taken by the 
attending staff from the non-access arm, which is the same arm used by the 
Finometer. Therefore, we had to stop the Finometer after it has taken initial 
measurements to let the attending staff obtain a predialysis NIBP reading, then we 
re-applied the Finometer once the NIBP reading was taken. This has caused a delay 
of approximately 5 minutes between the predialysis Finometer reading and its 
corresponding predialysis NIBP reading. However in patients with central line access, 
we were able to obtain an NIBP reading from one arm and a simultaneous reading 
from the other arm. Finometer was then kept running throughout the entire 
haemodialysis session. Also, at the end of the dialysis session, the Finometer had to 
be stopped in patients with AV fistulae as they were requested to apply pressure on 
the site of haemodialysis using the arm that was used by the Finometer to control 
any bleeding. As soon as the bleeding was controlled the Finometer was re-attached 
and kept operating for 5 minutes to bring a post dialysis reading. Once the post 
dialysis Finometer reading was obtained, the Finometer was stopped and a post 
GLDO\VLV1,%3PHDVXUHPHQWZDVREWDLQHGIURPWKH)LQRPHWHU¶VDUP  
On the other hand, in patients with central line access the Finometer was kept 
operating throughout the entire haemodialysis session, including the time when a 
post dialysis NIBP measurement was taken by the attending staff from the other 
arm. 
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All actions taken during the procedure of maintenance haemodialysis were noted in 
WKHSDWLHQW¶VGDWDVKHets along with their times, which were obtained strictly from 
WKH)LQRPHWHU¶VFORFNIRUthe purpose of standardisation. These actions included the 
start and the end of the procedure, and the NIBP measurements. In patients with 
central line vascular access, we SUHVVHGWKH)LQRPHWHU¶V>PDUN@EXWWRQZKHQHYHr an 
NIBP measurement was taken simultaneously whilst the Finometer was operating. 
The mark option of the Finometer is discussed in section 5.3.2.3.   
6.3.2.4 Data management 
Using BeatScope version 1.1a software (product of Finapres Medical Systems BV, 
Arnhem) data from the Finometer was retrieved on a computer in Microsoft excel 
format, and beat-by-beat haemodynamic data obtained from the Finometer was 
further averaged over 10 second intervals. The procedure of data retrieval from the 
Finometer is discussed in details in section 4.1.1.2. 
We applied fairly similar methods to those previously used in the service evaluation 
RILQGXFWLRQRIDQDHVWKHVLDWRDQDO\VHWKH)LQRPHWHU¶VGDWDEXWZLWKDIHZ
alterations in both the figures and the techniques (section 5.3.2.4).  
 In brief, we identified the haemodynamic readings that corresponded to different 
time points during the pURFHGXUHRIKDHPRGLDO\VLVRQWKH)LQRPHWHU¶VUDZGDWDH[FHO
spreadsheets. These were the haemodynamic readings at the times of the start and 
readings at 0.5 hours intervals from the start till the end of haemodialysis, readings 
that correspond to the NIBP measurements taken, the highest and the lowest BP 
readings, and a few conditional criteria involving time durations when BP values 
were at predetermined levels (figure 19).  
  
 
 
153 
 
In patients with central line vascular access, we were able to identify and highlight 
WKH)LQRPHWHU¶VUHDGLQJVWKDWVLPXOWDQHRXVO\FRUUHVSRQGHGWRWKH1,%3UHDGLQJV by 
XVLQJWKH³>)LQ@(YHQW0DUN´ODEHOVWKDWZHUHGLVSOD\HGRQWKH)LQRPHWHU¶VUDZGDWD
excel spreadsheet. However, in patients with AV fistulae, we simply highlighted the 
readings that were closest in WLPLQJWRWKH1,%3¶V7KHVHKLJKOLJKWHGUHDGLQJVZHUH
accordingly labeled as NIBP1 (pre dialysis reading) and NIBP2 (post dialysis 
reading).  
Using a different colour, we then highlighted the start and the end of the procedure, 
and rows of haemodynamic variables corresponding to 0.5 hour, 1 hour, 1.5 hours, 
2 hours, 2.5 hours, 3 hours, 3.5 hours and 4 hours from the start to the end of the 
haemodialysis procedure.  
We then used the ³conditional formatting´ tool that is available in Microsoft excel to 
identify the highest and lowest SBP, DBP and MBP values. Both, the row that 
represented the highest BP value and the row that represented the lowest BP 
readings were chosen on the basis of, if two out of the three readings of SBP, DBP 
and MBP coincided in being the highest and the lowest readings respectively. On a 
few occasions when those criteria were not met, we simply chose the row that 
involved the highest BP and the lowest BP reading according to the highest SBP and 
the lowest SBP values respectively. The chosen highest and lowest BP rows were 
then highlighted using a third colour.  
Lastly, we averaged the haemodynamic data in this service evaluation over 10 
seconds rather than on beat-by-beat basis, which enabled us to make use of the 
³countif´WRRORI0LFURVRIWH[FHO7KH³FRXQWLI´WRROFRXQWs the cells in a certain 
YDULDEOHFROXPQWKDWFRQWDLQDSUHVHWUXOHDQGVLQFHHDFKFHOOLQRXU)LQRPHWHU¶V
raw data sheet represented 10 seconds, all we had to do was multiply the number of 
FHOOVWKDWZHUHFDOFXODWHGE\WKH³countif´WRROE\ZKLFKJDYH the total duration 
spent according to the pre set rule in seconds, and by dividing this number by 60 it 
was converted into minutes.  
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The procedure we followed to identify the amount of time spent during each preset 
definition of hypertension and hypotenVLRQXVLQJWKH³FRXQWLI´WRROZDVDVIROORZV
We identified the absolute values of the 30% increase and the 30% decrease of the 
SBP, DBP and MBP from their baseline values per patient. These values along with 
their corresponding rules (e.g. countif the cells that contain readings higher than 
180) were entered separately to the ³FRXQWLI´WRRO SHUSDWLHQW¶VUDZGDWD)LQRPHWHU
excel sheet7KH³FRXQWLI´WRROWKHQcounted all the cells that met the entered rule.  
This has allowed us to calculate the time spent during each of the specified 
hypotension and hypertension definitions. We also used the ³FRXQWLI´tool to 
calculate the duration of time spent when the SBP readings were lower than 90 
mmHg, and higher than both, 160 mmHg and 180 mmHg.  
All the collected data including the data that was highlighted on the Finometer¶VGDWD
spreadsheets were transferred to 3 master excel spreadsheets, each designed to 
tackle a different question. These 3 spreadsheets were quite similar to those that 
were used in the service evaluation of induction of anaesthesia (sections 5.3.2.4.1, 
5.3.2.4.2 and 5.3.2.4.3). 
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The following 3 sections include descriptions of the 3 master spreadsheets that were 
used in this service evaluation: 
 
6.3.2.4.1 Master spreadsheet 1 - Comparing blood pressure recordings obtained by 
the Finometer and the NIBP device 
Master spreadsheet 1 was divided into 2 sections: The first section included 2 groups 
of columns (NIBP1 and NIBP2). Each group of columns was further divided into 8 
sub-columns, which were labeled DV1,%3¶V+56%3'%3DQG0%3DQG)LQRPHWHU¶V
HR, SBP, DBP and MBP. Two sets of paired Finometer and NIBP readings that were 
taken from the 25 patients at the times of pre dialysis and post dialysis were 
transferred from both the SDWLHQW¶VGDWDVKHHWVDQGWKH)LQRPHWHU¶VUDZGDWD
spreadsheets to their corresponding sites in master spreadsheet 1.  
The second section was designed to include other sets of data, each in a designated 
column. These data included the age, gender, height, weight, smoking, Haemoglobin 
(Hb) level, DM, HTN, CAD, COPD, and prescribed medications (statins, angiotensin 
converting enzyme inhibitors (ACEi) / angiotensin receptor blockers (ARB), beta 
blockers, calcium channel blockers, diuretics, insulin, oral hypoglycaemic drugs, anti-
ischaemic heart disease drugs, steroids, midodrine (vasoconstrictor) and others). We 
also included columns for haemodialysis related issues including, autonomic 
neuropathy, vascular calcification, hyperparathyroidism, Interdialytic weight gain, 
residual urine, amount of fluid to be removed, vascular access (AV fistula and central 
line), pump speed, duration on renal replacement therapy (RRT) and duration on 
haemodialysis.  
Categorical data was VFRUHGE\HLWKHU³´RU³´DFFRUGLQJWRWKHDEVHQFHRUWKH
presence of the parameter respectively. An illustrative example is given in section 
5.3.2.4.1.  
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6.3.2.4.2 Master spreadsheet 2 - Gross haemodynamic effects of maintenance 
haemodialysis as detected by the Finometer 
Master spreadsheet 2 was divided into 10 groups of columns according to their 
corresponding time intervals during the course of haemodialysis, a pre dialysis 
reading, readings at 0.5 hour, 1 hour, 1.5 hours, 2 hours, 2.5 hours, 3 hours, 3.5 
hours and 4 hours, and a post dialysis reading. As discussed earlier in section 
5.3.2.4.2, each group of columns was formed of 7 sub-columns for SBP, DBP, MBP, 
HR, SV, CO and TPR and the corresponding data was transferred to these columns 
IURPWKH)LQRPHWHU¶VUDZGDWDVSUHDGVKHHWV.  
 
6.3.2.4.3 Master spreadsheet 3 - Time and magnitude of haemodynamic changes as 
detected by the Finometer 
The haemodialysis service evaluation master spreadsheet 3 was identical to master 
spreadsheet 3 of the service evaluation of induction of anaesthesia. Master 
spreadsheet 3 is discussed in details in section 5.3.2.4.3. 
 
Having completed the 3 master spreadsheets, our data were ready for further 
analysis. Analysis of the data will be discussed in details later, each in its relevant 
section. 
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6.4  Results: Cohort analysis 
We approached 33 patients undergoing maintenance haemodialysis; 3 patients 
refused to take part in the evaluation due to inconvenience of extra monitoring; 1 
patient was unable to give informed consent; measurements were not successful in 
4 patients due to inability of the Finometer to detect a finger pulse waveform; 
successful Finometer measurements were obtained in 25 patients.  
The characteristics of our patients are displayed in table 21. 
 
Table 21. Cohort characteristics (n =25)  
  
 Mean (SD) or percentage 
Age (years) 61 (18.6)  
Gender  
o Male 48% 
o Female 52% 
Height (cm) 168 (12) 
Weight (kg) 80 (28) 
Hb (g/dL) 11 (1.6) 
Smokers 16% 
DM 24% 
HTN 48% 
CAD 36% 
COPD 8% 
Autonomic neuropathy 8% 
Hyperparathyroidism 68% 
Dialysis related information  
o Interdialytic weight gain (kg) 
o Residual urine (ml) 
o Duration on RRT (years) 
o Duration on HD (years) 
Vascular access 
o AV fistula 
o Central line 
1.9 (1.1) 
519 (725) 
5.5 (7.8)  
2.4 (3.6) 
 
76% 
24% 
Prescribed medications  
o Statins 68% 
o Steroids 
o Anti-ischaemic drugs 
o ACEi / ARB 
o Calcium channel blockers 
o Beta blockers 
o Insulin 
o Oral hypoglycaemic drugs 
16% 
60% 
44% 
36% 
32% 
12% 
16% 
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6.5 Results: Comparison of blood pressure measurements 
using NIBP and the Finometer during maintenance 
haemodialysis 
This section presents an evaluation of the feasibility of using the Finometer for BP 
monitoring during maintenance haemodialysis, by assessing its success rate in 
providing BP monitoring, and by comparing its BP readings to those obtained by the 
NIBP device during maintenance haemodialysis sessions for accuracy. 
6.5.1 Data handling and statistics  
The haemodynamic data that we needed for comparing the NIBP and the Finometer 
was obtained from master spreadsheet 1, which was discussed in details in section 
6.3.2.4.1. Statistical analysis of the data was then carried out using the Prism 
software. 
Firstly, we used paired t test to compare the corresponding measurements of both 
the NIBP and the Finometer in each of the 25 predialysis measurements and the 25 
post dialysis measurements, which were labeled as NIBP1 and NIBP2 respectively in 
master spreadsheet 1. 
Then we collectively transferred all the 50 pre and post dialysis paired sets of NIBP¶V 
and FinometeU¶V6%3 DBP and MBP readings from master spreadsheet 1 to the Prism 
software. Using the Prism software, we applied the correlation and linear regression 
methods to each of the 50 pairs of NIBP¶V DQG)LQRPHWHU¶V6%3'%3DQG0%37KH
correlation and linear regression methods are discussed in details in section 4.2.5. 
We then used the Bland and Altman technique to assess for the agreement between 
each of the NIBP¶V aQGWKH)LQRPHWHU¶VSDLUHGVHWVRI6%3'%3DQG0%3
readings. As explained earlier, a naive assessment was done. The Bland and Altman 
technique is discussed in details in section 4.2.4. 
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Finally, we applied both, the BHS and the AAMI criteria for accuracy of novel BP 
devices to our 50 paired sets of NIBP¶V DQG)LQRPHWHU¶V6%3DQG'%3UHDGLQJV that 
were obtained from master spreadsheet 1, as shown in table 1. The BHS and the 
AAMI criteria are discussed in details in sections 4.2.6 and 4.2.7 respectively, and 
the procedure we followed to apply the BHS criteria is discussed in section 5.5.1. 
 
6.5.2 Results   
 
Out of the 29 Finometer monitoring attempts, 25 were successful, equating to an 
86% success rate. 
6.5.2.1  Table comparing the pre and post dialysis BP as measured by the 
NIBP vs. Finometer 
Using paired t test, we compared each of the NIBP¶V and Finometer¶V 25 pre dialysis 
SBP, DBP and MBP measurements, and 25  post-dialysis SBP, DBP and MBP 
measurements, as shown in table 22 . No statistical significant differences were 
shown between any of the SBP, DBP and MBP measurements taken by the two 
devices, neither in the predialysis nor in the post dialysis period. 
 
Table 22. Comparison between the 1,%3¶VDQGWKH)LQRPHWHU¶Vpre dialysis and post dialysis 
BP readings 
 Pre-dialysis  Post-dialysis  
 NIBP Finometer P value NIBP Finometer P value 
 SBP 
(mmHg) 
141 (25) 142 (24) ns 130 (24) 128 (24) ns 
 DBP 
(mmHg) 
77 (13) 76 (15) ns 74 (11) 71 (12) ns 
MBP 
(mmHg) 
97 (15) 99 (15) ns 93 (14) 92 (14) ns 
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6.5.2.2 Correlation, and Bland and Altman analysis of the BP measurements 
of NIBP vs. Finometer    
The total 50 pairs of pre and post dialysis NIBP¶V and Finometer¶V SBP, DBP and MBP 
measurements that were obtained from the 25 patients were compared using 
correlation and linear regression, along with the Bland and Altman method. Our 
results showed a significant correlation between the measurements of the NIBP and 
the Finometer. The r2 and p values for the SBP, DBP and MBP were r2 = 0.64 and 
P<0.0001, r2 = 0.35 and P<0.0001, and r2 = 0.5 and P<0.0001 respectively. 
As mentioned earlier in section 4.2.4, the Bland and Altman technique assesses the 
limits of agreement of two devices, by plotting the differences against the averages 
of the readings simultaneously obtained from both devices on a graph. From this 
graph, the bias and the 95% limits of agreement are calculated. We applied the 
Bland and Altman technique and assessed the limits of agreements between the 
NIBP and the Finometer. The results showed that the bias for SBP, DBP and MBP was 
0.6, 1.44 and -1.12 mmHg respectively and the 95% limits of agreement (mean 
difference ± 1.96 SD) for the SBP, DBP and MBP were 31 to -30, 24 to -22 mmHg 
and 21 to -23 respectively. The line of goodness of fit showed that the Finometer 
and the NIBP were equal in terms of the SBP, DBP and MBP. See figures 32, 33 and 
34. 
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Figure 32. Pooled data for the SBP measurements of NIBP vs. Finometer.  Upper panel: 
Correlation and linear regression of pooled data for NIBP against Finometer. Lower panel: 
Bland-Altman plot of the differences between NIBP & Finometer against their averages. 
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Figure 33. Pooled data for the DBP measurements of NIBP vs. Finometer.  Upper panel: 
Correlation and linear regression of pooled data for NIBP against Finometer. Lower panel: 
Bland-Altman plot of the differences between NIBP & Finometer against their averages. 
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Figure 34.  Pooled data for the MBP measurements of NIBP vs. Finometer.  Upper panel: 
Correlation and linear regression of pooled data for NIBP against Finometer. Lower panel: 
Bland-Altman plot of the differences between NIBP & Finometer against their averages. 
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6.5.2.3 The BHS validation 
As mentioned earlier in section 4.2.6, the British Hypertension Society criteria for 
accuracy of BP machines are met when a BP machine achieves grade A/B when 
compared to the mercury device according to the calculations displayed in table 1.  
We applied the BHS criteria to compare each of the 50 SBP and DBP readings 
obtained from the Finometer with the NIBP device rather than the mercury device. 
Our results showed that the Finometer failed to meet the BHS criteria of accuracy of 
BP devices as illustrated in table 23. 
 
Table 23. Assessment of the accuracy of the Finometer by applying the BHS criteria 
 
Absolute difference between NIBP and Finometer 
 PP+J PP+J PP+J 
Cumulative 
percentages 
SBP % DBP% SBP % DBP% SBP % DBP% 
48 36 66 74 74 88 
Grade  C D C C D D 
 
6.5.2.4 The AAMI validation 
As mentioned earlier in section 4.2.7, The AAMI criteria for accuracy of BP machines 
are met when the mean difference between the novel device to be assessed for 
accuracy and the mercury device is less than 5 mmHg, with a standard deviation of 
less than 8 mmHg for both the SBP and the DBP.  
We applied the AAMI criteria and used the NIBP as the standard device to validate 
against instead of the mercury device, to all the 50 pairs of NIBP and Finometer SBP 
and DBP sets of data. Our results showed that the Finometer failed to meet the AAMI 
criteria for accuracy of BP devices. The mean difference (standard deviation) 
between the Finometer and the NIBP was 0.62 (15.6) mmHg for SBP, and 1.44 
(11.74) mmHg for DBP. 
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6.5.3 Discussion 
In our service evaluation we have assessed the feasibility of using the Finometer in a 
cohort of patients on chronic haemodialysis, who are known to have a variety of co-
morbid conditions.  
Firstly, knowing that patients undergoing chronic haemodialysis have a high 
incidence of vascular abnormalities, which are known to impede the ability of the 
Finometer to detect a pulse waveform from the finger, we evaluated the success rate 
of the Finometer in providing haemodynamic monitoring. The Finometer delivered 
successful haemodynamic monitoring in 86% of the total number of patients that the 
Finometer was attempted upon.  
Secondly, we assessed for the accuracy of the Finometer in terms of BP monitoring 
by comparing its readings to those obtained by the conventional NIBP devices, and it 
has shown an acceptable degree of accuracy. No significant differences between the 
two devices in terms of both, the pre dialysis and post dialysis SBP, DBP and MBP 
readings have been shown. Also, using correlation and linear regression techniques, 
a significant correlation was shown between the NIBP and the Finometer, the r2 and 
p values for the SBP, DBP and MBP were r2 = 0.64 and P<0.0001, r2 = 0.35 and 
P<0.0001, and r2 = 0.5 and P<0.0001 respectively. Bland and Altman analysis for 
assessment of the limit of agreement between the NIBP and the Finometer in our 
data, showed that the bias for SBP, DBP and MBP was -0.82, -3.83 and -3.12 mmHg 
respectively, and the 95% limits of agreement (mean difference ± 1.96 SD) for the 
SBP, DBP and MBP were 31 to -30, 24 to -22 and 21 to -23 mmHg respectively, as 
described earlier in section 5.5.3, these results indicate an acceptable agreement 
between both devices. Also, the line of goodness of fit showed that the Finometer 
and the NIBP were equal in terms of the SBP, DBP and MBP 
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However, the Finometer failed to meet both, the BHS and the AAMI criteria for 
accuracy of BP devices in our evaluation. A possible explanation for this is that we 
performed the validation on a much lesser number of patients than that 
recommended by the AAMI and BHS criteria (85 patients). Another explanation 
which was mentioned earlier in section 6.3.2.3 is that there was a time lag between 
both the predialysis and post dialysis Finometer readings and their corresponding 
NIBP readings in the 19 patients with AV fistulae, as we were not able to use the 
vascular access arm in these patients for BP monitoring by either device.  
There were agreements with our findings of accuracy of the Finometer in a number 
of studies, as discussed earlier in section 5.5.3.8, 143, 144  
We have started collecting further data after being granted ethics approval for 
resuming our work and running an observational study on a bigger scale. 
 
6.5.4 Conclusion 
The Finometer is a feasible option for BP monitoring in a cohort of patients on 
regular haemodialysis. Further studies are warranted to explore this potential. 
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6.6  Results: Gross haemodynamic changes in response to 
maintenance haemodialysis as detected by the 
Finometer 
This section presents an assessment of the gross haemodynamic changes that occur 
in response to maintenance haemodialysis. 
6.6.1 Data handling and statistics 
Statistical analysis was carried out using the Prism software, and all the data we 
needed for analysis in this section was obtained from master spreadsheet 2, which is 
discussed in details in section 6.3.2.4.2.  
We firstly performed 7 comparisons between the pre dialysis and post dialysis SBP, 
DBP, MBP, HR, SV, CO and TPR variables that were retrieved from master 
spreadsheet 2 using a paired t test.  
Then, to collectively assess the gross haemodynamic changes that occurred in our 
patients during haemodialysis, we transferred the collective haemodynamic data of 
SBP, DBP, MBP, HR, SV, CO and TPR at baseline, 0.5 hr, 1 hr, 1.5 hr, 2 hr, 2.5 hr, 3 
hr, 3.5 hr, 4 hr and post dialysis from master spreadsheet 2 to the Prism software, 
and applied ANOVA and 7XNH\¶VSRVWKRFWHVWWRWKHLQWHUYDOOLFGDWDRIHDFKYDULDEOH
$129$DQG7XNH\¶VSRVWKRFWHVWLVGLVFXVVHGLQGHWDLOVLQVHFWLRQ4.2.2.  
 Furthermore, we assessed for inter-patient variability in terms of haemodynamic 
responses to haemodialysis. In order to do that, we obtained the intervallic SBP, 
DBP, MBP, HR, SV, CO and TPR data at baseline, 0.5 hr, 1 hr, 1.5 hr, 2 hr, 2.5 hr, 3 
hr, 3.5 hr, 4 hr and post dialysis for each patient separately from master 
spreadsheet 2, and we plotted 7 graphs for each of the haemodynamic variables 
(SBP, DBP, MBP, HR, SV, CO and TPR). In each of the 7 graphs, 25 lines of 
intervallic data representing the 25 patients were plotted at baseline, 0.5 hr, 1 hr, 
1.5 hr, 2 hr, 2.5 hr, 3 hr, 3.5 hr, 4 hr and post dialysis. 
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6.6.2 Results  
6.6.2.1 Comparison between the )LQRPHWHU¶Vpredialysis and post dialysis 
readings (n = 25) 
8VLQJDWWHVWZHFRPSDUHGWKH)LQRPHWHU¶V25 predialysis and 25 post dialysis 
values of each of the haemodynamic variables (SBP, DBP, MBP, SV, CO and TPR). A 
significant drop in the SBP, MBP, SV and CO along with a significant rise in the HR 
was shown upon completion of haemodialysis. TPR remained stable however (Table 
24). 
 
Table 24. Paired t test for all )LQRPHWHU¶Vhaemodynamic variables pre and post dialysis (n = 
25) 
 Pre-dialysis Post-dialysis    P value 
 SBP (mmHg) 142 (24) 128 (24) 0.0038* 
 DBP (mmHg) 76 (15) 71 (12) 0.1315 
MBP (mmHg) 99 (15) 92 (14) 0.0390* 
HR (bpm) 74 (11) 80 (13) 0.0033* 
SV (ml) 91 (37) 76 (31) 0.0148* 
CO (l/m) 6.6 (2.6) 6 (2.6) < 0.0001* 
TPR (MU) 1.303 (1.06) 1.178 (0.712) 0.6136 
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6.6.2.2 $129$DQG7XNH\¶VSRVWKRFWHVW 
$129$DQG7XNH\¶VSRVWKRFWHVWZDVXVHGWRFRPSDUHthe values of each of the 
haemodynamic variables obtained by the Finometer (HR, SBP, DBP, MBP, SV, CO 
and TPR) at 0.5 hour time intervals, from the start till the end of the haemodialysis 
sessions. None of the variables has shown a significant change during the course of 
haemodialysis, as illustrated in table 25. 
 
Table 25. Mean (SD) of haemodynamic variables during routine haemodialysis 
Interval 
(min) 
Baseline 
(n=25) 
0.5 hr 
(n=24) 
1.5 hr 
(n=24) 
2.5 hr 
(n=23) 
3.5 hr 
(n=21) 
Post 
dialysis 
(n=25) 
P value 
HR 
(beats/m) 
74 (11) 76 (11) 73 (11) 76 (12) 79 (14) 80 (13) 0.4567 
SBP 
(mmHg) 
142 (24) 140 
(32) 
130 
(26) 
125 
(31) 
128 
(34) 
128  
(24) 
0.2293 
DBP 
(mmHg) 
76 (15) 77 (17) 72 (15) 70 (15) 70 (14) 71 (12) 0.4238 
MBP 
(mmHg) 
99 (15) 99 (23) 93 (18) 91 (20) 91 (19) 92 (14) 0.3861 
SV (ml) 91 (37) 81 (30) 77 (30) 76 (34) 72 (27) 76 (31) 0.714 
CO (l/m) 
6.6 (2.6) 6.0 
(2.3) 
5.6 
(2.2) 
5.6 
(2.3) 
5.5 
(1.8) 
6.0  
(2.6) 
0.8984 
TPR (MU) 
1.3 
(1.06) 
1.29 
(0.81) 
1.27 
(0.64) 
1.28 
(0.74) 
1.13 
(0.33) 
1.18 
(0.71) 
0.8804 
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6.6.2.3 Individual patient analysis of the haemodynamic response to 
haemodialysis 
 
We further compared each of the haemodynamic variables (HR, SBP, DBP, MBP, SV, 
CO and TPR) in relation to time on individual patient basis by plotting a graph for 
each variable. Each graph was a plot of the values of one of the haemodynamic 
variables against the 0.5 hourly time intervals for the 25 patients.  
Considerable inter-patient variability in terms of the magnitude and timing of all the 
haemodynamic YDULDEOHV¶responses to haemodialysis was shown (figures 35 ± 41). 
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Figure 35. Graph showing the SBP values at 0.5 hourly intervals during the whole period of 
haemodialysis for the 25 patients as detected by the Finometer  
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Figure 36. Graph showing the DBP values at 0.5 hourly intervals during the whole period of 
haemodialysis for the 25 patients as detected by the Finometer 
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Figure 37. Graph showing the MBP values at 0.5 hourly intervals during the whole period of 
haemodialysis for the 25 patients as detected by the Finometer 
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Figure 38. Graph showing the HR values at 0.5 hourly intervals during the whole period of 
haemodialysis for the 25 patients as detected by the Finometer 
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Figure 39. Graph showing the SV values at 0.5 hourly intervals during the whole period of 
haemodialysis for the 25 patients as detected by the Finometer 
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Figure 40. Graph showing the CO values at 0.5 hourly intervals during the whole period of 
haemodialysis for the 25 patients as detected by the Finometer 
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Figure 41. Graph showing the TPR values at 0.5 hourly intervals during the whole period of 
haemodialysis for the 25 patients as detected by the Finometer 
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6.6.3 Discussion 
As mentioned earlier in section 2.2, haemodialysis involves the removal of large 
volumes of fluids from the circulation in a relatively short period of time. Normally, 
the compensatory cardiovascular response of the body to the haemodialysis induced 
hypovolaemia involves an increased plasma refilling rate (PRR) that occurs at 
capillary level in opposition to the ultrafiltration rate (UFR)40, which keeps the blood 
volume constant. Also, in response to haemodialysis induced hypovolaemia, an 
increase in the venous tone and peripheral vascular resistance is encountered38, 44, 
along with  the activation of the sympathetic nervous system, which causes an initial 
increase followed by a decrease in the HR, and an increase in myocardial 
contractility.49, 50 Patients on chronic haemodialysis are known to have an impaired 
capacity of the normal cardiovascular response to haemodialysis induced 
hypovolaemia.39 This may be explained by the high incidence of co-morbid 
conditions amongst those patients. Also, they are usually prescribed medications, 
which may further limit the capacity of their compensatory haemodynamic responses 
to haemodialysis induced hypovolaemia. 
 Little is known about the gross haemodynamic response to routine haemodialysis, 
as this needs continuous haemodynamic monitoring on beat-by-beat basis which 
would have involved intra-arterial catheterisation. The routine use of intra-arterial 
BP monitoring is not justified due to its invasive nature and risk of complications.   
We utilised the Finometer, a continuous beat-by-beat noninvasive haemodynamic 
monitor that works by applying a finger cuff to monitor entire sessions of 
maintenance haemodialysis. The haemodynamic data that was generated by the 
Finometer on continuous basis was further analysed to identify the gross 
haemodynamic changes that occur in response to maintenance haemodialysis. The 
Finometer is discussed in details in section 2.6.4. 
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 Initially, we compared the pre and post dialysis values of haemodynamic variables. 
A significant drop in the SBP, MBP, SV and CO along with a significant rise in the HR 
was shown upon completion of the haemodialysis sessions. TPR remained stable 
however.  
We further analysed the 25 SDWLHQWV¶ haemodynamic data collectively in terms of 
changes in each of the haemodynamic variables (SBP, MBP, DBP, SV, CO, HR and 
TPR) that was encountered during haemodialysis at 30 minutes time intervals. No 
significant change was shown in any of the haemodynamic variables in response to 
routine haemodialysis. This may be explained by the cancelling out effect of the 
collective data analysis, as when we further analysed the same data on individual 
patient basis, extensive inter-patient variability in terms of timing and magnitude of 
haemodynamic responses of different variables to haemodialysis was shown. 
 
As previously mentioned, the normal cardiovascular response to volume loss would 
be an increase in the PRR, venous tone and peripheral vascular resistance, and a 
cardiac compensatory sympathetic stimulation that involves tachycardia initially 
followed by bradycardia, and an increase in the myocardial contractility. The 
resultant effect of this response would be an increased CO and TPR, thus keeping 
blood pressure stable in reaction to haemodialysis induced hypovolaemia. Our 
results suggest that failure of the normal compensatory cardiovascular response to 
haemodialysis may be due to failed TPR and CO responses. A possible explanation to 
our finding of a failed TPR (vasoconstrictor) response is that patients on chronic 
haemodialysis have a wide range of co-morbidities and are also on medications that 
may affect the integrity of their peripheral vascular responses such as, angiotensin 
converting enzyme inhibitors and calcium channel blockers. Another explanation 
could be the high incidence of autonomic neuropathy seen in patients on chronic 
haemodialysis, which is known to hinder their vasoconstrictor response.198  
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Also, it has been reported that an imbalance between the vaso-active substances, 
such as the vasodilator agents nitric oxide (NO) and calcitonin gene related peptide 
(CGRP), and the vasoconstrictor agents nor-adrenaline and angiotensin ll exists in 
patients on chronic haemodialysis.199 Moreover, emerging evidence suggests that NO 
plays an important role in the pathogenesis of intradialytic hypotension.200, 201 
Further studies to confirm our findings and to identify the cause of the failed 
vasoconstrictor response to chronic haemodialysis are warranted. 
 
6.6.4 Conclusion 
In a cohort of patients on chronic haemodialysis a significant drop in the BP, SV and 
CO along with a significant rise in the HR is shown in response to haemodialysis, 
whereas TPR remains stable. An inter-patient variability is observed in terms of the 
magnitude and timing of the haemodynamic responses to haemodialysis.  
A failed vasoconstrictor response to haemodialysis induced hypovolaemia is seen in 
patients on chronic haemodialysis, which may serve as an explanation for 
intradialytic hypotension.  
Continuous noninvasive haemodynamic monitoring using the Finometer provides a 
broad insight of the haemodynamics during haemodialysis, thus, the potential for 
identifying haemodynamic mishaps in individual patients undergoing chronic 
haemodialysis and subsequently prompting effective intervention.  
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6.7 Results: Assessment of the Incidence of significant 
hypotension during maintenance haemodialysis  
This section presents an assessment of the incidence of transient hypotension 
episodes during maintenance haemodialysis as detected by the Finometer. 
6.7.1 Data handling and statistics 
The haemodynamic data required for the assessment of the incidence of intradialytic 
K\SRWHQVLRQZDVUHWULHYHGIURPERWKWKHSDWLHQWV¶)LQRPHWHUUDZGDWDVKHHWV
and master spreadsheet 3, which were discussed in details in sections 6.3.2.4 and 
6.3.2.4.3 respectively.  
Data involving age, inter dialytic weight gain and vintage on haemodialysis were 
gathered from master spreadsheet 1, which was discussed in details in section 
6.3.2.4.1. 
The Prism software was used for statistical analysis of our data. 
Firstly, we used master spreadsheet 3 to bring the values of the SBP, DBP, MBP, HR, 
SV, CO and TPR during the BP troughs, their baseline values and their percentage 
changes from baseline values. We then transferred all the gathered haemodynamic 
data to the Prism software, and carried out a paired t test to compare the values of 
each of the SBP, DBP, MBP, HR, SV, CO and TPR during the BP troughs with their 
baseline values.  
We then used three definitions of hypotension episodes that were based upon 
changes from baseline values, namely, a more than 30% decrease in each of the 
SBP, DBP and MBP for more than 10 minutes.  
Recent evidence suggests that the frequent occurrence of episodes of hypotension of 
SBP less than 90 mmHg is associated with an increased risk of mortality.202 Based on 
this evidence, we used a fourth definition of intradialytic hypotension that implies 
this absolute figure of SBP less than 90 mmHg, for duration of more than 10 min. As 
mentioned earlier, we gathered the data needed for these assessments of BP 
UHGXFWLRQVIURPWKH)LQRPHWHU¶VUDZGDWDVSUHDGVKHHWV.   
 We further assigned our patients into 2 groups according to the occurrence of SBP 
of less than 90 mmHg for 10 min episodes; hypotension episode group (group 1) 
and no hypotension episode group (group 2). 
In group 1, we used ANOVA DQG7XNH\¶VSRVWKRFWHVt to compare the pre-dialysis, 
post-dialysis and mean values of all variables recorded during the hypotension 
episode. The mean values of all the variables during the hypotension episode were 
 
 
182 
 
FDOFXODWHGDVIROORZV:HXVHGWKH³FRQGLWLRQDOIRUPDWWLQJ´WRROWRKLJKOLJKWDOOWKH
cells in the SBP column that contained values lower than 90 in each of the 25 
SDWLHQWV¶)LQRPHWHU¶VUDZGDWDVKHHWVWKHQZHWUDQVIHUUHGWKHZKROHURZs of all 
variables which contained a highlighted SBP lower than 90 into a new clear excel 
sheet, and we calculated the mean and standard deviations of each of the variables.  
$129$DQG7XNH\¶VSRVWKRFWHVWis discussed in section 4.2.2, and conditional 
formatting is discussed in sections 5.3.2.4 and 6.3.2.4.   
We also calculated the total duration of time spent during each of the defined 
hypotension episodes (30% decreases in SBP, DBP and MBP, and SBP lower than 90 
mmHg) from the Finometer¶V raw data sheets, as described in section 6.3.2.4. 
In group 2, we compared pre and post dialysis SBP, DBP, MBP, HR, SV, CO and TPR 
using a paired t test. 
We then compared both groups 1 and 2 in terms of, predialysis SBP, DBP, MBP, HR, 
SV, CO and TPR, and post dialysis SBP, DBP, MBP, HR, SV, CO and TPR using an 
unpaired t test. We also compared the 2 groups in terms of age, Interdialytic weight 
gain and vintage (number of years) on haemodialysis using an unpaired t test. 
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6.7.2 Results  
6.7.2.1 Maximum decreases in the BP encountered during haemodialysis 
The percentage change of the lowest blood pressure reading from baseline values is 
shown in table 26; the changes in SBP, DBP and MBP were all statistically significant. 
The corresponding changes in HR, CO, SV and TPR are displayed in table 27, CO and 
SV showed a statistically significant decrease in comparison to baseline values, 
whereas HR and TPR remained stable.  
Table 26. Percentage change of lowest BP readings (troughs) from baseline as detected by the 
Finometer (n = 25) 
 Baseline Trough 
% change 
from baseline 
P value 
SBP (mmHg) 141 (24) 86 (27) 39% < 0.0001* 
DBP (mmHg) 76 (15) 47 (11) 38% < 0.0001* 
MBP (mmHg) 99 (15) 61 (16) 38% < 0.0001* 
 
 
Table 27. The change in HR, CO, SV &TPR during the BP trough (n = 25) 
 Baseline 
Reading 
during BP 
trough 
% change 
from baseline 
P value 
HR (beats/min) 74 (11) 75 (13) 1.4% 0.6776 
CO (l/min) 6.6 (2.6)  5.4 (2.7) 18% 0.0286* 
SV (ml) 91 (37) 72 (35) 21% 0.0063* 
TPR (MU) 1.3 (1.06) 1.01 (0.69) 22%       0.2365 
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6.7.2.2 Hypotension episodes of more than 30% decrease from baseline 
values of the SBP, DBP and MBP for more than 10 minutes  
 
Of the 25 patients, 8, 7 and 7 patients had an episode of more than 30% decrease 
from baseline values of the SBP, DBP and MBP respectively for more than 10 
minutes.  
The mean (SD) duration when the BP was less than 30% of the baseline value was 
21 (39), 21 (43) and 18 (36) minutes for the SBP, DBP and MBP respectively. 
 
6.7.2.3 Hypotension episodes of SBP less than 90mmHg for more than 10 
minutes (group 1) 
 
Of the 25 patients, 7 had a cumulative episode of SBP less than 90 mmHg for more 
than 10 minutes. The mean (SD) duration when the BP was less than 90 mmHg in 
group 1 was 55 (56) minutes. The shortest and the longest continuous durations 
when the SBP was less than 90 mmHg were 4.3 min and 150 min respectively. Table 
29 displays the durations of hypotension episodes of SBP less than 90 mmHg 
amongst patients who had such episodes. 
Using $129$DQG7XNH\¶VSRVWKRFWHVWZHFRPSDUHGWKHSUHGLDO\VLVSRVWGLDO\VLV
and the mean value during the hypotension episodes of each of the SBP, DBP, MBP, 
SV, CO and TPR in group 1.  Statistically significant drops from the pre dialysis 
values of the SBP, DBP and MBP were shown during the episode of hypotension. No 
significant changes in HR, SV, CO or TPR were encountered during those episodes of 
hypotension. Also there were no significant changes between all pre and post 
dialysis haemodynamic variables in group 1 as shown in table 28. 
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Table 28. Comparison between predialysis, post dialysis and the averaged values of 
haemodynamic variables during the hypotension episode (SBP less than 90mmHg) (ANOVA 
and Tukey's post hoc test) (n = 7) 
Variable 
A 
Predialysis 
B 
mean value during 
episode 
C 
Post dialysis 
A 
vs. 
B 
A 
vs. 
C 
B 
vs. 
C 
SBP (mmHg) 128 (18) 80 (5) 117 (23) * ns * 
MBP (mmHg) 97 (13) 62 (3) 88 (13) * ns * 
DBP (mmHg) 76 (15) 50 (4) 69 (9) * ns * 
HR (bpm) 76 (10) 76 (6) 79 (9) ns ns ns 
SV (ml) 70 (29) 53 (14) 62 (11) ns ns ns 
CO (l/m) 5.3 (2.1) 4 (1.2) 4.9 (0.9) ns ns ns 
TPR (MU) 1.37 (0.72) 1.213 (0.31) 1.184 (0.25) ns ns ns 
 
 
Table 29. Total duration of hypotension episodes of SBP less than 90 mmHg for more than 10 
minutes (n=7) 
 
Pts. who had SBP <90 > 10 min Total duration of episode (min) 
Pt 3 161 
Pt 4 26.2 
Pt 8 43.5 
Pt 14 12.8 
Pt 18 13.5 
Pt 22 25.8 
Pt 25 102.8 
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6.7.2.4 Comparison between pre and post dialysis haemodynamic variables 
in group 2 
 
In group 2, a comparison between the pre and post dialysis haemodynamic variables 
using a paired t test showed a significant decrease in the SBP, MBP and SV, along 
with a significant increase in the HR. The DBP, CO and TPR remained unchanged 
(Table 30).  
 
Table 30. Comparison of pre and post dialysis haemodynamic variables in group 2 (paired t 
test) 
 Pre dialysis Post dialysis P value 
HR (bpm) 73 (11) 81 (14) 0.009* 
SBP (mmHg) 147 (24) 131 (23) 0.003* 
MBP (mmHg) 99 (16) 93 (15) 0.036* 
DBP (mmHg) 76 (16) 72 (12) 0.15 
SV (ml) 99 (37) 81 (35) 0.024* 
CO (l/m) 7.1 (2.7) 6.5 (2.9) 0.26 
TPR (MU) 1.28 (1.19) 1.18 (0.83) 0.75 
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6.7.2.5 Comparison between group 1 and group 2 
 
Comparisons between group 1 and 2 in terms of the pre dialysis haemodynamic 
variables, post dialysis haemodynamic variables, age, inter-dialytic weight gain and 
vintage (number of years on haemodialysis) using un-paired t tests are displayed in 
tables 31 - 33. None of the comparisons showed a significant difference. 
 
Table 31. Comparison of the predialysis haemodynamic variables in both groups (unpaired t 
test) 
Predialysis Group 1 
Hypotension 
Group 2 
No hypotension 
P value 
HR (bpm) 76 (10) 73 (11) 0.6 
SBP (mmHg) 128 (18) 147 (24) 0.08 
MBP (mmHg) 97 (13) 99 (16) 0.7 
DBP (mmHg) 76 (15) 76 (16) 0.99 
SV (ml) 70 (29) 99 (37) 0.08 
CO (l/m) 5.3 (2.1) 7.1 (2.7) 0.14 
TPR (MU) 1.37 (0.72) 1.28 (1.19) 0.85 
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Table 32. Comparison of the post dialysis haemodynamic variables in both groups (unpaired T 
test) 
Post dialysis Group 1 
Hypotension 
Group 2 
No hypotension 
P value 
HR (bpm) 79 (9) 81 (14) 0.72 
SBP (mmHg) 117 (23) 131 (23) 0.18 
MBP (mmHg) 88 (13) 93 (15) 0.41 
DBP (mmHg) 69 (9) 72 (12) 0.61 
SV (ml) 62 (11) 81 (35)  0.18 
CO (l/m) 4.9 (0.9) 6.5 (2.9) 0.17 
TPR (MU) 1.18 (0.25) 1.18 (0.83)  0.98 
 
 
Table 33. Comparison of different factors for association with hypotensive episodes using an 
unpaired t test 
 Group 1 
Hypotension 
Group 2 
No hypotension 
P value 
Age (yrs) 58.4 (22.8) 62.4 (17.4) 0.64 
Interdialytic wt. 
gain (Kg) 
1.86 (1.25) 1.88 (1.03) 0.96 
Vintage (yrs) 4.4 (6.4) 1.6 (1.2) 0.08 
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6.7.3 Discussion 
Major advances in the area of haemodialysis have been accomplished over the last 
few years. This has aided in providing a better quality of life for patients on 
maintenance haemodialysis. Nevertheless, significant hypotension still continues to 
be the most common complication of haemodialysis, occurring in 25% to 50% of 
maintenance haemodialysis sessions.2, 3 Intradialytic hypotension is likely to cause a 
state of hypoperfusion that may affect the integrity of vital organs such as the heart 
and the brain. Emerging evidence suggests that intradialytic hypotension may 
indirectly cause chronic heart failure through aggravating a condition known as 
atherosclerosis independent myocardial stunning, which commonly occurs in patients 
undergoing chronic haemodialysis.61-64 Also, it has been shown that intradialytic 
hypotension causes a severe orthostatic drop in the cerebral blood flow velocity.203 
Furthermore, several studies have reported an association between intradialytic 
hypotension and an increased risk of mortality.6, 202, 204-206 Therefore, it is necessary 
to identify and manage intradialytic hypotension as early as possible during 
haemodialysis sessions in order to prevent its complications.  
In the current clinical practice BP monitoring during routine haemodialysis sessions 
is carried out using intermittent NIBP devices, usually 2-3 readings are taken during 
the whole 4 hour session including the pre and post dialysis readings. This might 
carry the risk of missing episodes of hypotension especially if they were 
asymptomatic. Asymptomatic hypotension is not unlikely to occur in a cohort of 
patients on chronic haemodialysis who may have gained tolerance to haemodialysis 
induced hypotension.  
In our service evaluation, we utilised a noninvasive continuous beat-by-beat 
haemodynamic monitor (Finometer) to assess the incidence of significant 
hypotension episodes. We also identified the corresponding changes in other 
haemodynamic variables, including, the HR, SV, CO and TPR in a cohort of patients 
on chronic haemodialysis.  
 
 
 
 
 
 
 
190 
 
We also identified both, the maximum decreases in the BP encountered during 
conventional haemodialysis, and the incidence of transient intradialytic hypotension. 
Moreover, we characterised the changes that occurred in the HR, SV, CO and TPR 
during both, the maximal decrease in the BP and the intradialytic hypotension 
episodes. Lastly, we compared the age, Interdialytic weight gain and vintage on 
haemodialysis of the patients who had an episode of SBP lower than 90 mmHg for 
more than 10 minutes with those who did not.   
In the cohort of 25 patients, acute significant BP drops were encountered during the 
course of haemodialysis. The mean percentage drops of the SBP, DBP and MBP from 
their corresponding baseline values were 39%, 38% and 38% respectively. There 
was a statistically significant drop from baseline values of the corresponding SV and 
CO with a mean percentage change of 21% and 18% respectively. A drop in the TPR 
from its baseline value equivalent to a mean percentage change of 22% was also 
shown, but it was not statistically significant. HR remained stable during the course 
of haemodialysis. 
In this cohort of patients, 32%, 28% and 28% had an episode of more than 30% 
decrease from baseline values of the SBP, DBP and MBP for more than 10 minutes 
respectively, and 28% had an episode of SBP less than 90 mmHg for more than 10 
minutes. The mean (SD) duration when the BP was less than 30% of the baseline 
value was 21 (39), 21 (43) and 18 (36) minutes for the SBP, DBP and MBP 
respectively. The mean (SD) duration when the SBP was less than 90 mmHg was 55 
(56) minutes.  
On further analysing the lower than 90 mmHg SBP for more than 10 minutes 
episodes of intradialytic hypotension, we found that there were no corresponding 
significant changes in any of the HR, SV, CO or TPR during the episode of 
hypotension indicating a failed cardiovascular compensatory mechanism to 
haemodialysis induced hypovolaemia. There were also no significant changes 
between any of the predialysis and post-dialysis haemodynamic variables in group 1.   
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On the other hand in group 2, a statistically significant decrease in the post-dialysis 
SBP, MBP and SV, along with a significant increase in the HR, from corresponding 
pre dialysis values was shown.  
We also attempted to point out any possible differences between the patients who 
developed hypotension and those who did not. The results showed no statistically 
significant differences on comparing groups 1 and 2 in terms of predialysis and post-
dialysis haemodynamic variables, or any of the patient characteristics. However, in 
this small sample size a trend of difference was shown in the predialysis SV in both 
groups. The mean (SD) SV for groups 1 and 2 was 70 (29) and 99 (37) ml 
respectively; p = 0.08. These results are subject to type 2 error, and they could give 
an indication of the likelihood of differences between the 2 groups, hence, they may 
help in future sample size calculations. Moreover, the predialysis SBP and SV were 
23% lower in group 1 than group 2, which is considered a clinically significant 
difference (more than 20% change from baseline)193, indicating that hypotension 
that was encountered in group 1 may have been due to a preload defect.  
Kinet and colleagues studied the haemodynamic response to intradialytic 
hypotension in 14 patients on regular haemodialysis who were not known to have 
any cardiovascular abnormalities. The patients were monitored using both, a 
pulmonary artery catheter and an intra-arterial catheter during a conventional 
haemodialysis session. Hypotension was defined as a more than 30 mmHg decrease 
of MBP from the baseline value regardless of the duration. In agreement with our 
findings of high incidence of intradialytic hypotension, they showed a 43% incidence 
of intradialytic hypotension and the mean (SE) MBP during intradialytic hypotension 
was 55 (4.1) mmHg. They also showed agreement with our findings of an 
unchanged HR and TPR during intradialytic hypotension. 206  
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Several studies have demonstrated the independent association of intradialytic 
hypotension with mortality.6, 204, 205 A study by Tisler and colleagues assessed the 
effect of both, frequent intradialytic hypotension (f-IDH) and occasional intradialytic 
hypotension (o-IDH) on patient survival. 958 maintenance haemodialysis patients 
were the subject of the study. Intradialytic hypotension episodes were defined as an 
SBP lower than 90 mmHg or a drop in the SBP of more than 30 mmHg from the 
baseline value which only responds to fluid administration. f-IDH was defined as 
more than 9 IDH episodes and o-IDH was defined as 1 to 2 IDH episodes in a period 
of 10 months observation. 85 patients from the group with no-IDH were assigned as 
a control group. The 3 groups of f-IDH, o-IDH and no-IDH were further followed up 
for a period that ranged between 0.3 to 37 months and the mortality rate was 
compared between the 3 groups. Their results showed mortality rates of 58%, 47% 
and 39% for the f-IDH, o-IDH and the no-IDH groups respectively during the follow 
up period. These results indicate that the mortality rates in the f-IDH groups are 
significantly higher than the o-IDH and the no-IDH groups.202 
Hence, it is important to identify the exact incidence and patho-physiology behind 
intradialytic hypotension, to be able to properly manage it and avoid its hazardous 
complications.   
Further studies that are designed to follow up patients for recurrence of intradialytic 
hypotension and for the incidence of mortality amongst the patients who suffer 
intradialytic hypotension are warranted. 
 
6.7.4 Conclusion 
Significant hypotension is commonly encountered during maintenance 
haemodialysis, which is possibly due to a deficient predialysis preload. Transient 
Intradialytic hypotension in patients on chronic haemodialysis can be explained by a 
failed compensatory cardiovascular response to haemodialysis induced 
hypovolaemia.    
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6.8  Results: Assessment of the Incidence of significant 
hypertension during maintenance haemodialysis  
This section presents an assessment of the incidence and magnitude of hypertension 
during maintenance haemodialysis as detected by the Finometer. 
6.8.1 Data handling and statistics 
The haemodynamic data required for the assessment of the incidence of intradialytic 
hyperWHQVLRQZDVUHWULHYHGIURPERWKWKHSDWLHQWV¶)LQRPHWHUUDZGDWDVKHHWV
and master spreadsheet 3, which were both, discussed in details in sections 6.3.2.4 
and 6.3.2.4.3 respectively.  
The Prism software was used for statistical analysis of our data. 
Firstly, we used master spreadsheet 3 to bring the values of the SBP, DBP, MBP, HR, 
SV, CO and TPR during the BP peaks, their baseline values and their percentage 
changes from baseline values. We then transferred all the gathered haemodynamic 
data to the Prism software, and carried out a paired t test to compare the values of 
each of the SBP, DBP, MBP, HR, SV, CO and TPR during the BP peaks with their 
baseline values.  
We then used three definitions of hypertension episodes that were based upon 
changes from baseline values, namely, a more than 30% increase in each of the 
SBP, DBP and MBP for more than 10 minutes.  
We also used two more definitions of hypertension that imply absolute figures rather 
than relative changes including, an SBP more than 160 mmHg as a reflection of 
moderate to severe hypertension, and an SBP more than 180 mmHg as a reflection 
of severe hypertension, both for a duration of more than 10 min.  We gathered all 
the data needed for these assessments of BP elevations that involved set definitions 
of hypertension IURPWKH)LQRPHWHU¶VUDZGDWDVSUHDGVKHHWV, as described earlier. 
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We further assigned our patients into 2 groups according to the occurrence of SBP 
more than 180 mmHg for more than10 min episodes into: a hypertension episode 
group (group 3) and a no hypertension episode group (group 4). 
In group 3, we used $129$DQG7XNH\¶VSRVWKRFWHVWWRFRPSDUHWKHSUH-dialysis, 
post-dialysis and mean values of all variables recorded during the hypertension 
episode. The mean values of all the variables during the hypertension episode were 
calculated using WKH³FRQGLWLRQDOIRUPDWWLQJ´WRRO, which was used to highlight all the 
cells in the SBP column that contained values higher than 180 in each of the 25 
patients¶)LQRPHWHU¶VUDZGDWDVKHHWV:HWhen transferred the whole rows of all 
variables which contained a highlighted SBP higher than 180 into a new clear excel 
sheet, and from that data on the new excel sheet we calculated the mean and 
standard deviations of each of the variables. $129$DQG7XNH\¶VSRVWKRFWHVWLV
discussed in section 4.2.2, and conditional formatting is discussed in sections 5.3.2.4 
and 6.3.2.4.   
We also calculated the total time spent during each of the defined hypertension 
episodes (30% decreases in SBP, DBP, MBP, SBP higher than 160 mmHg and SBP 
higher than 180 mmHg) from the SDWLHQWV¶)LQRPHWHU¶VUDZGDWDVKHHWVDV
described in section 6.3.2.4. 
In group 4, we compared pre and post dialysis SBP, DBP, MBP, HR, SV, CO and TPR 
using a paired t test. 
Lastly, we compared both groups 3 and 4 in terms of, predialysis SBP, DBP, MBP, 
HR, SV, CO and TPR, and post dialysis SBP, DBP, MBP, HR, SV, CO and TPR using an 
un-paired t test. We also compared the 2 groups in terms of age, Interdialytic weight 
gain and vintage on haemodialysis using an unpaired t test. 
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6.8.2 Results  
 
6.8.2.1 Maximum increases in the BP encountered during haemodialysis 
The percentage change of the highest blood pressure reading from baseline values is 
shown in table 34; the changes in SBP, DBP and MBP were all statistically significant. 
The corresponding changes in the HR, CO, SV and TPR are displayed in table 35; 
TPR showed a statistically significant increase, whereas SV and CO showed 
statistically significant decreases in comparison to baseline values. HR remained 
stable.  
 
Table 34. Percentage change of highest BP readings (peaks) from baseline as detected by the 
Finometer (n = 25) 
 Baseline Peak 
% change 
from baseline 
P value 
SBP (mmHg) 141 (24) 180 (32) 28% < 0.0001* 
DBP (mmHg) 76 (15) 109 (24) 43% < 0.0001* 
MBP (mmHg) 99 (15) 136 (27) 37% < 0.0001* 
 
 
Table 35. The change in HR, CO, SV &TPR during the BP peak (n = 25) 
 
 Baseline 
Reading during 
BP Peak 
% change 
from baseline 
P value 
HR (beats/min) 74 (11) 77 (13) 4% 0.3013 
CO (l/min) 6.6 (2.6)  4.8 (2.7) 27% 0.0002* 
SV (ml) 91 (37) 64 (37) 30% 0.0001* 
TPR (MU) 1.3 (1.06) 3.08 (2.81) 136%       0.0043* 
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6.8.2.2 Incidence of hypertension episodes 
 
We defined our five hypertension episodes as, a more than 30 % increase of the 
SBP, DBP or MBP from the baseline value for more than 10 minutes, and an SBP of 
more than 160 mmHg and more than 180 mmHg for more than 10 minutes 
indicating moderate to severe hypertension and severe hypertension respectively.  
Of the 25 patients, 3, 8 and 4 patients had an episode of more than 30% increase 
from baseline values of the SBP, DBP and MBP respectively for more than 10 
minutes. The mean (SD) duration when the BP was 30% higher than the baseline 
value was 22 (1.5), 44 (49) and 44 (34) minutes for the SBP, DBP and MBP 
respectively. 
13 patients had an episode of SBP higher than 160 mmHg for more than 10 minutes. 
8 of whom were known hypertensive. The mean (SD) duration when the SBP was 
more than 160 mmHg was 60 (55) minutes.  
4 patients had an episode of SBP higher than 180 mmHg for more than 10 minutes, 
they were all known hypertensive. The mean (SD) duration when the SBP was more 
than 180 mmHg was 79 (61) minutes.  
Table 36 displays the total durations of episodes of both, SBP more than 160 mmHg 
and SBP more than 180 mmHg amongst our patients.   
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Table 36. Total durations of hypertension episodes of both, SBP more than 160 mmHg and 
SBP more than 180 mmHg that were encountered for more than 10 minutes  
  
Pts. who had SBP 
> 160 
> 10 min (n=13) 
Total duration of 
episode (min) 
Pts. who had SBP 
> 180 
> 10 min (n=4) 
Total duration of 
episode (min) 
Pt 1 40 Pt 5 74 
Pt 5 128 Pt 6 159 
Pt 6 204 Pt 15 72 
Pt 7 88 Pt 20 10 
Pt 11 55   
Pt 12 28   
Pt 13 11   
Pt 14 13   
Pt 15 13   
Pt 19 43   
Pt 20 84   
Pt 21 49   
Pt 22 25   
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6.8.2.3 An assessment of the changes in all haemodynamic variables during 
the episodes of severe hypertension 
 
Using the haemodynamic data of the 4 patients who suffered an episode of SBP 
greater than 180 mmHg (group 3) during their haemodialysis sessions, we applied 
$129$DQG7XNH\¶VSRVWKRFWHVWWRFRPSDUHWKHSUHGLDO\VLVSRVWGLDO\VLVDQGthe 
mean values of the SBP, DBP, MBP, HR, SV, CO and TPR during the episode of 
severe hypertension.  
 A significant elevation was encountered in the SBP and MBP during the hypertension 
episode in comparison with the post dialysis readings. However, the DBP, HR, SV, 
CO and TPR remained stable during the hypertension episode. Also there were no 
significant changes between all pre and post dialysis haemodynamic variables in 
group 3 (Table 37).  
 
Table 37. Comparison between predialysis, post dialysis and the averaged values of 
haemodynamic variables during the hypertension episode of SBP greater than 180mmHg) 
(ANOVA and Tukey's post hoc test) (n = 4) 
Variable 
A 
Predialysis 
B 
mean value 
during episode 
C 
Post dialysis 
A 
vs. 
B 
A 
vs. 
C 
B 
vs. 
C 
SBP (mmHg) 177 (15) 196 (8) 151 (29) ns ns * 
MBP (mmHg) 111 (13) 129 (4)  101 (14) ns ns * 
DBP (mmHg) 83 (20) 94 (8) 73 (11) ns ns ns 
HR (bpm) 72 (5) 72 (11) 74 (7) ns ns ns 
SV (ml) 88 (37) 63 (18) 75 (34) ns ns ns 
CO (l/m) 6.3 (2.6) 4.4 (0.8) 5.7 (2.8) ns ns ns 
TPR (MU) 2.08 (2.3) 2.17 (0.42) 1.75 (1.47) ns ns ns  
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6.8.2.4 Comparison of pre and post dialysis haemodynamic variables in 
group 4 
 
In group 4, a comparison between the pre dialysis and post dialysis haemodynamic 
variables using a paired t test showed a significant decrease in SBP and SV, along 
with a significant increase in the HR. The DBP, MBP, CO and TPR remained 
unchanged (Table 38).  
 
Table 38. Comparison of pre and post dialysis haemodynamic variables in group 4 (paired t 
test) 
 Pre dialysis Post dialysis P value 
HR (bpm) 74 (11) 82 (13) 0.0034* 
SBP (mmHg) 135 (18) 122 (20) 0.016* 
MBP (mmHg) 96 (14) 90 (14) 0.0733 
DBP (mmHg) 75 (15) 71 (11) 0.2007 
SV (ml) 91 (37) 76 (32) 0.0131* 
CO (l/m) 6.7 (2.7) 6.1 (2.6) 0.1625 
TPR (MU) 1.2 (0.65) 1.1 (0.46) 0.5401 
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6.8.2.5 Comparison between group 3 and group 4 
 
Comparisons between group 3 and 4 in terms of the pre dialysis haemodynamic 
variables, post dialysis haemodynamic variables, age, inter-dialytic weight gain and 
vintage (number of years on haemodialysis) are displayed in tables 39 - 41. Both, 
the pre dialysis and the post dialysis SBP values were significantly higher in group 3 
than in group 4. None of the other comparisons showed significant differences. 
 
Table 39. Comparison of the predialysis haemodynamic variables in both groups (un-paired t 
test) 
Predialysis Group 3 
Hypertension 
Group 4 
No hypertension 
P value 
HR (bpm) 72 (5) 74 (11) 0.6348 
SBP (mmHg) 177 (15) 135 (18) 0.0002* 
MBP (mmHg) 111 (13) 96 (14) 0.0734 
DBP (mmHg) 83 (20) 75 (15) 0.3448 
SV (ml) 88 (37) 91 (37) 0.8751 
CO (l/m) 6.3 (2.6) 6.7 (2.7) 0.7869 
TPR (MU) 2.08 (2.3) 1.16 (0.65) 0.113 
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Table 40. Comparison of the post dialysis haemodynamic variables in both groups (un-paired t 
test) 
Post dialysis Group 3 
Hypertension 
Group 4 
No hypertension 
P value 
HR (bpm) 74 (7) 82 (13) 0.2497 
SBP (mmHg) 151 (29) 122 (20) 0.0213* 
MBP (mmHg) 101 (14) 90 (14) 0.1557 
DBP (mmHg) 73 (11) 71 (11) 0.7217 
SV (ml) 75 (34) 76 (32)  0.9238 
CO (l/m) 5.7 (2.8) 6.1 (2.6) 0.7661 
TPR (MU) 1.75 (1.47) 1.07 (0.846)  0.0804 
 
 
Table 41. Comparison of different factors for association with hypertensive episodes using an 
un-paired t test 
 Group 3 
Hypertension 
Group 4 
No hypertension 
P value 
Age (yrs) 74.5 (7.1) 58.8 (19.2) 0.1245 
Interdialytic wt. 
gain (Kg) 
1.88 (0.48) 1.88 (1.15) 0.9984 
Vintage (yrs) 2.4 (1.8) 2.4 (3.9) 0.9994 
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6.8.3 Discussion 
Hypertension is a major risk factor for cardiovascular disease.207  It is prevalent 
amongst chronic kidney disease patients, hence, the high incidence of cardiovascular 
disease in these patients.208, 209 The Joint National Committee on Prevention, 
Detection, Evaluation and Treatment of High Blood Pressure (JNC VII) defined 
K\SHUWHQVLRQDVDQ6%3PP+JDQGRUD'%3PP+JDQGLW
recommended to treat hypertension in chronic kidney disease patients to a target BP 
of < 130/80 mmHg.121  
Emerging evidence suggests that high predialysis BP and post-dialysis BP are 
associated with a high risk of mortality.209, 210 However, there is lack of data to 
assess the incidence and long term effects of hypertension during the course of 
conventional haemodialysis sessions, as this would have required intra-arterial 
catheterisation for continuous monitoring of the BP, which is an invasive procedure 
that is not routinely employed to avoid the risk of complications. As mentioned 
earlier, maintenance haemodialysis sessions, BP is monitored on intermittent basis 
2-3 times using the conventional NIBP devices, which may carry the risk of missing 
hypertensive events.  
We utilised a noninvasive continuous beat-by-beat haemodynamic monitor that 
works through a finger cuff in an attempt to gain a better insight of the exact 
incidence and magnitude of hypertension during the entire sessions of conventional 
haemodialysis. 
Our results showed that significant acute elevations in the BP were encountered 
during haemodialysis. The mean percentage elevation of the SBP, DBP and MBP from 
their baseline values during these acute BP elevations were 28%, 43% and 37% 
respectively. There was a statistically significant drop from baseline values of the 
corresponding SV and CO with a mean percentage change of 30% and 27% 
respectively, and a statistically significant elevation of the TPR from its baseline 
value with a mean percentage change of 136%. HR remained stable. 
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In this cohort of patients, 12%, 32% and 16% had an episode of more than 30% 
increase from baseline values of the SBP, DBP and MBP for more than 10 minutes 
respectively. 52% of the patients had an episode of SBP more than 160 mmHg for 
more than 10 minutes, and 16% had an episode of SBP more than 180 mmHg for 
more than 10 minutes. The mean (SD) duration when the BP was 30% higher than 
the baseline value was 22 (1.5), 44 (49) and 44 (34) minutes for the SBP, DBP and 
MBP respectively. The mean (SD) durations when the SBP was higher than 160 
mmHg and higher than 180 mmHg were 60 (55) and 79 (61) minutes respectively.  
As mentioned earlier we assigned our patients into 2 groups according to the 
incidence of episodes of SBP higher than 180 mmHg for 10 minutes into: group 3 
(hypertension episode group), and group 4 (no hypertension episode group).  
In group 3, a significant elevation was encountered in the SBP and MBP during the 
hypertension episode. However, the DBP, HR, SV, CO and TPR remained stable 
during the hypertension episode. Also there were no significant changes between all 
pre and post dialysis haemodynamic variables. 
In group 4, the post dialysis SBP and SV were significantly lower than their pre 
dialysis values, and the post dialysis HR was significantly higher than its pre dialysis 
value. However, the DBP, MBP, CO and TPR remained unchanged. The post dialysis 
drop in SBP which was associated with a drop in the SV in group 4, and the fact that 
in group 3 the SBP remained high even after dialysis, may serve as potential 
evidence that the severe hypertension episodes that were encountered in those 
patients during the haemodialysis sessions resulted from volume depletion. An issue 
of debate is that in group 3 the SV remained unchanged after haemodialysis induced 
further volume removal. This may be explained by an increased sympathetic 
stimulation with a resultant increased myocardial contractility in an attempt to keep 
the SV stable, as SV is dependent upon both, preload and myocardial contractility.  
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On comparing group 3 and group 4, we found that both, the pre dialysis and the 
post dialysis SBP values were significantly higher in group 3 than in group 4. These 
findings may further support our explanation of the cause of severe hypertension 
that is to be due to volume depletion, as the BP was higher in group 3 than in group 
4 from the start of haemodialysis and it has not improved by haemodialysis induced 
fluid removal, since it remained higher in group 3 till the end of haemodialysis.   
There were no significant differences between groups 3 and 4 in any of the other pre 
dialysis and post dialysis haemodynamic variables. Also, the age, inter-dialytic 
weight gain and the vintage on haemodialysis were not different in both groups. 
It should be mentioned that the Finometer in contrast with the NIBP monitors that 
are conventionally used during maintenance haemodialysis, has the merit of 
providing a more detailed insight of the haemodynamics, with the ability to record 
variables other than the BP and HR including, the SV, CO and TPR. This extra 
information about the haemodynamics may be implied by nephrologists for proper 
management of patients during haemodialysis in terms of hypertension and volume 
status adjustment, hence, preventing negative outcomes. 
There is lack of data to assess the incidence of hypertension during haemodialysis 
and its association with mortality. Nevertheless, the relationship between predialysis 
and post-dialysis hypertension, and cardiovascular morbidity and mortality has been 
reported in several studies.  
Zager and colleagues studied the effect of predialysis and post-dialysis elevated SBP 
and DBP on cardiovascular mortality in 5,433 patients on maintenance 
haemodialysis. Moderate elevation of the predialysis BP was encountered in 27% of 
their patients, and was defined as SBP 160-179 mmHg and DBP 110 mmHg or DBP 
100-109 mmHg and SBP < 180 mmHg. Moreover, the incidence of severe / very 
severe elevations of the pre-dialysis BP was 5%, and was GHILQHGDV6%3
PP+JDQGRU'%3mmHg. Their results also showed an increased incidence 
of mortality in association with severe post-dialysis hypertension. Pre-dialysis 
hypertension was not associated with an increased risk of mortality in their study.211 
Likewise, Foley and colleagues also reported an increased risk of mortality in 
association with a high post-dialysis SBP in 11,142 patients on maintenance 
haemodialysis.209  
In a bigger study sample of 16,959 patients on maintenance haemodialysis, Stidley 
and colleagues demonstrated an increased risk of mortality in association with a 
SUHGLDO\VLV6%3PP+J210  
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Further studies to confirm our findings of the high prevalence of intradialytic 
hypertension and to assess the effects intradialytic hypertension on morbidity and 
mortality are encouraged.  
 
6.8.4 Conclusion 
Significant elevations in the BP are commonly encountered, and are sustained for 
considerable periods during the course of maintenance haemodialysis.  
Acute hypertension can be explained by a significant decrease in the preload, which 
is over-corrected by a significant increase in the afterload.  
Episodes of sustained severe hypertension during haemodialysis can be explained by 
pre dialysis volume depletion.   
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6.9  Results: Assessment of the sensitivity of the 
conventional NIBP monitoring in detecting maximum 
changes in BP in comparison with the Finometer 
during maintenance haemodialysis 
 
In this section, we compared the ability of the conventional NIBP monitoring and the 
continuous noninvasive haemodynamic monitoring (Finometer) in detecting BP 
aberrations that occur during sessions of maintenance haemodialysis. 
6.9.1 Data handling and statistics 
 
We obtained the baseline SBP, DBP and MBP (NIBP1) readings and the post dialysis 
SBP, DBP and MBP (NIBP2) readings from master spreadsheet 2. We then obtained 
the SBP, DBP, MBP and +5UHDGLQJVGXULQJWKH)LQRPHWHU¶V%3SHDNVDQGWKH%3
troughs from master spreadsheets 3.  Master spreadsheets 2 and 3 are discussed in 
details in sections 6.3.2.4.2 and 6.3.2.4.3 respectively. 
We then transferred these readings to the Prism software and carried out 3 main 
comparisons using a paired t test. Initially, we compared the baseline NIBP (SBP, 
DBP and MBP) readings with their corresponding post dialysis NIBP (SBP, DBP and 
MBP) readings. We then compared the baseline NIBP (SBP, DBP and MBP) readings 
ZLWKWKH)LQRPHWHU¶VSBP, DBP and MBP readings during BP peaks, and the 
)LQRPHWHU¶VSBP, DBP and MBP readings during BP troughs. We also calculated the 
percentage changes of each of the post dialysis NIBP (SBP, DBP and MBP) readings, 
the SBP, DBP and MBP readings GXULQJWKH)LQRPHWHU¶V%3peaks and the SBP, DBP 
and MBP UHDGLQJVGXULQJWKH)LQRPHWHU¶V%3WURXJKV, from their corresponding SBP, 
DBP and MBP NIBP baseline values. 
The time lag between both the highest and the lowest blood pressure values 
recorded by the Finometer and their next available NIBP measurement, were 
obtained from master spreadsheet 3. 
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6.9.2 Results  
6.9.2.1 BP changes in response to haemodialysis as detected by the NIBP 
device 
 
We assessed the magnitude of changes in BP that were detected by the NIBP device 
by comparing its 2 sets of pre dialysis and post dialysis readings of SBP, DBP and 
MBP using a paired t test for each comparison. 
A statistically significant decrease in the post dialysis SBP was shown in comparison 
to the pre dialysis SBP, but no significant differences were shown between the post 
and pre dialysis readings of either of the DBP and MBP. 
7KHSHUFHQWDJHFKDQJHVRIWKH1,%3¶6SRVWGLDO\VLVUHDGLQJVIURPWKHLU
corresponding pre dialysis readings were 8%, 4% and 4% for the SBP, DBP and MBP 
respectively (table 42). 
 
Table 42. Comparison of the 2 sets of NIBP readings that were taken during the whole period 
of haemodialysis using a paired t test (n = 25)  
 
Baseline NIBP 1 
(pre dialysis 
reading) 
NIBP 2 (post 
dialysis reading) 
% change of NIBP 2 
from baseline NIBP 1 
P value 
SBP 
(mmHg) 
141 (25) 130 (23) 8 % 0.0479* 
DBP 
(mmHg) 
77 (13) 74 (10) 4 % 0.2802 
MBP 
(mmHg) 
97 (14) 93 (14) 4 % 0.2418 
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6.9.2.2 BP troughs detected by the Finometer during haemodialysis  
 
We assessed the absolute values of SBP, DBP and MBP during the maximum 
decrease (trough) in BP per patient as detected by the Finometer. Then we 
compared these values with their corresponding baseline NIBP values of SBP, DBP 
and MBP using a paired t test.  
7KH)LQRPHWHU¶V6%3'%3DQG0%3YDOXHVGXULQJWKH%3WURXJKZHUHDOOVLJQLILFDQWO\
lower than their corresponding baseline NIBP SBP, DBP and MBP values, equating to 
a 39%, 39% and 37% decrease respectively (table 43). 
Table 44 displays the time lag between the BP trough and the next available NIBP 
measurement, which was > 2 hours in 14 patients, 1 to 2 hours in 6 patients and 
less than 1 hour in 5 patients. The mean (SD) of the time lag between the BP trough 
and the next available NIBP measurement was 2 hours and 7 minutes. 
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Table 43. Percentage change of lowest BP readings (troughs) detected by the Finometer from 
baseline NIBP readings using a paired t test (n = 25) 
 Baseline NIBP1 
Trough 
Finometer 
% change of 
trough from 
baseline NIBP 
P value 
SBP (mmHg) 
141 (25) 86 (26) 39 % <0.0001* 
DBP (mmHg) 77 (13) 47 (11) 39 % <0.0001* 
MBP (mmHg) 97 (14) 61 (16) 37 % <0.0001* 
 
 
 
Table 44. Time lag between lowest blood pressure readings detected by the Finometer and 
next available NIBP readings 
Time lag < 1 hour 1-2 hours > 2 hours 
n of patients 
(n = 25) 
5 6 14 
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6.9.2.3 BP peaks detected by the Finometer during haemodialysis  
 
We also assessed the absolute values of SBP, DBP and MBP during the maximum 
increases in BP (peaks) per patient as detected by the Finometer. Then we 
compared these values with their corresponding baseline NIBP values of SBP, DBP 
and MBP using a paired t test.  
The FinomeWHU¶V6%3'%3DQG0%3YDOXHVGXULQJWKH%3SHDNZHUHDOOVLJQLILFDQWO\
higher than their corresponding baseline NIBP SBP, DBP and MBP values, equating to 
a 28%, 42% and 39% increase respectively (table 45). 
Table 46 displays the time lag between the BP trough and the next available NIBP 
measurement, which was > 2 hours in 14 patients, 1 to 2 hours in 4 patients and 
less than 1 hour in 7 patients. The mean (SD) of the time lag between the BP peak 
and the next available NIBP measurement was 2 hours and 13 minutes. 
  
 
 
211 
 
 
Table 45. Percentage change of highest BP readings (peaks) detected by the Finometer from 
baseline NIBP readings (n = 25)  
 Baseline 
NIBP1  
Peak Finometer 
% change of 
peak from 
baseline 
NIBP 
P value 
SBP (mmHg) 
141 (25) 180 (31) 28 % <0.0001* 
DBP (mmHg) 77 (13) 109 (23) 42 % <0.0001* 
MBP (mmHg) 97 (14) 135 (27) 39 % <0.0001* 
 
 
Table 46. Time lag between highest blood pressure readings detected by the Finometer and 
next available NIBP readings 
Time lag < 1 hour 1-2 hours > 2 hours 
n of patients 
(n = 25) 
7 4 14 
 
  
 
 
212 
 
 
6.9.3 Discussion 
As mentioned earlier, haemodynamic instability is not unlikely to occur during 
haemodialysis. This mainly is due to the removal of vast amounts of fluids from the 
circulation in a relatively short period of time. Also, hypertension is highly prevalent 
amongst patients on maintenance haemodialysis, to which they are usually 
prescribed vasodilator drugs such as ACEi and CCB.  These vasodilator drugs are 
known to DIIHFWWKHLQWHJULW\RIWKHSDWLHQWV¶ compensatory cardiovascular response 
to haemodialysis induced hypovolaemia.  
Theoretically, maintenance haemodialysis sessions would be best monitored by 
intra-arterial catheterisation. However, its routine use is not justified due to its 
invasive nature and the risk of complications. Routine haemodialysis sessions are 
conventionally monitored by the intermittent oscillometric NIBP devices, only 2-3 
measurements are usually taken during the whole 4 hour session of haemodialysis 
including a predialysis and a post-dialysis reading. This may carry the risk of missing 
BP aberrations especially that patients on maintenance haemodialysis are 
acclimatised to vast haemodynamic changes, which may cause those BP aberrations 
to be symptomless. Therefore, additional readings which are prompted by patient 
symptoms will not be attempted by the attending staff.     
We utilised an accurate noninvasive continuous beat-by-beat BP monitor that works 
through applying a finger cuff (Finometer) to test the sensitivity of the conventional 
NIBP devices in detecting BP aberrations. 
Our result showed that current practice of measuring NIBP is not reliable in detecting 
BP aberrations and that the Finometer provides a more comprehensive surveillance 
of the BP during maintenance haemodialysis.  
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As mentioned earlier, only 2 NIBP readings were taken for all our patients during the 
entire session of haemodialysis (a predialysis and a post-dialysis NIBP reading). This 
was because none of our patients had symptoms suggestive of hypotension; 
therefore, no extra NIBP measurements were attempted by the attending staff.  
NIBP detected an 8%, 4% and 4% decrease in the post-dialysis SBP, DBP and MBP 
readings from their corresponding baseline (predialysis) NIBP readings respectively. 
Only the change in the SBP showed statistical significance. However, this 8% change 
in the SBP is not considered of clinical importance. 
Continuous BP monitoring using the Finometer on the other hand detected 
statistically significant drops of 39%, 39% and 37% in SBP, DBP and MBP from 
baseline NIBP readings respectively, and statistically significant elevations of 28%, 
42% and 39% in SBP, DBP and MBP from baseline NIBP readings respectively. 
The mean time lag between BP troughs that were detected by the Finometer and 
their next available NIBP was 2 hours and 7 minutes, whereas the mean time lag 
between BP peaks that were detected by the Finometer and their next available NIBP 
was 2 hours and 13 minutes.    
As previously discussed, the policy in our haemodialysis unit in regards to the 
frequency of NIBP measurements, was to take a pre dialysis and a post dialysis 
measurement. Extra measurements were to be taken whenever the patient 
experiences symptoms suggestive of hypotension. Policies involving the frequency of 
NIBP measurements may be different in other units. Therefore, the applicability of 
our results may be questioned by the fact that only two NIBP readings (predialysis 
and a post-dialysis) were taken for all of our patients during their haemodialysis 
sessions, as none of our patients has experienced symptoms suggestive of 
hypotension, which would have prompted extra BP measurements to be taken.  
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Symptomless hypotension that was observed in all our patients who have developed 
intradialytic hypotension is possibly explained by the tolerance that patients on 
chronic haemodialysis might have gained to the vast haemodynamic changes that 
they are subjected to 3 times per week during their continuous haemodialysis 
sessions. 
There is lack of data in literature to describe the sensitivity of conventional NIBP in 
detecting BP aberrations during maintenance haemodialysis. Studies to explore this 
potential are warranted, due to its impact on patient safety. 
 
6.9.4 Conclusion 
Monitoring the BP noninvasively on continuous basis using the Finometer is more 
reliable than the conventionally used protocols of intermittent NIBP measurements 
during maintenance haemodialysis in detecting BP aberrations, especially that 
patients on chronic haemodialysis may have gained tolerance to hypotension, which 
may rather pass unnoticed.  
 
 
  
 
 
215 
 
 
6.10 Summary 
 
In this service evaluation, we aimed to assess the adequacy of patient safety 
provided by the conventionally used protocols of intermittent NIBP measurements 
during maintenance haemodialysis sessions, in a cohort of patients who as 
previously mentioned are known to have co-morbid conditions such as hypertension 
and autonomic neuropathy, and are on various medications including anti-
hypertensive drugs. These factors are likely to affect their compensatory 
cardiovascular responses to haemodialysis induced hypovolaemia, which normally 
keeps the blood pressure stable in response to hypovolaemia.  
In order to complete this assessment, we explored the following inter-related 
research issues:  
Firstly, we assessed the feasibility of using the Finometer for monitoring of 
maintenance haemodialysis by, evaluating the success rate of the Finometer in 
providing haemodynamic monitoring, and by comparing its BP measurements that 
were averaged over 10 second intervals with those obtained by the NIBP monitors 
during maintenance haemodialysis. Our results showed that adequate Finometer 
recordings were generated in 86% of cases, and that the Finometer is accurate in 
terms of BP monitoring. Hence, the Finometer is a feasible option for BP monitoring 
during maintenance haemodialysis. 
Secondly, we assessed the gross haemodynamic changes that occur in response to 
haemodialysis. Our results showed that a significant drop in the SBP and MBP was 
encountered post-dialysis; this was accompanied by a significant drop in the SV and 
CO, and a significant rise in the HR. TPR remained unchanged. It was also shown 
that there was inter-patient variability in terms of the timing and magnitude of 
haemodynamic responses to haemodialysis.  
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Thirdly, we assessed the incidence, magnitude and duration of significant 
hypotension during maintenance haemodialysis, and we identified the corresponding 
changes in other haemodynamic variables too. Our results showed that during 
maintenance haemodialysis, the BP acutely dropped to significantly low values, 
which were associated with significant drops in SV and CO, TPR and HR remained 
stable. Sustained hypotension episodes of SBP less than 90 mmHg for more than 10 
minutes were encountered in 28% of our patients, and there were no associated 
significant changes in any of the HR, SV, CO and TPR, indicating a total failure of the 
compensatory cardiovascular mechanisms to haemodialysis induced hypovolaemia. 
The compensatory cardiovascular mechanisms to haemodialysis induced 
hypovolaemia are discussed in details in section 2.2.3.   
As previously mentioned, we have assigned the patients into two groups according 
to the incidence of hypotension episodes of SBP less than 90 mmHg for more than 
10 minutes into group 1 (hypotension episode group) and group 2 (no hypotension 
episode group). No statistical significant differences were shown on comparing 
groups 1 and 2 in terms of predialysis and post-dialysis haemodynamic variables, or 
any of the patient characteristics. However, in this small sample size a trend of 
difference was shown in the predialysis SV in both groups. The mean (SD) SV for 
groups 1 and 2 was 70 (29) and 99 (37) ml respectively; p = 0.08. These results are 
subject to type 2 error, and they could give an indication of the likelihood of 
differences between the 2 groups, hence, they may help in future sample size 
calculations.  
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Fourthly, we assessed the incidence, magnitude and duration of significant 
hypertension during maintenance haemodialysis, and we identified the 
corresponding changes in other haemodynamic variables as well. Our results showed 
that significant acute BP elevations were encountered during haemodialysis, which 
were associated with a decreased SV and CO, along with a significantly increased 
TPR and a stable HR. We also demonstrated that sustained moderate to severe 
hypertension (SBP more than 160 mmHg) for more than 10 minutes occurred in 
52% of the patients, and that sustained severe hypertension (SBP more than 180 
mmHg) for more than 10 minutes occurred in 16% of the patients.  
As discussed earlier, we have assigned the 25 patients into two further groups 
according to the incidence of severe hypertension episodes of SBP more than 180 
mmHg for more than 10 minutes into group 3 (hypertension episode group) and 
group 4 (no hypertension episode group). In group 3, a significant elevation was 
encountered in the SBP and MBP during the hypertension episode. However, the 
DBP, HR, SV, CO and TPR remained stable during the hypertension episode. Also 
there were no significant changes between all pre and post dialysis haemodynamic 
variables. 
Fifthly, we assessed the sensitivity of the conventional NIBP devices in detecting BP 
aberrations that are encountered during maintenance haemodialysis in comparison 
to the Finometer. We found that the NIBP conventionally set to take 2-3 readings 
during the haemodialysis session, was oblivious to all BP aberrations that were 
detected by the Finometer. It is also worth mentioning that 2 of our patients (patient 
14 and 22) suffered both, an intradialytic hypotension episode of SBP < 90 mmHg 
and an intradialytic hypertension episode with SBP > 160 mmHg for more than 10 
minutes in the same haemodialysis session. 
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Owing to our results and to the fact that both, intradialytic hypotension and 
hypertension are associated with poor patient outcomes 6, 204-206, 209, 210, it is obvious 
that the conventional NIBP monitors do not provide adequate patient safety during 
maintenance haemodialysis sessions, and that noninvasive continuous 
haemodynamic monitoring by the Finometer provides a safer option to maintenance 
haemodialysis patients.  
We have also demonstrated a failed cardiovascular response to haemodialysis 
induced hypovolaemia with resultant hypotension. This was explained by the failed 
TPR response to haemodialysis induced hypovolaemia that was shown during both, 
the acute drops in BP and the intradialytic hypotension episodes.  
We believe that the ability of the Finometer to give a better insight of the 
haemodynamic changes that occur at the time of intradialytic BP aberrations, may 
aid physicians to understand the patho-physiology behind those BP aberrations in 
cohorts of patients on chronic haemodialysis, subsequently, enabling the early 
detection and appropriate targeted management of those haemodynamic mishaps.  
The major limitation to our work was the small sample size. As mentioned earlier, 
we have been granted ethics approval to perform an observational study, which will 
be a continuation of our work on a bigger scale.   
In conclusion, continuous haemodynamic monitoring offers a safer option for 
patients on regular haemodialysis than conventional NIBP monitoring, through better 
detection of the frequently occurring BP aberrations and through aiding to diagnose 
their cause, hence, giving the physicians a better chance for prompt and proper 
management of these BP aberrations. 
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7 General discussion and conclusion 
 
Induction of anaesthesia and haemodialysis are two clinical settings where vast 
changes in the haemodynamics are likely to occur, due to the introduction of drugs 
and techniques that have direct effects on the cardiovascular system in the former, 
DQGGXHWRWKHUHPRYDORIODUJHYROXPHVRIIOXLGVIURPWKHSDWLHQWV¶FLUFXODWLRQLQD
short period of time in the latter. 
We tested the adequacy of current practice of BP measurement protocols in clinical 
settings of routine induction of anaesthesia and maintenance haemodialysis. This 
was accomplished by the following:  
Initially, we assessed the feasibility of using the Finometer in both clinical settings of 
induction of anaesthesia and haemodialysis, by assessing its success rate in 
monitoring the BP and by comparing its measurements with those obtained by the 
conventional NIBP monitors for accuracy. Our results showed that the Finometer was 
successful and accurate in both our evaluations of induction of anaesthesia and 
haemodialysis, reflecting its feasibility for use in cohorts of patients undergoing 
routine induction of anaesthesia and maintenance haemodialysis.  
Using the Finometer for haemodynamic monitoring during routine induction of 
anaesthesia and maintenance haemodialysis, we assessed the incidence, magnitude 
and duration of both, hypotension episodes and hypertension episodes. As 
mentioned earlier, both, significant hypotension and significant hypertension 
episodes that are encountered in anaesthesia and haemodialysis are known to be 
associated with poor patient outcomes. We found a high incidence of both significant 
hypotension and hypertension in induction of anaesthesia and haemodialysis. 
Furthermore, with the Finometer having the merit of recording haemodynamic 
variables such as the HR, SV, CO and TPR, we were able to obtain extra information 
about the patho-physiology of such BP aberrations. 
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We further assessed the sensitivity of the conventional intermittent NIBP devices in 
detecting the maximum changes in BP that occurred during routine induction of 
anaesthesia and maintenance haemodialysis in comparison with continuous 
noninvasive BP monitoring using the Finometer. It needs to be mentioned that we 
did not interfere with the frequency of the NIBP measurements that was 
predetermined by the attending anaesthetists or nephrologists. Our results clearly 
demonstrated that in cohorts of patients undergoing induction of anaesthesia and 
maintenance haemodialysis, where major haemodynamic changes are likely to 
occur, continuous noninvasive BP monitoring using the Finometer is superior to 
conventional intermittent NIBP measurement protocols in detecting BP aberrations.  
In conclusion, significant episodes of both, hypotension and hypertension commonly 
occur in routine induction of anaesthesia and maintenance haemodialysis. 
Continuous haemodynamic monitoring by the Finometer is more reliable than the 
conventionally used protocols of intermittent NIBP measurements in detecting these 
changes. The Finometer also provides extra haemodynamic information that can be 
used in pinning out the exact haemodynamic patho-physiology behind these BP 
aberrations.  
These findings clearly suggest that continuous noninvasive haemodynamic 
monitoring using the Finometer is a safer option to patients undergoing routine 
induction of anaesthesia and maintenance haemodialysis than the conventional BP 
measurement protocols that involve BP measurements taken intermittently using 
NIBP devices.  
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8 Future directions 
 
This thesis demonstrated that continuous noninvasive finger arterial pressure 
monitoring is feasible in cohorts of patients undergoing induction of anaesthesia and 
maintenance haemodialysis. Moreover, it was demonstrated that its use during 
induction of anaesthesia and maintenance haemodialysis may help improve the 
quality of patient care provided.  
Our findings in this thesis have generated several related hypotheses and 
unanswered questions, which are discussed in the following sections.  
8.1 Use of the Finometer in operating theatres 
 
We assessed the feasibility of using the Finometer solely during the period of 
induction of anaesthesia. We have specifically chosen the time of induction of 
anaesthesia as we anticipated that major haemodynamic changes would occur, as a 
resultant of the simultaneous administration of several drugs and the employment of 
different techniques in a short period of time, which all have a direct effect on the 
cardiovascular system.  
Further to our findings, an assessment of the feasibility of using the Finometer 
during the whole surgical procedure is warranted and we suggest that it includes the 
following: 
o An assessment of the accuracy of the Finometer in terms of CO monitoring 
in comparison with a validated CO measurement technique. 
o An assessment of whether if extra information provided by the Finometer 
can be used for fluid optimisation prior to surgery, and the impact of this on 
haemodynamic stability during anaesthesia.  
As discussed in section 5.8, we used the Finometer to haemodynamically monitor 
one patient during the whole period of general anaesthesia in an attempt to illustrate 
the importance of running a service evaluation / study that assesses the feasibility of 
using the Finometer during the whole period of anaesthesia.  
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8.2 Use of the Finometer in haemodialysis  
As previously mentioned, our findings in regards to the patients undergoing 
maintenance haemodialysis are limited by the small sample size. We were obliged to 
terminate our service evaluation and seek ethics approval after showing results that 
involved patient safety issues. However, we have been granted ethics approval for 
running an observational study, which will be a continuation of our assessment of 
the adequacy of patient safety provided by the currently used NIBP devices in 
maintenance haemodialysis on a bigger scale. We are currently in the process of 
collecting data. 
We recommend the adoption of a study aiming to assess if patients who had an 
episode of hypotension respond in the same way in successive sessions. Also, to 
assess if the haemodynamic response of patients who have DM differs from that of 
those who do not have DM. 
Lastly, a study to assess the effect of haemodialysis on endothelial function is 
encouraged. 
  
 
 
223 
 
8.3 Use of the Finometer in intensive care units 
The feasibility of using the Finometer in critically ill patients is an area that needs to 
be explored. Hypothetically, if the Finometer was found feasible, it would help save 
valuable time and effort, due to the fact that it is reliable and easily applicable in a 
few minutes.  
In patients who require invasive haemodynamic monitoring, it may be used 
temporarily to bridge the time period when lengthy invasive procedures are being 
installed to the patient. Moreover, its use in patients who are more stable may help 
avoid complications and extra costs of invasive procedures.  
We recommend that the assessment of the feasibility of the Finometer in critically ill 
patients includes the following: 
o An assessment of the success rate of the Finometer in generating 
haemodynamic recordings, especially that the critically ill patients have a high 
incidence of shock and vasoconstricted extremities. As mentioned earlier, 
YDVRFRQVWULFWHGH[WUHPLWLHVPD\DIIHFWWKHDELOLW\RIWKH)LQRPHWHU¶VSXOVH
plethysmograph to detect a pulse waveform from the finger. 
o An assessment of the accuracy of the Finometer in terms of BP monitoring in 
comparison with the intra-arterial measurements. 
o An assessment of the accuracy of the Finometer in terms of CO monitoring in 
comparison with a validated CO measurement technique.
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